id	sid	tid	token	lemma	pos
cuesj-1226	1	1	tx_1	tx_1	PROPN
cuesj-1226	1	2	~	~	X
cuesj-1226	1	3	abs	ab	NOUN
cuesj-1226	1	4	:	:	PUNCT
cuesj-1226	1	5	at	at	ADP
cuesj-1226	1	6	/	/	SYM
cuesj-1226	1	7	add	add	VERB
cuesj-1226	1	8	:	:	PUNCT
cuesj-1226	1	9	tx_2	tx_2	PROPN
cuesj-1226	1	10	~	~	NOUN
cuesj-1226	1	11	abs	ab	NOUN
cuesj-1226	1	12	:	:	PUNCT
cuesj-1226	1	13	at	at	ADP
cuesj-1226	1	14	31	31	NUM
cuesj-1226	1	15	http://journals.cihanuniversity.edu.iq/index.php/cuesj	http://journals.cihanuniversity.edu.iq/index.php/cuesj	ADJ
cuesj-1226	1	16	cuesj	cuesj	ADJ
cuesj-1226	1	17	2024	2024	NUM
cuesj-1226	1	18	,	,	PUNCT
cuesj-1226	1	19	8	8	NUM
cuesj-1226	1	20	(	(	PUNCT
cuesj-1226	1	21	2	2	NUM
cuesj-1226	1	22	):	):	PUNCT
cuesj-1226	1	23	31	31	NUM
cuesj-1226	1	24	-	-	SYM
cuesj-1226	1	25	35	35	NUM
cuesj-1226	1	26	research	research	NOUN
cuesj-1226	1	27	article	article	NOUN
cuesj-1226	1	28	vitamin	vitamin	NOUN
cuesj-1226	1	29	d	d	PROPN
cuesj-1226	1	30	levels	level	NOUN
cuesj-1226	1	31	in	in	ADP
cuesj-1226	1	32	coronavirus	coronavirus	NOUN
cuesj-1226	1	33	-	-	PUNCT
cuesj-1226	1	34	infected	infect	VERB
cuesj-1226	1	35	individuals	individual	NOUN
cuesj-1226	1	36	and	and	CCONJ
cuesj-1226	1	37	its	its	PRON
cuesj-1226	1	38	correlation	correlation	NOUN
cuesj-1226	1	39	with	with	ADP
cuesj-1226	1	40	certain	certain	ADJ
cuesj-1226	1	41	hematological	hematological	ADJ
cuesj-1226	1	42	markers	marker	NOUN
cuesj-1226	2	1	muhsin	muhsin	PROPN
cuesj-1226	2	2	h.	h.	PROPN
cuesj-1226	2	3	ubeid1	ubeid1	PROPN
cuesj-1226	2	4	,	,	PUNCT
cuesj-1226	2	5	ameena	ameena	PROPN
cuesj-1226	2	6	s.	s.	PROPN
cuesj-1226	2	7	m.	m.	PROPN
cuesj-1226	2	8	juma2	juma2	PROPN
cuesj-1226	2	9	,	,	PUNCT
cuesj-1226	2	10	shakir	shakir	PROPN
cuesj-1226	2	11	m.	m.	PROPN
cuesj-1226	2	12	al	al	PROPN
cuesj-1226	2	13	-	-	PUNCT
cuesj-1226	2	14	awqati3	awqati3	PROPN
cuesj-1226	2	15	,	,	PUNCT
cuesj-1226	2	16	tanya	tanya	PROPN
cuesj-1226	2	17	s.	s.	PROPN
cuesj-1226	2	18	salih4	salih4	PROPN
cuesj-1226	2	19	,	,	PUNCT
cuesj-1226	2	20	muhamed	muhamed	PROPN
cuesj-1226	2	21	a.	a.	NOUN
cuesj-1226	2	22	abbas5	abbas5	PROPN
cuesj-1226	3	1	1department	1department	NUM
cuesj-1226	3	2	of	of	ADP
cuesj-1226	3	3	anesthesia	anesthesia	PROPN
cuesj-1226	3	4	technologies	technology	NOUN
cuesj-1226	3	5	,	,	PUNCT
cuesj-1226	3	6	cihan	cihan	VERB
cuesj-1226	3	7	university	university	NOUN
cuesj-1226	3	8	-	-	PUNCT
cuesj-1226	3	9	erbil	erbil	PROPN
cuesj-1226	3	10	,	,	PUNCT
cuesj-1226	3	11	kurdistan	kurdistan	PROPN
cuesj-1226	3	12	region	region	NOUN
cuesj-1226	3	13	,	,	PUNCT
cuesj-1226	3	14	iraq	iraq	PROPN
cuesj-1226	3	15	,	,	PUNCT
cuesj-1226	3	16	2department	2department	NUM
cuesj-1226	3	17	of	of	ADP
cuesj-1226	3	18	medical	medical	ADJ
cuesj-1226	3	19	microbiology	microbiology	NOUN
cuesj-1226	3	20	,	,	PUNCT
cuesj-1226	3	21	college	college	NOUN
cuesj-1226	3	22	of	of	ADP
cuesj-1226	3	23	science	science	NOUN
cuesj-1226	3	24	,	,	PUNCT
cuesj-1226	3	25	cihan	cihan	VERB
cuesj-1226	3	26	university	university	NOUN
cuesj-1226	3	27	-	-	PUNCT
cuesj-1226	3	28	erbil	erbil	PROPN
cuesj-1226	3	29	,	,	PUNCT
cuesj-1226	3	30	kurdistan	kurdistan	PROPN
cuesj-1226	3	31	region	region	NOUN
cuesj-1226	3	32	,	,	PUNCT
cuesj-1226	3	33	iraq	iraq	PROPN
cuesj-1226	3	34	,	,	PUNCT
cuesj-1226	3	35	3department	3department	NUM
cuesj-1226	3	36	of	of	ADP
cuesj-1226	3	37	anesthesia	anesthesia	PROPN
cuesj-1226	3	38	technologies	technology	NOUN
cuesj-1226	3	39	,	,	PUNCT
cuesj-1226	3	40	college	college	NOUN
cuesj-1226	3	41	of	of	ADP
cuesj-1226	3	42	science	science	NOUN
cuesj-1226	3	43	,	,	PUNCT
cuesj-1226	3	44	cihan	cihan	VERB
cuesj-1226	3	45	university	university	NOUN
cuesj-1226	3	46	-	-	PUNCT
cuesj-1226	3	47	erbil	erbil	PROPN
cuesj-1226	3	48	,	,	PUNCT
cuesj-1226	3	49	kurdistan	kurdistan	PROPN
cuesj-1226	3	50	region	region	NOUN
cuesj-1226	3	51	,	,	PUNCT
cuesj-1226	3	52	iraq	iraq	PROPN
cuesj-1226	3	53	,	,	PUNCT
cuesj-1226	3	54	4department	4department	NUM
cuesj-1226	3	55	of	of	ADP
cuesj-1226	3	56	physiotherapy	physiotherapy	NOUN
cuesj-1226	3	57	,	,	PUNCT
cuesj-1226	3	58	college	college	NOUN
cuesj-1226	3	59	of	of	ADP
cuesj-1226	3	60	health	health	PROPN
cuesj-1226	3	61	technology	technology	NOUN
cuesj-1226	3	62	,	,	PUNCT
cuesj-1226	3	63	cihan	cihan	VERB
cuesj-1226	3	64	university	university	NOUN
cuesj-1226	3	65	-	-	PUNCT
cuesj-1226	3	66	erbil	erbil	PROPN
cuesj-1226	3	67	,	,	PUNCT
cuesj-1226	3	68	kurdistan	kurdistan	PROPN
cuesj-1226	3	69	region	region	NOUN
cuesj-1226	3	70	,	,	PUNCT
cuesj-1226	3	71	iraq	iraq	PROPN
cuesj-1226	3	72	,	,	PUNCT
cuesj-1226	3	73	5college	5college	PROPN
cuesj-1226	3	74	of	of	ADP
cuesj-1226	3	75	pharmacy	pharmacy	NOUN
cuesj-1226	3	76	,	,	PUNCT
cuesj-1226	3	77	cihan	cihan	VERB
cuesj-1226	3	78	university	university	NOUN
cuesj-1226	3	79	-	-	PUNCT
cuesj-1226	3	80	erbil	erbil	PROPN
cuesj-1226	3	81	,	,	PUNCT
cuesj-1226	3	82	kurdistan	kurdistan	ADJ
cuesj-1226	3	83	region	region	NOUN
cuesj-1226	3	84	,	,	PUNCT
cuesj-1226	3	85	iraq	iraq	PROPN
cuesj-1226	3	86	abstract	abstract	VERB
cuesj-1226	3	87	the	the	DET
cuesj-1226	3	88	world	world	NOUN
cuesj-1226	3	89	and	and	CCONJ
cuesj-1226	3	90	nearly	nearly	ADV
cuesj-1226	3	91	all	all	DET
cuesj-1226	3	92	our	our	PRON
cuesj-1226	3	93	health	health	NOUN
cuesj-1226	3	94	-	-	PUNCT
cuesj-1226	3	95	care	care	NOUN
cuesj-1226	3	96	systems	system	NOUN
cuesj-1226	3	97	were	be	AUX
cuesj-1226	3	98	confronted	confront	VERB
cuesj-1226	3	99	by	by	ADP
cuesj-1226	3	100	a	a	DET
cuesj-1226	3	101	significant	significant	ADJ
cuesj-1226	3	102	threat	threat	NOUN
cuesj-1226	3	103	declared	declare	VERB
cuesj-1226	3	104	by	by	ADP
cuesj-1226	3	105	the	the	DET
cuesj-1226	3	106	severe	severe	ADJ
cuesj-1226	3	107	acute	acute	ADJ
cuesj-1226	3	108	respiratory	respiratory	ADJ
cuesj-1226	3	109	syndrome	syndrome	NOUN
cuesj-1226	3	110	coronavirus-2	coronavirus-2	NUM
cuesj-1226	3	111	(	(	PUNCT
cuesj-1226	3	112	sars	sar	NOUN
cuesj-1226	3	113	-	-	PUNCT
cuesj-1226	3	114	cov-2	cov-2	NOUN
cuesj-1226	3	115	)	)	PUNCT
cuesj-1226	3	116	.	.	PUNCT
cuesj-1226	4	1	determining	determine	VERB
cuesj-1226	4	2	the	the	DET
cuesj-1226	4	3	sars	sar	NOUN
cuesj-1226	4	4	-	-	PUNCT
cuesj-1226	4	5	cov-2	cov-2	NOUN
cuesj-1226	4	6	or	or	CCONJ
cuesj-1226	4	7	covid-19	covid-19	PROPN
cuesj-1226	4	8	’s	’s	PART
cuesj-1226	4	9	prognostic	prognostic	ADJ
cuesj-1226	4	10	and	and	CCONJ
cuesj-1226	4	11	modifiable	modifiable	ADJ
cuesj-1226	4	12	measures	measure	NOUN
cuesj-1226	4	13	surely	surely	ADV
cuesj-1226	4	14	would	would	AUX
cuesj-1226	4	15	largely	largely	ADV
cuesj-1226	4	16	contribute	contribute	VERB
cuesj-1226	4	17	to	to	PART
cuesj-1226	4	18	outcome	outcome	VERB
cuesj-1226	4	19	improvement	improvement	NOUN
cuesj-1226	4	20	despite	despite	SCONJ
cuesj-1226	4	21	the	the	DET
cuesj-1226	4	22	deficiency	deficiency	NOUN
cuesj-1226	4	23	of	of	ADP
cuesj-1226	4	24	causative	causative	ADJ
cuesj-1226	4	25	therapy	therapy	NOUN
cuesj-1226	4	26	that	that	PRON
cuesj-1226	4	27	affected	affect	VERB
cuesj-1226	4	28	nearly	nearly	ADV
cuesj-1226	4	29	200	200	NUM
cuesj-1226	4	30	million	million	NUM
cuesj-1226	4	31	people	people	NOUN
cuesj-1226	4	32	,	,	PUNCT
cuesj-1226	4	33	3.5	3.5	NUM
cuesj-1226	4	34	million	million	NUM
cuesj-1226	4	35	fatal	fatal	ADJ
cuesj-1226	4	36	incidences	incidence	NOUN
cuesj-1226	4	37	,	,	PUNCT
cuesj-1226	4	38	and	and	CCONJ
cuesj-1226	4	39	it	it	PRON
cuesj-1226	4	40	is	be	AUX
cuesj-1226	4	41	still	still	ADV
cuesj-1226	4	42	airborne	airborne	ADJ
cuesj-1226	4	43	.	.	PUNCT
cuesj-1226	5	1	the	the	DET
cuesj-1226	5	2	research	research	NOUN
cuesj-1226	5	3	examined	examine	VERB
cuesj-1226	5	4	probable	probable	ADJ
cuesj-1226	5	5	relations	relation	NOUN
cuesj-1226	5	6	between	between	ADP
cuesj-1226	5	7	the	the	DET
cuesj-1226	5	8	levels	level	NOUN
cuesj-1226	5	9	of	of	ADP
cuesj-1226	5	10	vitamin	vitamin	NOUN
cuesj-1226	5	11	d	d	NOUN
cuesj-1226	5	12	(	(	PUNCT
cuesj-1226	5	13	vitd	vitd	NOUN
cuesj-1226	5	14	)	)	PUNCT
cuesj-1226	5	15	and	and	CCONJ
cuesj-1226	5	16	immunological	immunological	ADJ
cuesj-1226	5	17	markers	marker	NOUN
cuesj-1226	5	18	.	.	PUNCT
cuesj-1226	6	1	hence	hence	ADV
cuesj-1226	6	2	,	,	PUNCT
cuesj-1226	6	3	a	a	DET
cuesj-1226	6	4	sample	sample	NOUN
cuesj-1226	6	5	of	of	ADP
cuesj-1226	6	6	200	200	NUM
cuesj-1226	6	7	lecturers	lecturer	NOUN
cuesj-1226	6	8	and	and	CCONJ
cuesj-1226	6	9	students	student	NOUN
cuesj-1226	6	10	from	from	ADP
cuesj-1226	6	11	cihan	cihan	ADP
cuesj-1226	6	12	university	university	NOUN
cuesj-1226	6	13	-	-	PUNCT
cuesj-1226	6	14	erbil	erbil	PROPN
cuesj-1226	6	15	were	be	AUX
cuesj-1226	6	16	assigned	assign	VERB
cuesj-1226	6	17	(	(	PUNCT
cuesj-1226	6	18	150	150	NUM
cuesj-1226	6	19	 	 	SPACE
cuesj-1226	6	20	males	male	NOUN
cuesj-1226	6	21	and	and	CCONJ
cuesj-1226	6	22	50	50	NUM
cuesj-1226	6	23	  	  	SPACE
cuesj-1226	6	24	females	female	NOUN
cuesj-1226	6	25	)	)	PUNCT
cuesj-1226	6	26	,	,	PUNCT
cuesj-1226	6	27	aged	aged	ADJ
cuesj-1226	6	28	22–25	22–25	NUM
cuesj-1226	6	29	,	,	PUNCT
cuesj-1226	6	30	with	with	ADP
cuesj-1226	6	31	some	some	DET
cuesj-1226	6	32	respondents	respondent	NOUN
cuesj-1226	6	33	being	be	AUX
cuesj-1226	6	34	treated	treat	VERB
cuesj-1226	6	35	for	for	ADP
cuesj-1226	6	36	a	a	DET
cuesj-1226	6	37	previous	previous	ADJ
cuesj-1226	6	38	covid-19	covid-19	PROPN
cuesj-1226	6	39	infection	infection	NOUN
cuesj-1226	6	40	.	.	PUNCT
cuesj-1226	7	1	the	the	DET
cuesj-1226	7	2	results	result	NOUN
cuesj-1226	7	3	showed	show	VERB
cuesj-1226	7	4	that	that	SCONJ
cuesj-1226	7	5	98	98	NUM
cuesj-1226	7	6	(	(	PUNCT
cuesj-1226	7	7	or	or	CCONJ
cuesj-1226	7	8	49	49	NUM
cuesj-1226	7	9	%	%	NOUN
cuesj-1226	7	10	)	)	PUNCT
cuesj-1226	7	11	of	of	ADP
cuesj-1226	7	12	the	the	DET
cuesj-1226	7	13	200	200	NUM
cuesj-1226	7	14	 	 	SPACE
cuesj-1226	7	15	samples	sample	NOUN
cuesj-1226	7	16	had	have	VERB
cuesj-1226	7	17	covid-19	covid-19	PROPN
cuesj-1226	7	18	infection	infection	NOUN
cuesj-1226	7	19	.	.	PUNCT
cuesj-1226	8	1	males	male	NOUN
cuesj-1226	8	2	60/98	60/98	NUM
cuesj-1226	8	3	had	have	VERB
cuesj-1226	8	4	a	a	DET
cuesj-1226	8	5	greater	great	ADJ
cuesj-1226	8	6	prevalence	prevalence	NOUN
cuesj-1226	8	7	rate	rate	NOUN
cuesj-1226	8	8	(	(	PUNCT
cuesj-1226	8	9	61	61	NUM
cuesj-1226	8	10	%	%	NOUN
cuesj-1226	8	11	)	)	PUNCT
cuesj-1226	8	12	,	,	PUNCT
cuesj-1226	8	13	while	while	SCONJ
cuesj-1226	8	14	females	female	NOUN
cuesj-1226	8	15	38/98	38/98	NUM
cuesj-1226	8	16	had	have	VERB
cuesj-1226	8	17	a	a	DET
cuesj-1226	8	18	lower	low	ADJ
cuesj-1226	8	19	rate	rate	NOUN
cuesj-1226	8	20	(	(	PUNCT
cuesj-1226	8	21	39	39	NUM
cuesj-1226	8	22	%	%	NOUN
cuesj-1226	8	23	)	)	PUNCT
cuesj-1226	8	24	.	.	PUNCT
cuesj-1226	9	1	according	accord	VERB
cuesj-1226	9	2	to	to	ADP
cuesj-1226	9	3	immunological	immunological	ADJ
cuesj-1226	9	4	elisa	elisa	NOUN
cuesj-1226	9	5	results	result	NOUN
cuesj-1226	9	6	,	,	PUNCT
cuesj-1226	9	7	every	every	DET
cuesj-1226	9	8	patient	patient	NOUN
cuesj-1226	9	9	had	have	VERB
cuesj-1226	9	10	positive	positive	ADJ
cuesj-1226	9	11	igg	igg	NOUN
cuesj-1226	9	12	antibodies	antibody	NOUN
cuesj-1226	9	13	and	and	CCONJ
cuesj-1226	9	14	negative	negative	ADJ
cuesj-1226	9	15	igm	igm	PROPN
cuesj-1226	9	16	antibodies	antibodie	VERB
cuesj-1226	9	17	.	.	PUNCT
cuesj-1226	10	1	compared	compare	VERB
cuesj-1226	10	2	to	to	ADP
cuesj-1226	10	3	the	the	DET
cuesj-1226	10	4	healthy	healthy	ADJ
cuesj-1226	10	5	group	group	NOUN
cuesj-1226	10	6	,	,	PUNCT
cuesj-1226	10	7	the	the	DET
cuesj-1226	10	8	serum	serum	NOUN
cuesj-1226	10	9	levels	level	NOUN
cuesj-1226	10	10	of	of	ADP
cuesj-1226	10	11	ige	ige	PROPN
cuesj-1226	10	12	rose	rise	VERB
cuesj-1226	10	13	considerably	considerably	ADV
cuesj-1226	10	14	in	in	ADP
cuesj-1226	10	15	covid-19	covid-19	PROPN
cuesj-1226	10	16	 	 	SPACE
cuesj-1226	10	17	patients	patient	NOUN
cuesj-1226	10	18	.	.	PUNCT
cuesj-1226	11	1	however	however	ADV
cuesj-1226	11	2	,	,	PUNCT
cuesj-1226	11	3	compared	compare	VERB
cuesj-1226	11	4	to	to	ADP
cuesj-1226	11	5	the	the	DET
cuesj-1226	11	6	healthy	healthy	ADJ
cuesj-1226	11	7	group	group	NOUN
cuesj-1226	11	8	,	,	PUNCT
cuesj-1226	11	9	the	the	DET
cuesj-1226	11	10	serum	serum	NOUN
cuesj-1226	11	11	level	level	NOUN
cuesj-1226	11	12	of	of	ADP
cuesj-1226	11	13	vitamin	vitamin	NOUN
cuesj-1226	11	14	d3	d3	PROPN
cuesj-1226	11	15	in	in	ADP
cuesj-1226	11	16	the	the	DET
cuesj-1226	11	17	covid-19	covid-19	PROPN
cuesj-1226	11	18	-	-	PUNCT
cuesj-1226	11	19	recovered	recover	VERB
cuesj-1226	11	20	patients	patient	NOUN
cuesj-1226	11	21	showed	show	VERB
cuesj-1226	11	22	a	a	DET
cuesj-1226	11	23	considerable	considerable	ADJ
cuesj-1226	11	24	reduction	reduction	NOUN
cuesj-1226	11	25	.	.	PUNCT
cuesj-1226	12	1	the	the	DET
cuesj-1226	12	2	mean	mean	ADJ
cuesj-1226	12	3	results	result	NOUN
cuesj-1226	12	4	for	for	ADP
cuesj-1226	12	5	hematological	hematological	ADJ
cuesj-1226	12	6	parameters	parameter	NOUN
cuesj-1226	12	7	indicated	indicate	VERB
cuesj-1226	12	8	a	a	DET
cuesj-1226	12	9	non	non	ADJ
cuesj-1226	12	10	-	-	ADJ
cuesj-1226	12	11	significant	significant	ADJ
cuesj-1226	12	12	increase	increase	NOUN
cuesj-1226	12	13	in	in	ADP
cuesj-1226	12	14	the	the	DET
cuesj-1226	12	15	number	number	NOUN
cuesj-1226	12	16	of	of	ADP
cuesj-1226	12	17	red	red	ADJ
cuesj-1226	12	18	blood	blood	NOUN
cuesj-1226	12	19	cells	cell	NOUN
cuesj-1226	12	20	relative	relative	ADJ
cuesj-1226	12	21	to	to	ADP
cuesj-1226	12	22	the	the	DET
cuesj-1226	12	23	healthy	healthy	ADJ
cuesj-1226	12	24	group	group	NOUN
cuesj-1226	12	25	but	but	CCONJ
cuesj-1226	12	26	a	a	DET
cuesj-1226	12	27	significant	significant	ADJ
cuesj-1226	12	28	increase	increase	NOUN
cuesj-1226	12	29	in	in	ADP
cuesj-1226	12	30	the	the	DET
cuesj-1226	12	31	wbc	wbc	ADJ
cuesj-1226	12	32	count	count	NOUN
cuesj-1226	12	33	,	,	PUNCT
cuesj-1226	12	34	hb	hb	PROPN
cuesj-1226	12	35	concentration	concentration	NOUN
cuesj-1226	12	36	,	,	PUNCT
cuesj-1226	12	37	and	and	CCONJ
cuesj-1226	12	38	platelets	platelet	NOUN
cuesj-1226	12	39	.	.	PUNCT
cuesj-1226	13	1	thus	thus	ADV
cuesj-1226	13	2	,	,	PUNCT
cuesj-1226	13	3	the	the	DET
cuesj-1226	13	4	result	result	NOUN
cuesj-1226	13	5	indicates	indicate	VERB
cuesj-1226	13	6	the	the	DET
cuesj-1226	13	7	necessity	necessity	NOUN
cuesj-1226	13	8	for	for	ADP
cuesj-1226	13	9	interventional	interventional	ADJ
cuesj-1226	13	10	studies	study	NOUN
cuesj-1226	13	11	on	on	ADP
cuesj-1226	13	12	vitamin	vitamin	NOUN
cuesj-1226	13	13	d	d	NOUN
cuesj-1226	13	14	supplementation	supplementation	NOUN
cuesj-1226	13	15	in	in	ADP
cuesj-1226	13	16	sars	sar	NOUN
cuesj-1226	13	17	-	-	PUNCT
cuesj-1226	13	18	cov-2	cov-2	ADV
cuesj-1226	13	19	-	-	PUNCT
cuesj-1226	13	20	infected	infect	VERB
cuesj-1226	13	21	persons	person	NOUN
cuesj-1226	13	22	by	by	ADP
cuesj-1226	13	23	showing	show	VERB
cuesj-1226	13	24	a	a	DET
cuesj-1226	13	25	correlation	correlation	NOUN
cuesj-1226	13	26	between	between	ADP
cuesj-1226	13	27	vitamin	vitamin	NOUN
cuesj-1226	13	28	d	d	NOUN
cuesj-1226	13	29	deficit	deficit	NOUN
cuesj-1226	13	30	and	and	CCONJ
cuesj-1226	13	31	wbc	wbc	ADJ
cuesj-1226	13	32	count	count	NOUN
cuesj-1226	13	33	during	during	ADP
cuesj-1226	13	34	covid-19	covid-19	PROPN
cuesj-1226	13	35	recovery	recovery	NOUN
cuesj-1226	13	36	.	.	PUNCT
cuesj-1226	14	1	keywords	keyword	NOUN
cuesj-1226	14	2	:	:	PUNCT
cuesj-1226	14	3	covid-19	covid-19	PROPN
cuesj-1226	14	4	,	,	PUNCT
cuesj-1226	14	5	recovery	recovery	NOUN
cuesj-1226	14	6	,	,	PUNCT
cuesj-1226	14	7	vitamin	vitamin	NOUN
cuesj-1226	14	8	d	d	PROPN
cuesj-1226	14	9	,	,	PUNCT
cuesj-1226	14	10	ige	ige	PROPN
cuesj-1226	14	11	,	,	PUNCT
cuesj-1226	14	12	hematology	hematology	NOUN
cuesj-1226	14	13	introduction	introduction	NOUN
cuesj-1226	14	14	up	up	ADP
cuesj-1226	14	15	until	until	ADP
cuesj-1226	14	16	the	the	DET
cuesj-1226	14	17	severe	severe	ADJ
cuesj-1226	14	18	acute	acute	ADJ
cuesj-1226	14	19	respiratory	respiratory	ADJ
cuesj-1226	14	20	syndrome	syndrome	NOUN
cuesj-1226	14	21	(	(	PUNCT
cuesj-1226	14	22	sars	sars	PROPN
cuesj-1226	14	23	)	)	PUNCT
cuesj-1226	14	24	outbreak	outbreak	NOUN
cuesj-1226	14	25	in	in	ADP
cuesj-1226	14	26	2002	2002	NUM
cuesj-1226	14	27	,	,	PUNCT
cuesj-1226	14	28	coronaviruses	coronaviruse	NOUN
cuesj-1226	14	29	(	(	PUNCT
cuesj-1226	14	30	cov2	cov2	PROPN
cuesj-1226	14	31	)	)	PUNCT
cuesj-1226	14	32	were	be	AUX
cuesj-1226	14	33	mainly	mainly	ADV
cuesj-1226	14	34	known	know	VERB
cuesj-1226	14	35	to	to	PART
cuesj-1226	14	36	cause	cause	VERB
cuesj-1226	14	37	mild	mild	ADJ
cuesj-1226	14	38	respiratory	respiratory	ADJ
cuesj-1226	14	39	and	and	CCONJ
cuesj-1226	14	40	gastrointestinal	gastrointestinal	ADJ
cuesj-1226	14	41	illnesses	illness	NOUN
cuesj-1226	14	42	.	.	PUNCT
cuesj-1226	15	1	however	however	ADV
cuesj-1226	15	2	,	,	PUNCT
cuesj-1226	15	3	around	around	ADP
cuesj-1226	15	4	that	that	DET
cuesj-1226	15	5	time	time	NOUN
cuesj-1226	15	6	,	,	PUNCT
cuesj-1226	15	7	they	they	PRON
cuesj-1226	15	8	also	also	ADV
cuesj-1226	15	9	showed	show	VERB
cuesj-1226	15	10	signs	sign	NOUN
cuesj-1226	15	11	of	of	ADP
cuesj-1226	15	12	serious	serious	ADJ
cuesj-1226	15	13	pathogenicity	pathogenicity	NOUN
cuesj-1226	15	14	in	in	ADP
cuesj-1226	15	15	humans	human	NOUN
cuesj-1226	15	16	and	and	CCONJ
cuesj-1226	15	17	the	the	DET
cuesj-1226	15	18	ability	ability	NOUN
cuesj-1226	15	19	to	to	PART
cuesj-1226	15	20	spread	spread	VERB
cuesj-1226	15	21	infectiously.[1	infectiously.[1	ADV
cuesj-1226	15	22	]	]	X
cuesj-1226	15	23	scholars[2	scholars[2	PRON
cuesj-1226	15	24	]	]	PUNCT
cuesj-1226	15	25	named	name	VERB
cuesj-1226	15	26	(	(	PUNCT
cuesj-1226	15	27	3	3	X
cuesj-1226	15	28	)	)	PUNCT
cuesj-1226	15	29	beta	beta	NOUN
cuesj-1226	15	30	coronaviruses	coronaviruse	NOUN
cuesj-1226	15	31	:	:	PUNCT
cuesj-1226	15	32	sars	sar	NOUN
cuesj-1226	15	33	-	-	PUNCT
cuesj-1226	15	34	cov-2	cov-2	NOUN
cuesj-1226	15	35	,	,	PUNCT
cuesj-1226	15	36	middle	middle	ADJ
cuesj-1226	15	37	east	east	PROPN
cuesj-1226	15	38	respiratory	respiratory	ADJ
cuesj-1226	15	39	syndrome	syndrome	NOUN
cuesj-1226	15	40	-	-	PUNCT
cuesj-1226	15	41	cov	cov	NOUN
cuesj-1226	15	42	,	,	PUNCT
cuesj-1226	15	43	and	and	CCONJ
cuesj-1226	15	44	sars	sars	PROPN
cuesj-1226	15	45	-	-	PUNCT
cuesj-1226	15	46	cov2	cov2	PROPN
cuesj-1226	15	47	that	that	PRON
cuesj-1226	15	48	prompted	prompt	VERB
cuesj-1226	15	49	to	to	ADP
cuesj-1226	15	50	sweeping	sweeping	ADJ
cuesj-1226	15	51	breakouts	breakout	NOUN
cuesj-1226	15	52	causing	cause	VERB
cuesj-1226	15	53	human	human	ADJ
cuesj-1226	15	54	fatality	fatality	NOUN
cuesj-1226	15	55	rates	rate	NOUN
cuesj-1226	15	56	to	to	PART
cuesj-1226	15	57	amplify	amplify	VERB
cuesj-1226	15	58	the	the	DET
cuesj-1226	15	59	past	past	ADJ
cuesj-1226	15	60	two	two	NUM
cuesj-1226	15	61	decades	decade	NOUN
cuesj-1226	15	62	.	.	PUNCT
cuesj-1226	16	1	sars	sar	NOUN
cuesj-1226	16	2	-	-	PUNCT
cuesj-1226	16	3	cov-2	cov-2	NOUN
cuesj-1226	16	4	in	in	ADP
cuesj-1226	16	5	particular	particular	ADJ
cuesj-1226	16	6	,	,	PUNCT
cuesj-1226	16	7	up	up	ADP
cuesj-1226	16	8	to	to	ADP
cuesj-1226	16	9	the	the	DET
cuesj-1226	16	10	present	present	ADJ
cuesj-1226	16	11	time	time	NOUN
cuesj-1226	16	12	,	,	PUNCT
cuesj-1226	16	13	originated	originate	VERB
cuesj-1226	16	14	in	in	ADP
cuesj-1226	16	15	the	the	DET
cuesj-1226	16	16	killing	killing	NOUN
cuesj-1226	16	17	of	of	ADP
cuesj-1226	16	18	nearly	nearly	ADV
cuesj-1226	16	19	3	3	NUM
cuesj-1226	16	20	million	million	NUM
cuesj-1226	16	21	and	and	CCONJ
cuesj-1226	16	22	affected	affect	VERB
cuesj-1226	16	23	about	about	ADV
cuesj-1226	16	24	130	130	NUM
cuesj-1226	16	25	million	million	NUM
cuesj-1226	16	26	citizens.[3	citizens.[3	NOUN
cuesj-1226	16	27	]	]	PUNCT
cuesj-1226	16	28	according	accord	VERB
cuesj-1226	16	29	to	to	ADP
cuesj-1226	16	30	rasheed	rasheed	VERB
cuesj-1226	16	31	et	et	PROPN
cuesj-1226	16	32	al	al	PROPN
cuesj-1226	16	33	.	.	PUNCT
cuesj-1226	17	1	[	[	X
cuesj-1226	17	2	4	4	X
cuesj-1226	17	3	]	]	PUNCT
cuesj-1226	17	4	and	and	CCONJ
cuesj-1226	17	5	habib	habib	PROPN
cuesj-1226	17	6	et	et	PROPN
cuesj-1226	17	7	al	al	PROPN
cuesj-1226	17	8	.	.	PROPN
cuesj-1226	17	9	,[5	,[5	PROPN
cuesj-1226	17	10	]	]	PUNCT
cuesj-1226	17	11	the	the	DET
cuesj-1226	17	12	first	first	ADJ
cuesj-1226	17	13	case	case	NOUN
cuesj-1226	17	14	was	be	AUX
cuesj-1226	17	15	reported	report	VERB
cuesj-1226	17	16	from	from	ADP
cuesj-1226	17	17	iraq	iraq	PROPN
cuesj-1226	17	18	on	on	ADP
cuesj-1226	17	19	february	february	PROPN
cuesj-1226	17	20	24th	24th	NOUN
cuesj-1226	17	21	and	and	CCONJ
cuesj-1226	17	22	the	the	DET
cuesj-1226	17	23	first	first	ADJ
cuesj-1226	17	24	case	case	NOUN
cuesj-1226	17	25	from	from	ADP
cuesj-1226	17	26	basrah	basrah	PROPN
cuesj-1226	17	27	on	on	ADP
cuesj-1226	17	28	march	march	PROPN
cuesj-1226	17	29	9th	9th	NOUN
cuesj-1226	17	30	.	.	PUNCT
cuesj-1226	18	1	the	the	DET
cuesj-1226	18	2	total	total	ADJ
cuesj-1226	18	3	number	number	NOUN
cuesj-1226	18	4	of	of	ADP
cuesj-1226	18	5	reported	report	VERB
cuesj-1226	18	6	cases	case	NOUN
cuesj-1226	18	7	is	be	AUX
cuesj-1226	18	8	still	still	ADV
cuesj-1226	18	9	quite	quite	ADV
cuesj-1226	18	10	low	low	ADJ
cuesj-1226	18	11	despite	despite	SCONJ
cuesj-1226	18	12	a	a	DET
cuesj-1226	18	13	rise	rise	NOUN
cuesj-1226	18	14	in	in	ADP
cuesj-1226	18	15	newly	newly	ADV
cuesj-1226	18	16	detected	detect	VERB
cuesj-1226	18	17	cases	case	NOUN
cuesj-1226	18	18	.	.	PUNCT
cuesj-1226	19	1	it	it	PRON
cuesj-1226	19	2	is	be	AUX
cuesj-1226	19	3	not	not	PART
cuesj-1226	19	4	clear	clear	ADJ
cuesj-1226	19	5	how	how	SCONJ
cuesj-1226	19	6	many	many	ADJ
cuesj-1226	19	7	of	of	ADP
cuesj-1226	19	8	these	these	DET
cuesj-1226	19	9	situations	situation	NOUN
cuesj-1226	19	10	there	there	PRON
cuesj-1226	19	11	are	be	VERB
cuesj-1226	19	12	in	in	ADP
cuesj-1226	19	13	reality	reality	NOUN
cuesj-1226	19	14	.	.	PUNCT
cuesj-1226	20	1	the	the	DET
cuesj-1226	20	2	identification	identification	NOUN
cuesj-1226	20	3	of	of	ADP
cuesj-1226	20	4	successful	successful	ADJ
cuesj-1226	20	5	cases	case	NOUN
cuesj-1226	20	6	,	,	PUNCT
cuesj-1226	20	7	which	which	PRON
cuesj-1226	20	8	reduced	reduce	VERB
cuesj-1226	20	9	the	the	DET
cuesj-1226	20	10	infection	infection	NOUN
cuesj-1226	20	11	reservoir	reservoir	NOUN
cuesj-1226	20	12	,	,	PUNCT
cuesj-1226	20	13	social	social	ADJ
cuesj-1226	20	14	isolation	isolation	NOUN
cuesj-1226	20	15	,	,	PUNCT
cuesj-1226	20	16	and	and	CCONJ
cuesj-1226	20	17	personal	personal	ADJ
cuesj-1226	20	18	security	security	NOUN
cuesj-1226	20	19	measures	measure	NOUN
cuesj-1226	20	20	that	that	PRON
cuesj-1226	20	21	disrupted	disrupt	VERB
cuesj-1226	20	22	transmission	transmission	NOUN
cuesj-1226	20	23	,	,	PUNCT
cuesj-1226	20	24	and	and	CCONJ
cuesj-1226	20	25	the	the	DET
cuesj-1226	20	26	closure	closure	NOUN
cuesj-1226	20	27	of	of	ADP
cuesj-1226	20	28	iraq	iraq	PROPN
cuesj-1226	20	29	’s	’s	PART
cuesj-1226	20	30	borders	border	NOUN
cuesj-1226	20	31	with	with	ADP
cuesj-1226	20	32	other	other	ADJ
cuesj-1226	20	33	nations	nation	NOUN
cuesj-1226	20	34	–	–	PUNCT
cuesj-1226	20	35	particularly	particularly	ADV
cuesj-1226	20	36	iran	iran	PROPN
cuesj-1226	20	37	,	,	PUNCT
cuesj-1226	20	38	which	which	PRON
cuesj-1226	20	39	may	may	AUX
cuesj-1226	20	40	have	have	AUX
cuesj-1226	20	41	been	be	AUX
cuesj-1226	20	42	the	the	DET
cuesj-1226	20	43	main	main	ADJ
cuesj-1226	20	44	source	source	NOUN
cuesj-1226	20	45	of	of	ADP
cuesj-1226	20	46	the	the	DET
cuesj-1226	20	47	first	first	ADJ
cuesj-1226	20	48	covid-19	covid-19	PROPN
cuesj-1226	20	49	cases	case	NOUN
cuesj-1226	20	50	–	–	PUNCT
cuesj-1226	20	51	are	be	AUX
cuesj-1226	20	52	other	other	ADJ
cuesj-1226	20	53	factors	factor	NOUN
cuesj-1226	20	54	that	that	PRON
cuesj-1226	20	55	may	may	AUX
cuesj-1226	20	56	have	have	AUX
cuesj-1226	20	57	contributed	contribute	VERB
cuesj-1226	20	58	to	to	ADP
cuesj-1226	20	59	the	the	DET
cuesj-1226	20	60	reduction	reduction	NOUN
cuesj-1226	20	61	in	in	ADP
cuesj-1226	20	62	the	the	DET
cuesj-1226	20	63	incidence.[4	incidence.[4	NOUN
cuesj-1226	20	64	]	]	PUNCT
cuesj-1226	20	65	however	however	ADV
cuesj-1226	20	66	,	,	PUNCT
cuesj-1226	20	67	the	the	DET
cuesj-1226	20	68	covid-19	covid-19	PROPN
cuesj-1226	20	69	strain	strain	NOUN
cuesj-1226	20	70	that	that	PRON
cuesj-1226	20	71	is	be	AUX
cuesj-1226	20	72	corresponding	corresponding	ADJ
cuesj-1226	20	73	author	author	NOUN
cuesj-1226	20	74	:	:	PUNCT
cuesj-1226	20	75	muhsin	muhsin	PROPN
cuesj-1226	20	76	h.	h.	PROPN
cuesj-1226	20	77	ubeid	ubeid	PROPN
cuesj-1226	20	78	,	,	PUNCT
cuesj-1226	20	79	department	department	NOUN
cuesj-1226	20	80	of	of	ADP
cuesj-1226	20	81	general	general	ADJ
cuesj-1226	20	82	biology	biology	NOUN
cuesj-1226	20	83	,	,	PUNCT
cuesj-1226	20	84	cihan	cihan	NOUN
cuesj-1226	20	85	universityerbil	universityerbil	NOUN
cuesj-1226	20	86	,	,	PUNCT
cuesj-1226	20	87	kurdistan	kurdistan	PROPN
cuesj-1226	20	88	region	region	NOUN
cuesj-1226	20	89	,	,	PUNCT
cuesj-1226	20	90	iraq	iraq	PROPN
cuesj-1226	20	91	.	.	PUNCT
cuesj-1226	21	1	e	e	X
cuesj-1226	21	2	-	-	NOUN
cuesj-1226	21	3	mail	mail	NOUN
cuesj-1226	21	4	:	:	PUNCT
cuesj-1226	21	5	muhsin.hmeadi@cihanuniversity.edu.iq	muhsin.hmeadi@cihanuniversity.edu.iq	NOUN
cuesj-1226	21	6	received	receive	VERB
cuesj-1226	21	7	:	:	PUNCT
cuesj-1226	21	8	may	may	AUX
cuesj-1226	21	9	26	26	NUM
cuesj-1226	21	10	,	,	PUNCT
cuesj-1226	21	11	2024	2024	NUM
cuesj-1226	21	12	accepted	accept	VERB
cuesj-1226	21	13	:	:	PUNCT
cuesj-1226	21	14	july	july	PROPN
cuesj-1226	21	15	02	02	NUM
cuesj-1226	21	16	,	,	PUNCT
cuesj-1226	21	17	2024	2024	NUM
cuesj-1226	21	18	published	publish	VERB
cuesj-1226	21	19	:	:	PUNCT
cuesj-1226	21	20	july	july	PROPN
cuesj-1226	21	21	30	30	NUM
cuesj-1226	21	22	,	,	PUNCT
cuesj-1226	21	23	2024	2024	NUM
cuesj-1226	21	24	doi	doi	NOUN
cuesj-1226	21	25	:	:	PUNCT
cuesj-1226	21	26	10.24086	10.24086	NUM
cuesj-1226	21	27	/	/	SYM
cuesj-1226	21	28	cuesj.v8n2y2024.pp31	cuesj.v8n2y2024.pp31	PROPN
cuesj-1226	21	29	-	-	ADJ
cuesj-1226	21	30	35	35	NUM
cuesj-1226	21	31	copyright	copyright	NOUN
cuesj-1226	21	32	©	©	PROPN
cuesj-1226	21	33	2024	2024	NUM
cuesj-1226	21	34	muhsin	muhsin	PROPN
cuesj-1226	21	35	h.	h.	PROPN
cuesj-1226	21	36	ubeid	ubeid	PROPN
cuesj-1226	21	37	,	,	PUNCT
cuesj-1226	21	38	ameena	ameena	PROPN
cuesj-1226	21	39	s.	s.	PROPN
cuesj-1226	21	40	m.	m.	PROPN
cuesj-1226	21	41	juma	juma	PROPN
cuesj-1226	21	42	,	,	PUNCT
cuesj-1226	21	43	shakir	shakir	PROPN
cuesj-1226	21	44	m.	m.	PROPN
cuesj-1226	21	45	al	al	PROPN
cuesj-1226	21	46	-	-	PUNCT
cuesj-1226	21	47	awqati	awqati	PROPN
cuesj-1226	21	48	,	,	PUNCT
cuesj-1226	21	49	tanya	tanya	PROPN
cuesj-1226	21	50	s.	s.	PROPN
cuesj-1226	21	51	salih	salih	PROPN
cuesj-1226	21	52	,	,	PUNCT
cuesj-1226	21	53	muhamed	muhamed	PROPN
cuesj-1226	21	54	a.	a.	NOUN
cuesj-1226	21	55	abbas	abbas	PROPN
cuesj-1226	21	56	.	.	PUNCT
cuesj-1226	22	1	this	this	PRON
cuesj-1226	22	2	is	be	AUX
cuesj-1226	22	3	an	an	DET
cuesj-1226	22	4	open	open	ADJ
cuesj-1226	22	5	-	-	PUNCT
cuesj-1226	22	6	access	access	NOUN
cuesj-1226	22	7	article	article	NOUN
cuesj-1226	22	8	distributed	distribute	VERB
cuesj-1226	22	9	under	under	ADP
cuesj-1226	22	10	the	the	DET
cuesj-1226	22	11	creative	creative	ADJ
cuesj-1226	22	12	commons	common	NOUN
cuesj-1226	22	13	attribution	attribution	NOUN
cuesj-1226	22	14	license	license	NOUN
cuesj-1226	22	15	.	.	PUNCT
cuesj-1226	23	1	cihan	cihan	VERB
cuesj-1226	23	2	university	university	NOUN
cuesj-1226	23	3	-	-	PUNCT
cuesj-1226	23	4	erbil	erbil	PROPN
cuesj-1226	23	5	scientific	scientific	ADJ
cuesj-1226	23	6	journal	journal	NOUN
cuesj-1226	23	7	(	(	PUNCT
cuesj-1226	23	8	cuesj	cuesj	ADJ
cuesj-1226	23	9	)	)	PUNCT
cuesj-1226	23	10	ubeid	ubeid	NOUN
cuesj-1226	23	11	,	,	PUNCT
cuesj-1226	23	12	et	et	PROPN
cuesj-1226	23	13	al	al	PROPN
cuesj-1226	23	14	.	.	PUNCT
cuesj-1226	23	15	:	:	PUNCT
cuesj-1226	24	1	vitamin	vitamin	NOUN
cuesj-1226	24	2	d	d	PROPN
cuesj-1226	24	3	levels	level	NOUN
cuesj-1226	24	4	in	in	ADP
cuesj-1226	24	5	coronavirus	coronavirus	NOUN
cuesj-1226	24	6	-	-	PUNCT
cuesj-1226	24	7	infected	infect	VERB
cuesj-1226	24	8	individuals	individual	NOUN
cuesj-1226	24	9	32	32	NUM
cuesj-1226	24	10	http://journals.cihanuniversity.edu.iq/index.php/cuesj	http://journals.cihanuniversity.edu.iq/index.php/cuesj	ADJ
cuesj-1226	24	11	cuesj	cuesj	NOUN
cuesj-1226	24	12	2024	2024	NUM
cuesj-1226	24	13	,	,	PUNCT
cuesj-1226	24	14	8	8	NUM
cuesj-1226	24	15	(	(	PUNCT
cuesj-1226	24	16	2	2	NUM
cuesj-1226	24	17	):	):	PUNCT
cuesj-1226	24	18	31	31	NUM
cuesj-1226	24	19	-	-	SYM
cuesj-1226	24	20	35	35	NUM
cuesj-1226	24	21	currently	currently	ADV
cuesj-1226	24	22	causing	cause	VERB
cuesj-1226	24	23	most	most	ADJ
cuesj-1226	24	24	cases	case	NOUN
cuesj-1226	24	25	has	have	AUX
cuesj-1226	24	26	entered	enter	VERB
cuesj-1226	24	27	iraq	iraq	PROPN
cuesj-1226	24	28	and	and	CCONJ
cuesj-1226	24	29	spread	spread	VERB
cuesj-1226	24	30	throughout	throughout	ADP
cuesj-1226	24	31	the	the	DET
cuesj-1226	24	32	world.[6	world.[6	NOUN
cuesj-1226	24	33	]	]	PUNCT
cuesj-1226	24	34	determining	determine	VERB
cuesj-1226	24	35	the	the	DET
cuesj-1226	24	36	exact	exact	ADJ
cuesj-1226	24	37	cause	cause	NOUN
cuesj-1226	24	38	of	of	ADP
cuesj-1226	24	39	sickness	sickness	NOUN
cuesj-1226	24	40	,	,	PUNCT
cuesj-1226	24	41	be	be	AUX
cuesj-1226	24	42	it	it	PRON
cuesj-1226	24	43	coronavirus	coronavirus	NOUN
cuesj-1226	24	44	or	or	CCONJ
cuesj-1226	24	45	any	any	DET
cuesj-1226	24	46	other	other	ADJ
cuesj-1226	24	47	cause	cause	NOUN
cuesj-1226	24	48	,	,	PUNCT
cuesj-1226	24	49	requires	require	VERB
cuesj-1226	24	50	a	a	DET
cuesj-1226	24	51	covid-19	covid-19	PROPN
cuesj-1226	24	52	diagnosis	diagnosis	NOUN
cuesj-1226	24	53	.	.	PUNCT
cuesj-1226	25	1	although	although	SCONJ
cuesj-1226	25	2	there	there	PRON
cuesj-1226	25	3	are	be	VERB
cuesj-1226	25	4	numerous	numerous	ADJ
cuesj-1226	25	5	testing	testing	NOUN
cuesj-1226	25	6	options	option	NOUN
cuesj-1226	25	7	,	,	PUNCT
cuesj-1226	25	8	an	an	DET
cuesj-1226	25	9	immunological	immunological	ADJ
cuesj-1226	25	10	screen	screen	NOUN
cuesj-1226	25	11	test	test	NOUN
cuesj-1226	25	12	for	for	ADP
cuesj-1226	25	13	immunoglobulins	immunoglobulin	NOUN
cuesj-1226	25	14	is	be	AUX
cuesj-1226	25	15	the	the	DET
cuesj-1226	25	16	quickest.[3	quickest.[3	NOUN
cuesj-1226	25	17	]	]	PUNCT
cuesj-1226	25	18	the	the	DET
cuesj-1226	25	19	benefits	benefit	NOUN
cuesj-1226	25	20	and	and	CCONJ
cuesj-1226	25	21	drawbacks	drawback	NOUN
cuesj-1226	25	22	of	of	ADP
cuesj-1226	25	23	vitamin	vitamin	NOUN
cuesj-1226	25	24	d	d	NOUN
cuesj-1226	25	25	supplementation	supplementation	NOUN
cuesj-1226	25	26	have	have	AUX
cuesj-1226	25	27	been	be	AUX
cuesj-1226	25	28	widely	widely	ADV
cuesj-1226	25	29	discussed	discuss	VERB
cuesj-1226	25	30	,	,	PUNCT
cuesj-1226	25	31	with	with	ADP
cuesj-1226	25	32	both	both	DET
cuesj-1226	25	33	sides	side	NOUN
cuesj-1226	25	34	presenting	present	VERB
cuesj-1226	25	35	strong	strong	ADJ
cuesj-1226	25	36	cases	case	NOUN
cuesj-1226	25	37	.	.	PUNCT
cuesj-1226	26	1	the	the	DET
cuesj-1226	26	2	discussion	discussion	NOUN
cuesj-1226	26	3	has	have	AUX
cuesj-1226	26	4	intensified	intensify	VERB
cuesj-1226	26	5	due	due	ADP
cuesj-1226	26	6	to	to	ADP
cuesj-1226	26	7	the	the	DET
cuesj-1226	26	8	covid-19	covid-19	PROPN
cuesj-1226	26	9	pandemic.[4	pandemic.[4	PRON
cuesj-1226	26	10	]	]	PUNCT
cuesj-1226	26	11	while	while	SCONJ
cuesj-1226	26	12	vitamin	vitamin	NOUN
cuesj-1226	26	13	d	d	NOUN
cuesj-1226	26	14	specialists	specialist	NOUN
cuesj-1226	26	15	welcomed	welcome	VERB
cuesj-1226	26	16	the	the	DET
cuesj-1226	26	17	request	request	NOUN
cuesj-1226	26	18	for	for	ADP
cuesj-1226	26	19	additional	additional	ADJ
cuesj-1226	26	20	testing	testing	NOUN
cuesj-1226	26	21	,	,	PUNCT
cuesj-1226	26	22	many	many	ADJ
cuesj-1226	26	23	in	in	ADP
cuesj-1226	26	24	the	the	DET
cuesj-1226	26	25	scientific	scientific	ADJ
cuesj-1226	26	26	community	community	NOUN
cuesj-1226	26	27	expressed	express	VERB
cuesj-1226	26	28	worry	worry	NOUN
cuesj-1226	26	29	about	about	ADP
cuesj-1226	26	30	the	the	DET
cuesj-1226	26	31	absence	absence	NOUN
cuesj-1226	26	32	of	of	ADP
cuesj-1226	26	33	clear	clear	ADJ
cuesj-1226	26	34	standards	standard	NOUN
cuesj-1226	26	35	in	in	ADP
cuesj-1226	26	36	light	light	NOUN
cuesj-1226	26	37	of	of	ADP
cuesj-1226	26	38	covid-19	covid-19	PROPN
cuesj-1226	26	39	.	.	PUNCT
cuesj-1226	27	1	numerous	numerous	ADJ
cuesj-1226	27	2	experts	expert	NOUN
cuesj-1226	27	3	have	have	AUX
cuesj-1226	27	4	determined	determine	VERB
cuesj-1226	27	5	that	that	SCONJ
cuesj-1226	27	6	taking	take	VERB
cuesj-1226	27	7	supplements	supplement	NOUN
cuesj-1226	27	8	of	of	ADP
cuesj-1226	27	9	vitamin	vitamin	NOUN
cuesj-1226	27	10	d	d	NOUN
cuesj-1226	27	11	is	be	AUX
cuesj-1226	27	12	generally	generally	ADV
cuesj-1226	27	13	healthy	healthy	ADJ
cuesj-1226	27	14	and	and	CCONJ
cuesj-1226	27	15	that	that	SCONJ
cuesj-1226	27	16	any	any	DET
cuesj-1226	27	17	potential	potential	ADJ
cuesj-1226	27	18	low	low	ADJ
cuesj-1226	27	19	toxicity	toxicity	NOUN
cuesj-1226	27	20	will	will	AUX
cuesj-1226	27	21	undoubtedly	undoubtedly	ADV
cuesj-1226	27	22	be	be	AUX
cuesj-1226	27	23	offset	offset	VERB
cuesj-1226	27	24	by	by	ADP
cuesj-1226	27	25	any	any	DET
cuesj-1226	27	26	prospective	prospective	ADJ
cuesj-1226	27	27	benefits	benefit	NOUN
cuesj-1226	27	28	regarding	regard	VERB
cuesj-1226	27	29	the	the	DET
cuesj-1226	27	30	safety	safety	NOUN
cuesj-1226	27	31	of	of	ADP
cuesj-1226	27	32	covid-19.[7	covid-19.[7	NOUN
cuesj-1226	27	33	]	]	X
cuesj-1226	27	34	the	the	DET
cuesj-1226	27	35	purpose	purpose	NOUN
cuesj-1226	27	36	of	of	ADP
cuesj-1226	27	37	this	this	DET
cuesj-1226	27	38	study	study	NOUN
cuesj-1226	27	39	is	be	AUX
cuesj-1226	27	40	to	to	PART
cuesj-1226	27	41	look	look	VERB
cuesj-1226	27	42	at	at	ADP
cuesj-1226	27	43	potential	potential	ADJ
cuesj-1226	27	44	relationships	relationship	NOUN
cuesj-1226	27	45	between	between	ADP
cuesj-1226	27	46	vitamin	vitamin	NOUN
cuesj-1226	27	47	d	d	NOUN
cuesj-1226	27	48	levels	level	NOUN
cuesj-1226	27	49	and	and	CCONJ
cuesj-1226	27	50	certain	certain	ADJ
cuesj-1226	27	51	blood	blood	NOUN
cuesj-1226	27	52	parameters	parameter	NOUN
cuesj-1226	27	53	,	,	PUNCT
cuesj-1226	27	54	such	such	ADJ
cuesj-1226	27	55	as	as	ADP
cuesj-1226	27	56	pcv	pcv	NOUN
cuesj-1226	27	57	,	,	PUNCT
cuesj-1226	27	58	wbc	wbc	PROPN
cuesj-1226	27	59	,	,	PUNCT
cuesj-1226	27	60	and	and	CCONJ
cuesj-1226	27	61	rbc	rbc	PROPN
cuesj-1226	27	62	in	in	ADP
cuesj-1226	27	63	patients	patient	NOUN
cuesj-1226	27	64	who	who	PRON
cuesj-1226	27	65	have	have	VERB
cuesj-1226	27	66	positive	positive	ADJ
cuesj-1226	27	67	covid-19	covid-19	PROPN
cuesj-1226	27	68	immunoglobulin	immunoglobulin	NOUN
cuesj-1226	27	69	levels	level	NOUN
cuesj-1226	27	70	.	.	PUNCT
cuesj-1226	28	1	methodology	methodology	NOUN
cuesj-1226	28	2	blood	blood	NOUN
cuesj-1226	28	3	samples	sample	NOUN
cuesj-1226	28	4	from	from	ADP
cuesj-1226	28	5	the	the	DET
cuesj-1226	28	6	retrieved	retrieve	VERB
cuesj-1226	28	7	cases	case	NOUN
cuesj-1226	28	8	,	,	PUNCT
cuesj-1226	28	9	a	a	DET
cuesj-1226	28	10	total	total	NOUN
cuesj-1226	28	11	of	of	ADP
cuesj-1226	28	12	98	98	NUM
cuesj-1226	28	13	aseptic	aseptic	ADJ
cuesj-1226	28	14	blood	blood	NOUN
cuesj-1226	28	15	samples	sample	NOUN
cuesj-1226	28	16	were	be	AUX
cuesj-1226	28	17	taken	take	VERB
cuesj-1226	28	18	.	.	PUNCT
cuesj-1226	29	1	using	use	VERB
cuesj-1226	29	2	sterile	sterile	ADJ
cuesj-1226	29	3	,	,	PUNCT
cuesj-1226	29	4	disposable	disposable	ADJ
cuesj-1226	29	5	syringes	syrinx	NOUN
cuesj-1226	29	6	,	,	PUNCT
cuesj-1226	29	7	7	7	NUM
cuesj-1226	29	8	ml	ml	NOUN
cuesj-1226	29	9	of	of	ADP
cuesj-1226	29	10	blood	blood	NOUN
cuesj-1226	29	11	were	be	AUX
cuesj-1226	29	12	taken	take	VERB
cuesj-1226	29	13	from	from	ADP
cuesj-1226	29	14	each	each	DET
cuesj-1226	29	15	patient	patient	NOUN
cuesj-1226	29	16	and	and	CCONJ
cuesj-1226	29	17	control	control	NOUN
cuesj-1226	29	18	group	group	NOUN
cuesj-1226	29	19	.	.	PUNCT
cuesj-1226	30	1	blood	blood	NOUN
cuesj-1226	30	2	samples	sample	NOUN
cuesj-1226	30	3	were	be	AUX
cuesj-1226	30	4	put	put	VERB
cuesj-1226	30	5	into	into	ADP
cuesj-1226	30	6	an	an	DET
cuesj-1226	30	7	edta	edta	NOUN
cuesj-1226	30	8	tube	tube	NOUN
cuesj-1226	30	9	(	(	PUNCT
cuesj-1226	30	10	2	2	NUM
cuesj-1226	30	11	ml	ml	NOUN
cuesj-1226	30	12	)	)	PUNCT
cuesj-1226	30	13	for	for	ADP
cuesj-1226	30	14	hematological	hematological	ADJ
cuesj-1226	30	15	parameter	parameter	NOUN
cuesj-1226	30	16	testing	testing	NOUN
cuesj-1226	30	17	and	and	CCONJ
cuesj-1226	30	18	a	a	DET
cuesj-1226	30	19	gel	gel	NOUN
cuesj-1226	30	20	tube	tube	NOUN
cuesj-1226	30	21	(	(	PUNCT
cuesj-1226	30	22	5	5	NUM
cuesj-1226	30	23	ml	ml	NOUN
cuesj-1226	30	24	)	)	PUNCT
cuesj-1226	30	25	,	,	PUNCT
cuesj-1226	30	26	which	which	PRON
cuesj-1226	30	27	was	be	AUX
cuesj-1226	30	28	centrifuged	centrifuge	VERB
cuesj-1226	30	29	at	at	ADP
cuesj-1226	30	30	2500	2500	NUM
cuesj-1226	30	31	rpm	rpm	NOUN
cuesj-1226	30	32	for	for	ADP
cuesj-1226	30	33	15	15	NUM
cuesj-1226	30	34	min	min	NOUN
cuesj-1226	30	35	to	to	PART
cuesj-1226	30	36	collect	collect	VERB
cuesj-1226	30	37	serum	serum	NOUN
cuesj-1226	30	38	.	.	PUNCT
cuesj-1226	31	1	each	each	DET
cuesj-1226	31	2	patient	patient	NOUN
cuesj-1226	31	3	’s	’s	PART
cuesj-1226	31	4	serum	serum	NOUN
cuesj-1226	31	5	was	be	AUX
cuesj-1226	31	6	kept	keep	VERB
cuesj-1226	31	7	in	in	ADP
cuesj-1226	31	8	eppendorf	eppendorf	PROPN
cuesj-1226	31	9	tubes	tube	NOUN
cuesj-1226	31	10	at	at	ADP
cuesj-1226	31	11	−20	−20	PROPN
cuesj-1226	31	12	°	°	ADP
cuesj-1226	31	13	c	c	NOUN
cuesj-1226	31	14	until	until	SCONJ
cuesj-1226	31	15	it	it	PRON
cuesj-1226	31	16	was	be	AUX
cuesj-1226	31	17	needed	need	VERB
cuesj-1226	31	18	for	for	ADP
cuesj-1226	31	19	elisa	elisa	NOUN
cuesj-1226	31	20	to	to	PART
cuesj-1226	31	21	estimate	estimate	VERB
cuesj-1226	31	22	the	the	DET
cuesj-1226	31	23	levels	level	NOUN
cuesj-1226	31	24	of	of	ADP
cuesj-1226	31	25	igm	igm	PROPN
cuesj-1226	31	26	and	and	CCONJ
cuesj-1226	31	27	igg	igg	PROPN
cuesj-1226	31	28	antibodies	antibody	NOUN
cuesj-1226	31	29	and	and	CCONJ
cuesj-1226	31	30	cobas	cobas	NUM
cuesj-1226	31	31	e411	e411	PROPN
cuesj-1226	31	32	to	to	PART
cuesj-1226	31	33	estimate	estimate	VERB
cuesj-1226	31	34	the	the	DET
cuesj-1226	31	35	levels	level	NOUN
cuesj-1226	31	36	of	of	ADP
cuesj-1226	31	37	ige	ige	PROPN
cuesj-1226	31	38	and	and	CCONJ
cuesj-1226	31	39	vitamin	vitamin	NOUN
cuesj-1226	31	40	d3	d3	PROPN
cuesj-1226	31	41	.	.	PUNCT
cuesj-1226	32	1	il-10	il-10	X
cuesj-1226	32	2	elisa	elisa	AUX
cuesj-1226	32	3	test	test	VERB
cuesj-1226	32	4	the	the	DET
cuesj-1226	32	5	serum	serum	NOUN
cuesj-1226	32	6	sample	sample	NOUN
cuesj-1226	32	7	was	be	AUX
cuesj-1226	32	8	thawed	thaw	VERB
cuesj-1226	32	9	and	and	CCONJ
cuesj-1226	32	10	brought	bring	VERB
cuesj-1226	32	11	to	to	ADP
cuesj-1226	32	12	room	room	NOUN
cuesj-1226	32	13	temperature	temperature	NOUN
cuesj-1226	32	14	before	before	ADP
cuesj-1226	32	15	the	the	DET
cuesj-1226	32	16	antibodies	antibody	NOUN
cuesj-1226	32	17	(	(	PUNCT
cuesj-1226	32	18	igm	igm	NOUN
cuesj-1226	32	19	and	and	CCONJ
cuesj-1226	32	20	igg	igg	PROPN
cuesj-1226	32	21	)	)	PUNCT
cuesj-1226	32	22	test	test	NOUN
cuesj-1226	32	23	was	be	AUX
cuesj-1226	32	24	run	run	VERB
cuesj-1226	32	25	on	on	ADP
cuesj-1226	32	26	each	each	DET
cuesj-1226	32	27	sample	sample	NOUN
cuesj-1226	32	28	using	use	VERB
cuesj-1226	32	29	the	the	DET
cuesj-1226	32	30	elisa	elisa	NOUN
cuesj-1226	32	31	assay	assay	VERB
cuesj-1226	32	32	.	.	PUNCT
cuesj-1226	33	1	hematological	hematological	ADJ
cuesj-1226	33	2	tests	test	NOUN
cuesj-1226	33	3	within	within	ADP
cuesj-1226	33	4	an	an	DET
cuesj-1226	33	5	hour	hour	NOUN
cuesj-1226	33	6	after	after	ADP
cuesj-1226	33	7	sample	sample	NOUN
cuesj-1226	33	8	collection	collection	NOUN
cuesj-1226	33	9	,	,	PUNCT
cuesj-1226	33	10	the	the	DET
cuesj-1226	33	11	complete	complete	ADJ
cuesj-1226	33	12	blood	blood	NOUN
cuesj-1226	33	13	count	count	NOUN
cuesj-1226	33	14	for	for	SCONJ
cuesj-1226	33	15	each	each	DET
cuesj-1226	33	16	case	case	NOUN
cuesj-1226	33	17	and	and	CCONJ
cuesj-1226	33	18	control	control	NOUN
cuesj-1226	33	19	group	group	NOUN
cuesj-1226	33	20	was	be	AUX
cuesj-1226	33	21	determined	determine	VERB
cuesj-1226	33	22	using	use	VERB
cuesj-1226	33	23	the	the	DET
cuesj-1226	33	24	automated	automate	VERB
cuesj-1226	33	25	medonic	medonic	ADJ
cuesj-1226	33	26	three	three	NUM
cuesj-1226	33	27	-	-	PUNCT
cuesj-1226	33	28	parameter	parameter	NOUN
cuesj-1226	33	29	coulter	coulter	NOUN
cuesj-1226	33	30	.	.	PUNCT
cuesj-1226	34	1	immunological	immunological	ADJ
cuesj-1226	34	2	test	test	NOUN
cuesj-1226	34	3	utilizing	utilize	VERB
cuesj-1226	34	4	a	a	DET
cuesj-1226	34	5	fully	fully	ADV
cuesj-1226	34	6	automated	automate	VERB
cuesj-1226	34	7	cobas	cobas	PROPN
cuesj-1226	34	8	e411	e411	PROPN
cuesj-1226	34	9	to	to	PART
cuesj-1226	34	10	ascertain	ascertain	VERB
cuesj-1226	34	11	the	the	DET
cuesj-1226	34	12	quantity	quantity	NOUN
cuesj-1226	34	13	of	of	ADP
cuesj-1226	34	14	each	each	DET
cuesj-1226	34	15	component	component	NOUN
cuesj-1226	34	16	in	in	ADP
cuesj-1226	34	17	serum	serum	NOUN
cuesj-1226	34	18	,	,	PUNCT
cuesj-1226	34	19	the	the	DET
cuesj-1226	34	20	ige	ige	PROPN
cuesj-1226	34	21	and	and	CCONJ
cuesj-1226	34	22	vitamin	vitamin	NOUN
cuesj-1226	34	23	d3	d3	PROPN
cuesj-1226	34	24	tests	test	NOUN
cuesj-1226	34	25	were	be	AUX
cuesj-1226	34	26	carried	carry	VERB
cuesj-1226	34	27	out	out	ADP
cuesj-1226	34	28	.	.	PUNCT
cuesj-1226	35	1	statistical	statistical	ADJ
cuesj-1226	35	2	analysis	analysis	NOUN
cuesj-1226	35	3	after	after	ADP
cuesj-1226	35	4	statistical	statistical	ADJ
cuesj-1226	35	5	evaluation	evaluation	NOUN
cuesj-1226	35	6	and	and	CCONJ
cuesj-1226	35	7	analysis	analysis	NOUN
cuesj-1226	35	8	,	,	PUNCT
cuesj-1226	35	9	the	the	DET
cuesj-1226	35	10	data	datum	NOUN
cuesj-1226	35	11	were	be	AUX
cuesj-1226	35	12	arranged	arrange	VERB
cuesj-1226	35	13	in	in	ADP
cuesj-1226	35	14	tables	table	NOUN
cuesj-1226	35	15	.	.	PUNCT
cuesj-1226	36	1	version	version	NOUN
cuesj-1226	36	2	20	20	NUM
cuesj-1226	36	3	of	of	ADP
cuesj-1226	36	4	the	the	DET
cuesj-1226	36	5	statistical	statistical	ADJ
cuesj-1226	36	6	package	package	NOUN
cuesj-1226	36	7	for	for	ADP
cuesj-1226	36	8	the	the	DET
cuesj-1226	36	9	social	social	ADJ
cuesj-1226	36	10	sciences	sciences	PROPN
cuesj-1226	36	11	computer	computer	NOUN
cuesj-1226	36	12	application	application	NOUN
cuesj-1226	36	13	was	be	AUX
cuesj-1226	36	14	utilized	utilize	VERB
cuesj-1226	36	15	.	.	PUNCT
cuesj-1226	37	1	student	student	NOUN
cuesj-1226	37	2	’s	’s	PART
cuesj-1226	37	3	t	t	PROPN
cuesj-1226	37	4	-	-	PUNCT
cuesj-1226	37	5	test	test	NOUN
cuesj-1226	37	6	was	be	AUX
cuesj-1226	37	7	used	use	VERB
cuesj-1226	37	8	to	to	PART
cuesj-1226	37	9	compare	compare	VERB
cuesj-1226	37	10	quantitative	quantitative	ADJ
cuesj-1226	37	11	variables	variable	NOUN
cuesj-1226	37	12	.	.	PUNCT
cuesj-1226	38	1	if	if	SCONJ
cuesj-1226	38	2	the	the	DET
cuesj-1226	38	3	p	p	X
cuesj-1226	38	4	<	<	X
cuesj-1226	38	5	0.05	0.05	NUM
cuesj-1226	38	6	or	or	CCONJ
cuesj-1226	38	7	0.01	0.01	NUM
cuesj-1226	38	8	for	for	ADP
cuesj-1226	38	9	the	the	DET
cuesj-1226	38	10	results	result	NOUN
cuesj-1226	38	11	,	,	PUNCT
cuesj-1226	38	12	they	they	PRON
cuesj-1226	38	13	were	be	AUX
cuesj-1226	38	14	deemed	deem	VERB
cuesj-1226	38	15	significant	significant	ADJ
cuesj-1226	38	16	and	and	CCONJ
cuesj-1226	38	17	highly	highly	ADV
cuesj-1226	38	18	significant	significant	ADJ
cuesj-1226	38	19	,	,	PUNCT
cuesj-1226	38	20	respectively	respectively	ADV
cuesj-1226	38	21	.	.	PUNCT
cuesj-1226	39	1	results	result	VERB
cuesj-1226	39	2	gender	gender	NOUN
cuesj-1226	39	3	of	of	ADP
cuesj-1226	39	4	the	the	DET
cuesj-1226	39	5	covid-19	covid-19	PROPN
cuesj-1226	39	6	-	-	PUNCT
cuesj-1226	39	7	recovered	recover	VERB
cuesj-1226	39	8	patients	patient	NOUN
cuesj-1226	39	9	figure	figure	VERB
cuesj-1226	39	10	1	1	NUM
cuesj-1226	39	11	represents	represent	VERB
cuesj-1226	39	12	the	the	DET
cuesj-1226	39	13	percentage	percentage	NOUN
cuesj-1226	39	14	of	of	ADP
cuesj-1226	39	15	the	the	DET
cuesj-1226	39	16	gender	gender	NOUN
cuesj-1226	39	17	of	of	ADP
cuesj-1226	39	18	covid-19	covid-19	PROPN
cuesj-1226	39	19	-	-	PUNCT
cuesj-1226	39	20	recovered	recover	VERB
cuesj-1226	39	21	patients	patient	NOUN
cuesj-1226	39	22	.	.	PUNCT
cuesj-1226	40	1	the	the	DET
cuesj-1226	40	2	number	number	NOUN
cuesj-1226	40	3	of	of	ADP
cuesj-1226	40	4	patients	patient	NOUN
cuesj-1226	40	5	was	be	AUX
cuesj-1226	40	6	(	(	PUNCT
cuesj-1226	40	7	98	98	NUM
cuesj-1226	40	8	)	)	PUNCT
cuesj-1226	40	9	,	,	PUNCT
cuesj-1226	40	10	38	38	NUM
cuesj-1226	40	11	(	(	PUNCT
cuesj-1226	40	12	39	39	NUM
cuesj-1226	40	13	%	%	NOUN
cuesj-1226	40	14	)	)	PUNCT
cuesj-1226	40	15	were	be	AUX
cuesj-1226	40	16	females	female	NOUN
cuesj-1226	40	17	,	,	PUNCT
cuesj-1226	40	18	and	and	CCONJ
cuesj-1226	40	19	60	60	NUM
cuesj-1226	40	20	(	(	PUNCT
cuesj-1226	40	21	61	61	NUM
cuesj-1226	40	22	%	%	NOUN
cuesj-1226	40	23	)	)	PUNCT
cuesj-1226	40	24	were	be	AUX
cuesj-1226	40	25	males	male	NOUN
cuesj-1226	40	26	.	.	PUNCT
cuesj-1226	41	1	positive	positive	ADJ
cuesj-1226	41	2	and	and	CCONJ
cuesj-1226	41	3	negative	negative	ADJ
cuesj-1226	41	4	cases	case	NOUN
cuesj-1226	41	5	of	of	ADP
cuesj-1226	41	6	igm	igm	PROPN
cuesj-1226	41	7	and	and	CCONJ
cuesj-1226	41	8	igg	igg	PROPN
cuesj-1226	41	9	among	among	ADP
cuesj-1226	41	10	covid-19	covid-19	PROPN
cuesj-1226	41	11	-	-	PUNCT
cuesj-1226	41	12	recovered	recover	VERB
cuesj-1226	41	13	patients	patient	NOUN
cuesj-1226	41	14	results	result	NOUN
cuesj-1226	41	15	showed	show	VERB
cuesj-1226	41	16	that	that	SCONJ
cuesj-1226	41	17	all	all	DET
cuesj-1226	41	18	participants	participant	NOUN
cuesj-1226	41	19	were	be	AUX
cuesj-1226	41	20	negative	negative	ADJ
cuesj-1226	41	21	for	for	ADP
cuesj-1226	41	22	igm	igm	PROPN
cuesj-1226	41	23	antibodies	antibody	NOUN
cuesj-1226	41	24	and	and	CCONJ
cuesj-1226	41	25	all	all	PRON
cuesj-1226	41	26	were	be	AUX
cuesj-1226	41	27	positive	positive	ADJ
cuesj-1226	41	28	for	for	SCONJ
cuesj-1226	41	29	igg	igg	PROPN
cuesj-1226	41	30	antibodies	antibodie	VERB
cuesj-1226	42	1	[	[	X
cuesj-1226	42	2	table	table	NOUN
cuesj-1226	42	3	1	1	NUM
cuesj-1226	42	4	]	]	PUNCT
cuesj-1226	42	5	.	.	PUNCT
cuesj-1226	43	1	mean	mean	VERB
cuesj-1226	43	2	serum	serum	NOUN
cuesj-1226	43	3	levels	level	NOUN
cuesj-1226	43	4	of	of	ADP
cuesj-1226	43	5	ige	ige	PROPN
cuesj-1226	43	6	among	among	ADP
cuesj-1226	43	7	covid-19	covid-19	PROPN
cuesj-1226	43	8	-	-	PUNCT
cuesj-1226	43	9	recovered	recover	VERB
cuesj-1226	43	10	patients	patient	NOUN
cuesj-1226	43	11	and	and	CCONJ
cuesj-1226	43	12	healthy	healthy	ADJ
cuesj-1226	43	13	group	group	NOUN
cuesj-1226	43	14	table	table	NOUN
cuesj-1226	43	15	2	2	NUM
cuesj-1226	43	16	shows	show	VERB
cuesj-1226	43	17	that	that	SCONJ
cuesj-1226	43	18	the	the	DET
cuesj-1226	43	19	mean	mean	ADJ
cuesj-1226	43	20	serum	serum	NOUN
cuesj-1226	43	21	concentration	concentration	NOUN
cuesj-1226	43	22	of	of	ADP
cuesj-1226	43	23	ige	ige	PROPN
cuesj-1226	43	24	from	from	ADP
cuesj-1226	43	25	covid-19	covid-19	PROPN
cuesj-1226	43	26	patients	patient	NOUN
cuesj-1226	43	27	is	be	AUX
cuesj-1226	43	28	highly	highly	ADV
cuesj-1226	43	29	increased	increase	VERB
cuesj-1226	43	30	when	when	SCONJ
cuesj-1226	43	31	compared	compare	VERB
cuesj-1226	43	32	with	with	ADP
cuesj-1226	43	33	the	the	DET
cuesj-1226	43	34	healthy	healthy	ADJ
cuesj-1226	43	35	control	control	NOUN
cuesj-1226	43	36	group	group	NOUN
cuesj-1226	43	37	(	(	PUNCT
cuesj-1226	43	38	p	p	X
cuesj-1226	43	39	<	<	X
cuesj-1226	43	40	0.1	0.1	NUM
cuesj-1226	43	41	)	)	PUNCT
cuesj-1226	43	42	.	.	PUNCT
cuesj-1226	44	1	mean	mean	VERB
cuesj-1226	44	2	serum	serum	NOUN
cuesj-1226	44	3	levels	level	NOUN
cuesj-1226	44	4	of	of	ADP
cuesj-1226	44	5	vitamin	vitamin	NOUN
cuesj-1226	44	6	d3	d3	PROPN
cuesj-1226	44	7	among	among	ADP
cuesj-1226	44	8	covid-19	covid-19	PROPN
cuesj-1226	44	9	-	-	PUNCT
cuesj-1226	44	10	recovered	recover	VERB
cuesj-1226	44	11	patients	patient	NOUN
cuesj-1226	44	12	and	and	CCONJ
cuesj-1226	44	13	healthy	healthy	ADJ
cuesj-1226	44	14	group	group	NOUN
cuesj-1226	44	15	the	the	DET
cuesj-1226	44	16	means	mean	NOUN
cuesj-1226	44	17	of	of	ADP
cuesj-1226	44	18	serum	serum	NOUN
cuesj-1226	44	19	vitamin	vitamin	NOUN
cuesj-1226	44	20	d3	d3	PROPN
cuesj-1226	44	21	levels	level	NOUN
cuesj-1226	44	22	in	in	ADP
cuesj-1226	44	23	covid-19	covid-19	PROPN
cuesj-1226	44	24	-	-	PUNCT
cuesj-1226	44	25	recovered	recover	VERB
cuesj-1226	44	26	patients	patient	NOUN
cuesj-1226	44	27	were	be	AUX
cuesj-1226	44	28	significantly	significantly	ADV
cuesj-1226	44	29	low	low	ADJ
cuesj-1226	44	30	(	(	PUNCT
cuesj-1226	44	31	p	p	X
cuesj-1226	44	32	<	<	X
cuesj-1226	44	33	0.01	0.01	NUM
cuesj-1226	44	34	)	)	PUNCT
cuesj-1226	44	35	when	when	SCONJ
cuesj-1226	44	36	compared	compare	VERB
cuesj-1226	44	37	to	to	ADP
cuesj-1226	44	38	the	the	DET
cuesj-1226	44	39	healthy	healthy	ADJ
cuesj-1226	44	40	group	group	NOUN
cuesj-1226	45	1	[	[	X
cuesj-1226	45	2	table	table	NOUN
cuesj-1226	45	3	3	3	NUM
cuesj-1226	45	4	]	]	PUNCT
cuesj-1226	45	5	.	.	PUNCT
cuesj-1226	46	1	mean	mean	ADJ
cuesj-1226	46	2	levels	level	NOUN
cuesj-1226	46	3	of	of	ADP
cuesj-1226	46	4	hematological	hematological	ADJ
cuesj-1226	46	5	parameters	parameter	NOUN
cuesj-1226	46	6	among	among	ADP
cuesj-1226	46	7	covid-19	covid-19	PROPN
cuesj-1226	46	8	-	-	PUNCT
cuesj-1226	46	9	recovered	recover	VERB
cuesj-1226	46	10	patients	patient	NOUN
cuesj-1226	46	11	and	and	CCONJ
cuesj-1226	46	12	healthy	healthy	ADJ
cuesj-1226	46	13	group	group	NOUN
cuesj-1226	46	14	table	table	NOUN
cuesj-1226	46	15	4	4	NUM
cuesj-1226	46	16	shows	show	VERB
cuesj-1226	46	17	all	all	DET
cuesj-1226	46	18	means	mean	NOUN
cuesj-1226	46	19	of	of	ADP
cuesj-1226	46	20	hematological	hematological	ADJ
cuesj-1226	46	21	parameters	parameter	NOUN
cuesj-1226	46	22	versus	versus	ADP
cuesj-1226	46	23	healthy	healthy	ADJ
cuesj-1226	46	24	group	group	NOUN
cuesj-1226	46	25	mean	mean	NOUN
cuesj-1226	46	26	levels	level	NOUN
cuesj-1226	46	27	.	.	PUNCT
cuesj-1226	47	1	when	when	SCONJ
cuesj-1226	47	2	the	the	DET
cuesj-1226	47	3	mean	mean	NOUN
cuesj-1226	47	4	of	of	ADP
cuesj-1226	47	5	total	total	ADJ
cuesj-1226	47	6	wbc	wbc	ADJ
cuesj-1226	47	7	count	count	NOUN
cuesj-1226	47	8	in	in	ADP
cuesj-1226	47	9	covid-19	covid-19	PROPN
cuesj-1226	47	10	-	-	PUNCT
cuesj-1226	47	11	recovered	recover	VERB
cuesj-1226	47	12	patients	patient	NOUN
cuesj-1226	47	13	was	be	AUX
cuesj-1226	47	14	compared	compare	VERB
cuesj-1226	47	15	to	to	ADP
cuesj-1226	47	16	the	the	DET
cuesj-1226	47	17	healthy	healthy	ADJ
cuesj-1226	47	18	group	group	NOUN
cuesj-1226	47	19	,	,	PUNCT
cuesj-1226	47	20	it	it	PRON
cuesj-1226	47	21	showed	show	VERB
cuesj-1226	47	22	a	a	DET
cuesj-1226	47	23	highly	highly	ADV
cuesj-1226	47	24	significant	significant	ADJ
cuesj-1226	47	25	increase	increase	NOUN
cuesj-1226	47	26	(	(	PUNCT
cuesj-1226	47	27	p	p	X
cuesj-1226	47	28	<	<	X
cuesj-1226	47	29	0.01	0.01	NUM
cuesj-1226	47	30	)	)	PUNCT
cuesj-1226	47	31	.	.	PUNCT
cuesj-1226	48	1	while	while	SCONJ
cuesj-1226	48	2	the	the	DET
cuesj-1226	48	3	mean	mean	ADJ
cuesj-1226	48	4	level	level	NOUN
cuesj-1226	48	5	of	of	ADP
cuesj-1226	48	6	lymphocyte	lymphocyte	ADJ
cuesj-1226	48	7	counts	count	NOUN
cuesj-1226	48	8	reveals	reveal	VERB
cuesj-1226	48	9	a	a	DET
cuesj-1226	48	10	highly	highly	ADV
cuesj-1226	48	11	significant	significant	ADJ
cuesj-1226	48	12	decrease	decrease	NOUN
cuesj-1226	48	13	when	when	SCONJ
cuesj-1226	48	14	compared	compare	VERB
cuesj-1226	48	15	to	to	ADP
cuesj-1226	48	16	the	the	DET
cuesj-1226	48	17	healthy	healthy	ADJ
cuesj-1226	48	18	group	group	NOUN
cuesj-1226	48	19	(	(	PUNCT
cuesj-1226	48	20	p	p	X
cuesj-1226	48	21	<	<	X
cuesj-1226	48	22	0.01	0.01	NUM
cuesj-1226	48	23	)	)	PUNCT
cuesj-1226	48	24	,	,	PUNCT
cuesj-1226	48	25	the	the	DET
cuesj-1226	48	26	mean	mean	NOUN
cuesj-1226	48	27	of	of	ADP
cuesj-1226	48	28	granulocyte	granulocyte	ADJ
cuesj-1226	48	29	counts	count	NOUN
cuesj-1226	48	30	of	of	ADP
cuesj-1226	48	31	covid-19	covid-19	PROPN
cuesj-1226	48	32	-	-	PUNCT
cuesj-1226	48	33	recovered	recover	VERB
cuesj-1226	48	34	patients	patient	NOUN
cuesj-1226	48	35	presents	present	VERB
cuesj-1226	48	36	a	a	DET
cuesj-1226	48	37	non	non	ADJ
cuesj-1226	48	38	-	-	ADJ
cuesj-1226	48	39	significant	significant	ADJ
cuesj-1226	48	40	rise	rise	NOUN
cuesj-1226	48	41	in	in	ADP
cuesj-1226	48	42	comparison	comparison	NOUN
cuesj-1226	48	43	to	to	ADP
cuesj-1226	48	44	the	the	DET
cuesj-1226	48	45	mean	mean	ADJ
cuesj-1226	48	46	neutrophil	neutrophil	ADJ
cuesj-1226	48	47	counts	count	NOUN
cuesj-1226	48	48	of	of	ADP
cuesj-1226	48	49	the	the	DET
cuesj-1226	48	50	healthy	healthy	ADJ
cuesj-1226	48	51	figure	figure	NOUN
cuesj-1226	48	52	1	1	NUM
cuesj-1226	48	53	:	:	PUNCT
cuesj-1226	48	54	gender	gender	NOUN
cuesj-1226	48	55	of	of	ADP
cuesj-1226	48	56	the	the	DET
cuesj-1226	48	57	covid-19	covid-19	PROPN
cuesj-1226	48	58	-	-	PUNCT
cuesj-1226	48	59	recovered	recover	VERB
cuesj-1226	48	60	patients	patient	NOUN
cuesj-1226	48	61	ubeid	ubeid	NOUN
cuesj-1226	48	62	,	,	PUNCT
cuesj-1226	48	63	et	et	PROPN
cuesj-1226	48	64	al	al	PROPN
cuesj-1226	48	65	.	.	PUNCT
cuesj-1226	48	66	:	:	PUNCT
cuesj-1226	49	1	vitamin	vitamin	NOUN
cuesj-1226	49	2	d	d	PROPN
cuesj-1226	49	3	levels	level	NOUN
cuesj-1226	49	4	in	in	ADP
cuesj-1226	49	5	coronavirus	coronavirus	NOUN
cuesj-1226	49	6	-	-	PUNCT
cuesj-1226	49	7	infected	infect	VERB
cuesj-1226	49	8	individuals	individual	NOUN
cuesj-1226	49	9	33	33	NUM
cuesj-1226	49	10	http://journals.cihanuniversity.edu.iq/index.php/cuesj	http://journals.cihanuniversity.edu.iq/index.php/cuesj	ADJ
cuesj-1226	49	11	cuesj	cuesj	NOUN
cuesj-1226	49	12	2024	2024	NUM
cuesj-1226	49	13	,	,	PUNCT
cuesj-1226	49	14	8	8	NUM
cuesj-1226	49	15	(	(	PUNCT
cuesj-1226	49	16	2	2	NUM
cuesj-1226	49	17	):	):	PUNCT
cuesj-1226	49	18	31	31	NUM
cuesj-1226	49	19	-	-	SYM
cuesj-1226	49	20	35	35	NUM
cuesj-1226	49	21	group	group	NOUN
cuesj-1226	49	22	(	(	PUNCT
cuesj-1226	49	23	p	p	X
cuesj-1226	49	24	≥	≥	NOUN
cuesj-1226	49	25	0.05	0.05	NUM
cuesj-1226	49	26	)	)	PUNCT
cuesj-1226	49	27	.	.	PUNCT
cuesj-1226	50	1	however	however	ADV
cuesj-1226	50	2	,	,	PUNCT
cuesj-1226	50	3	the	the	DET
cuesj-1226	50	4	mean	mean	ADJ
cuesj-1226	50	5	counts	count	NOUN
cuesj-1226	50	6	of	of	ADP
cuesj-1226	50	7	monocytes	monocyte	NOUN
cuesj-1226	50	8	showed	show	VERB
cuesj-1226	50	9	a	a	DET
cuesj-1226	50	10	non	non	ADJ
cuesj-1226	50	11	-	-	ADJ
cuesj-1226	50	12	significant	significant	ADJ
cuesj-1226	50	13	difference	difference	NOUN
cuesj-1226	50	14	between	between	ADP
cuesj-1226	50	15	covid-19recovered	covid-19recovere	VERB
cuesj-1226	50	16	patients	patient	NOUN
cuesj-1226	50	17	and	and	CCONJ
cuesj-1226	50	18	the	the	DET
cuesj-1226	50	19	healthy	healthy	ADJ
cuesj-1226	50	20	group	group	NOUN
cuesj-1226	50	21	(	(	PUNCT
cuesj-1226	50	22	p	p	X
cuesj-1226	50	23	≥	≥	NOUN
cuesj-1226	50	24	0.05	0.05	NUM
cuesj-1226	50	25	)	)	PUNCT
cuesj-1226	50	26	.	.	PUNCT
cuesj-1226	51	1	the	the	DET
cuesj-1226	51	2	mean	mean	ADJ
cuesj-1226	51	3	count	count	NOUN
cuesj-1226	51	4	of	of	ADP
cuesj-1226	51	5	rbc	rbc	PROPN
cuesj-1226	51	6	in	in	ADP
cuesj-1226	51	7	covid-19	covid-19	PROPN
cuesj-1226	51	8	-	-	PUNCT
cuesj-1226	51	9	recovered	recover	VERB
cuesj-1226	51	10	patients	patient	NOUN
cuesj-1226	51	11	showed	show	VERB
cuesj-1226	51	12	a	a	DET
cuesj-1226	51	13	non	non	ADJ
cuesj-1226	51	14	-	-	ADJ
cuesj-1226	51	15	significant	significant	ADJ
cuesj-1226	51	16	rise	rise	NOUN
cuesj-1226	51	17	when	when	SCONJ
cuesj-1226	51	18	compared	compare	VERB
cuesj-1226	51	19	to	to	ADP
cuesj-1226	51	20	the	the	DET
cuesj-1226	51	21	healthy	healthy	ADJ
cuesj-1226	51	22	group	group	NOUN
cuesj-1226	51	23	(	(	PUNCT
cuesj-1226	51	24	p	p	X
cuesj-1226	51	25	≥	≥	NOUN
cuesj-1226	51	26	0.05	0.05	NUM
cuesj-1226	51	27	)	)	PUNCT
cuesj-1226	51	28	.	.	PUNCT
cuesj-1226	52	1	the	the	DET
cuesj-1226	52	2	mean	mean	ADJ
cuesj-1226	52	3	concentration	concentration	NOUN
cuesj-1226	52	4	of	of	ADP
cuesj-1226	52	5	hb	hb	PROPN
cuesj-1226	52	6	reveals	reveal	VERB
cuesj-1226	52	7	a	a	DET
cuesj-1226	52	8	highly	highly	ADV
cuesj-1226	52	9	significant	significant	ADJ
cuesj-1226	52	10	increase	increase	NOUN
cuesj-1226	52	11	when	when	SCONJ
cuesj-1226	52	12	compared	compare	VERB
cuesj-1226	52	13	to	to	ADP
cuesj-1226	52	14	the	the	DET
cuesj-1226	52	15	healthy	healthy	ADJ
cuesj-1226	52	16	group	group	NOUN
cuesj-1226	52	17	(	(	PUNCT
cuesj-1226	52	18	p	p	X
cuesj-1226	52	19	<	<	X
cuesj-1226	52	20	0.01	0.01	NUM
cuesj-1226	52	21	)	)	PUNCT
cuesj-1226	52	22	.	.	PUNCT
cuesj-1226	53	1	platelet	platelet	NOUN
cuesj-1226	53	2	mean	mean	PROPN
cuesj-1226	53	3	count	count	NOUN
cuesj-1226	53	4	presents	present	VERB
cuesj-1226	53	5	a	a	DET
cuesj-1226	53	6	significant	significant	ADJ
cuesj-1226	53	7	rise	rise	NOUN
cuesj-1226	53	8	when	when	SCONJ
cuesj-1226	53	9	compared	compare	VERB
cuesj-1226	53	10	to	to	ADP
cuesj-1226	53	11	the	the	DET
cuesj-1226	53	12	healthy	healthy	ADJ
cuesj-1226	53	13	group	group	NOUN
cuesj-1226	53	14	(	(	PUNCT
cuesj-1226	53	15	p	p	X
cuesj-1226	53	16	<	<	X
cuesj-1226	53	17	0.05	0.05	NUM
cuesj-1226	53	18	)	)	PUNCT
cuesj-1226	53	19	.	.	PUNCT
cuesj-1226	54	1	discussion	discussion	NOUN
cuesj-1226	54	2	from	from	ADP
cuesj-1226	54	3	98	98	NUM
cuesj-1226	54	4	blood	blood	NOUN
cuesj-1226	54	5	samples	sample	NOUN
cuesj-1226	54	6	(	(	PUNCT
cuesj-1226	54	7	60	60	NUM
cuesj-1226	54	8	males	male	NOUN
cuesj-1226	54	9	and	and	CCONJ
cuesj-1226	54	10	38	38	NUM
cuesj-1226	54	11	females	female	NOUN
cuesj-1226	54	12	)	)	PUNCT
cuesj-1226	54	13	,	,	PUNCT
cuesj-1226	54	14	the	the	DET
cuesj-1226	54	15	results	result	NOUN
cuesj-1226	54	16	indicated	indicate	VERB
cuesj-1226	54	17	that	that	SCONJ
cuesj-1226	54	18	20	20	NUM
cuesj-1226	54	19	were	be	AUX
cuesj-1226	54	20	infected	infect	VERB
cuesj-1226	54	21	with	with	ADP
cuesj-1226	54	22	covid-19	covid-19	PROPN
cuesj-1226	54	23	.	.	PUNCT
cuesj-1226	55	1	among	among	ADP
cuesj-1226	55	2	patients	patient	NOUN
cuesj-1226	55	3	with	with	ADP
cuesj-1226	55	4	covid-19	covid-19	PROPN
cuesj-1226	55	5	,	,	PUNCT
cuesj-1226	55	6	the	the	DET
cuesj-1226	55	7	majority	majority	NOUN
cuesj-1226	55	8	of	of	ADP
cuesj-1226	55	9	cases	case	NOUN
cuesj-1226	55	10	were	be	AUX
cuesj-1226	55	11	among	among	ADP
cuesj-1226	55	12	the	the	DET
cuesj-1226	55	13	male	male	ADJ
cuesj-1226	55	14	group	group	NOUN
cuesj-1226	55	15	60/98	60/98	NUM
cuesj-1226	55	16	(	(	PUNCT
cuesj-1226	55	17	61	61	NUM
cuesj-1226	55	18	%	%	NOUN
cuesj-1226	55	19	)	)	PUNCT
cuesj-1226	55	20	,	,	PUNCT
cuesj-1226	55	21	while	while	SCONJ
cuesj-1226	55	22	in	in	ADP
cuesj-1226	55	23	the	the	DET
cuesj-1226	55	24	female	female	ADJ
cuesj-1226	55	25	group	group	NOUN
cuesj-1226	55	26	,	,	PUNCT
cuesj-1226	55	27	the	the	DET
cuesj-1226	55	28	prevalence	prevalence	NOUN
cuesj-1226	55	29	was	be	AUX
cuesj-1226	55	30	38/98	38/98	NUM
cuesj-1226	55	31	(	(	PUNCT
cuesj-1226	55	32	39	39	NUM
cuesj-1226	55	33	%	%	NOUN
cuesj-1226	55	34	)	)	PUNCT
cuesj-1226	55	35	.	.	PUNCT
cuesj-1226	56	1	this	this	PRON
cuesj-1226	56	2	may	may	AUX
cuesj-1226	56	3	be	be	AUX
cuesj-1226	56	4	due	due	ADJ
cuesj-1226	56	5	to	to	ADP
cuesj-1226	56	6	the	the	DET
cuesj-1226	56	7	males	male	NOUN
cuesj-1226	56	8	in	in	ADP
cuesj-1226	56	9	our	our	PRON
cuesj-1226	56	10	region	region	NOUN
cuesj-1226	56	11	are	be	AUX
cuesj-1226	56	12	more	more	ADV
cuesj-1226	56	13	exposed	expose	VERB
cuesj-1226	56	14	to	to	ADP
cuesj-1226	56	15	people	people	NOUN
cuesj-1226	56	16	when	when	SCONJ
cuesj-1226	56	17	compared	compare	VERB
cuesj-1226	56	18	with	with	ADP
cuesj-1226	56	19	females	female	NOUN
cuesj-1226	56	20	who	who	PRON
cuesj-1226	56	21	spend	spend	VERB
cuesj-1226	56	22	most	most	ADJ
cuesj-1226	56	23	of	of	ADP
cuesj-1226	56	24	their	their	PRON
cuesj-1226	56	25	time	time	NOUN
cuesj-1226	56	26	at	at	ADP
cuesj-1226	56	27	home	home	NOUN
cuesj-1226	56	28	with	with	ADP
cuesj-1226	56	29	their	their	PRON
cuesj-1226	56	30	families	family	NOUN
cuesj-1226	56	31	.	.	PUNCT
cuesj-1226	57	1	another	another	DET
cuesj-1226	57	2	reason	reason	NOUN
cuesj-1226	57	3	may	may	AUX
cuesj-1226	57	4	be	be	AUX
cuesj-1226	57	5	due	due	ADJ
cuesj-1226	57	6	to	to	ADP
cuesj-1226	57	7	females	female	NOUN
cuesj-1226	57	8	having	have	VERB
cuesj-1226	57	9	more	more	ADJ
cuesj-1226	57	10	awareness	awareness	NOUN
cuesj-1226	57	11	in	in	ADP
cuesj-1226	57	12	comparison	comparison	NOUN
cuesj-1226	57	13	with	with	ADP
cuesj-1226	57	14	the	the	DET
cuesj-1226	57	15	males	male	NOUN
cuesj-1226	57	16	in	in	ADP
cuesj-1226	57	17	sanitation	sanitation	NOUN
cuesj-1226	57	18	level	level	NOUN
cuesj-1226	57	19	.	.	PUNCT
cuesj-1226	58	1	the	the	DET
cuesj-1226	58	2	test	test	NOUN
cuesj-1226	58	3	results	result	NOUN
cuesj-1226	58	4	indicated	indicate	VERB
cuesj-1226	58	5	that	that	SCONJ
cuesj-1226	58	6	for	for	ADP
cuesj-1226	58	7	igm	igm	PROPN
cuesj-1226	58	8	antibodies	antibodie	VERB
cuesj-1226	58	9	among	among	ADP
cuesj-1226	58	10	98	98	NUM
cuesj-1226	58	11	samples	sample	NOUN
cuesj-1226	58	12	,	,	PUNCT
cuesj-1226	58	13	all	all	PRON
cuesj-1226	58	14	of	of	ADP
cuesj-1226	58	15	them	they	PRON
cuesj-1226	58	16	were	be	AUX
cuesj-1226	58	17	negative	negative	ADJ
cuesj-1226	58	18	(	(	PUNCT
cuesj-1226	58	19	100	100	NUM
cuesj-1226	58	20	%	%	NOUN
cuesj-1226	58	21	)	)	PUNCT
cuesj-1226	58	22	,	,	PUNCT
cuesj-1226	58	23	while	while	SCONJ
cuesj-1226	58	24	for	for	SCONJ
cuesj-1226	58	25	igg	igg	PROPN
cuesj-1226	58	26	antibodies	antibodie	VERB
cuesj-1226	58	27	,	,	PUNCT
cuesj-1226	58	28	all	all	DET
cuesj-1226	58	29	samples	sample	NOUN
cuesj-1226	58	30	were	be	AUX
cuesj-1226	58	31	positive	positive	ADJ
cuesj-1226	58	32	(	(	PUNCT
cuesj-1226	58	33	100	100	NUM
cuesj-1226	58	34	%	%	NOUN
cuesj-1226	58	35	)	)	PUNCT
cuesj-1226	58	36	.	.	PUNCT
cuesj-1226	59	1	at	at	ADP
cuesj-1226	59	2	the	the	DET
cuesj-1226	59	3	same	same	ADJ
cuesj-1226	59	4	time	time	NOUN
cuesj-1226	59	5	,	,	PUNCT
cuesj-1226	59	6	ige	ige	NOUN
cuesj-1226	59	7	antibody	antibody	NOUN
cuesj-1226	59	8	level	level	NOUN
cuesj-1226	59	9	in	in	ADP
cuesj-1226	59	10	the	the	DET
cuesj-1226	59	11	serum	serum	NOUN
cuesj-1226	59	12	of	of	ADP
cuesj-1226	59	13	covid-19	covid-19	PROPN
cuesj-1226	59	14	-	-	PUNCT
cuesj-1226	59	15	recovered	recover	VERB
cuesj-1226	59	16	patients	patient	NOUN
cuesj-1226	59	17	is	be	AUX
cuesj-1226	59	18	significantly	significantly	ADV
cuesj-1226	59	19	increased	increase	VERB
cuesj-1226	59	20	compared	compare	VERB
cuesj-1226	59	21	to	to	ADP
cuesj-1226	59	22	the	the	DET
cuesj-1226	59	23	healthy	healthy	ADJ
cuesj-1226	59	24	group	group	NOUN
cuesj-1226	59	25	.	.	PUNCT
cuesj-1226	60	1	serum	serum	PROPN
cuesj-1226	60	2	vitamin	vitamin	NOUN
cuesj-1226	60	3	d3	d3	PROPN
cuesj-1226	60	4	detection	detection	NOUN
cuesj-1226	60	5	among	among	ADP
cuesj-1226	60	6	covid-19	covid-19	PROPN
cuesj-1226	60	7	-	-	PUNCT
cuesj-1226	60	8	recovered	recover	VERB
cuesj-1226	60	9	patients	patient	NOUN
cuesj-1226	60	10	revealed	reveal	VERB
cuesj-1226	60	11	that	that	SCONJ
cuesj-1226	60	12	means	mean	NOUN
cuesj-1226	60	13	were	be	AUX
cuesj-1226	60	14	highly	highly	ADV
cuesj-1226	60	15	significantly	significantly	ADV
cuesj-1226	60	16	declined	decline	VERB
cuesj-1226	60	17	(	(	PUNCT
cuesj-1226	60	18	mean	mean	PROPN
cuesj-1226	60	19	±	±	NUM
cuesj-1226	60	20	se	se	X
cuesj-1226	60	21	17.99	17.99	NUM
cuesj-1226	60	22	±	±	NUM
cuesj-1226	60	23	1.34	1.34	NUM
cuesj-1226	60	24	)	)	PUNCT
cuesj-1226	60	25	(	(	PUNCT
cuesj-1226	60	26	p	p	X
cuesj-1226	60	27	<	<	X
cuesj-1226	60	28	0.01	0.01	NUM
cuesj-1226	60	29	)	)	PUNCT
cuesj-1226	60	30	when	when	SCONJ
cuesj-1226	60	31	compared	compare	VERB
cuesj-1226	60	32	to	to	ADP
cuesj-1226	60	33	the	the	DET
cuesj-1226	60	34	healthy	healthy	ADJ
cuesj-1226	60	35	group	group	NOUN
cuesj-1226	60	36	(	(	PUNCT
cuesj-1226	60	37	mean	mean	PROPN
cuesj-1226	60	38	±	±	NUM
cuesj-1226	60	39	se	se	X
cuesj-1226	60	40	30.61	30.61	NUM
cuesj-1226	60	41	±	±	NUM
cuesj-1226	60	42	1.54	1.54	NUM
cuesj-1226	60	43	)	)	PUNCT
cuesj-1226	60	44	.	.	PUNCT
cuesj-1226	61	1	note	note	VERB
cuesj-1226	61	2	that	that	SCONJ
cuesj-1226	61	3	there	there	PRON
cuesj-1226	61	4	is	be	VERB
cuesj-1226	61	5	disagreement	disagreement	NOUN
cuesj-1226	61	6	over	over	ADP
cuesj-1226	61	7	the	the	DET
cuesj-1226	61	8	cut	cut	VERB
cuesj-1226	61	9	-	-	PUNCT
cuesj-1226	61	10	off	off	ADP
cuesj-1226	61	11	vitamin	vitamin	NOUN
cuesj-1226	61	12	d	d	NOUN
cuesj-1226	61	13	level	level	NOUN
cuesj-1226	61	14	for	for	ADP
cuesj-1226	61	15	assessing	assess	VERB
cuesj-1226	61	16	vitamin	vitamin	NOUN
cuesj-1226	61	17	d	d	NOUN
cuesj-1226	61	18	sufficiency	sufficiency	NOUN
cuesj-1226	61	19	or	or	CCONJ
cuesj-1226	61	20	deficiency	deficiency	NOUN
cuesj-1226	61	21	.	.	PUNCT
cuesj-1226	62	1	given	give	VERB
cuesj-1226	62	2	the	the	DET
cuesj-1226	62	3	importance	importance	NOUN
cuesj-1226	62	4	of	of	ADP
cuesj-1226	62	5	vitamin	vitamin	NOUN
cuesj-1226	62	6	d3	d3	PROPN
cuesj-1226	62	7	for	for	ADP
cuesj-1226	62	8	immune	immune	ADJ
cuesj-1226	62	9	system	system	NOUN
cuesj-1226	62	10	function	function	NOUN
cuesj-1226	62	11	,	,	PUNCT
cuesj-1226	62	12	many	many	ADJ
cuesj-1226	62	13	individuals	individual	NOUN
cuesj-1226	62	14	wonder	wonder	VERB
cuesj-1226	62	15	if	if	SCONJ
cuesj-1226	62	16	taking	take	VERB
cuesj-1226	62	17	supplements	supplement	NOUN
cuesj-1226	62	18	of	of	ADP
cuesj-1226	62	19	the	the	DET
cuesj-1226	62	20	vitamin	vitamin	NOUN
cuesj-1226	62	21	could	could	AUX
cuesj-1226	62	22	reduce	reduce	VERB
cuesj-1226	62	23	the	the	DET
cuesj-1226	62	24	risk	risk	NOUN
cuesj-1226	62	25	of	of	ADP
cuesj-1226	62	26	contracting	contract	VERB
cuesj-1226	62	27	the	the	DET
cuesj-1226	62	28	new	new	ADJ
cuesj-1226	62	29	coronavirus	coronavirus	NOUN
cuesj-1226	62	30	that	that	PRON
cuesj-1226	62	31	causes	cause	VERB
cuesj-1226	62	32	covid-19	covid-19	PROPN
cuesj-1226	62	33	.	.	PUNCT
cuesj-1226	63	1	although	although	SCONJ
cuesj-1226	63	2	there	there	PRON
cuesj-1226	63	3	is	be	VERB
cuesj-1226	63	4	currently	currently	ADV
cuesj-1226	63	5	no	no	DET
cuesj-1226	63	6	cure	cure	NOUN
cuesj-1226	63	7	for	for	ADP
cuesj-1226	63	8	covid-19	covid-19	PROPN
cuesj-1226	63	9	,	,	PUNCT
cuesj-1226	63	10	you	you	PRON
cuesj-1226	63	11	can	can	AUX
cuesj-1226	63	12	avoid	avoid	VERB
cuesj-1226	63	13	contracting	contract	VERB
cuesj-1226	63	14	the	the	DET
cuesj-1226	63	15	virus	virus	NOUN
cuesj-1226	63	16	by	by	ADP
cuesj-1226	63	17	taking	take	VERB
cuesj-1226	63	18	precautionary	precautionary	ADJ
cuesj-1226	63	19	steps	step	NOUN
cuesj-1226	63	20	,	,	PUNCT
cuesj-1226	63	21	such	such	ADJ
cuesj-1226	63	22	as	as	ADP
cuesj-1226	63	23	physical	physical	ADJ
cuesj-1226	63	24	isolation	isolation	NOUN
cuesj-1226	63	25	and	and	CCONJ
cuesj-1226	63	26	maintaining	maintain	VERB
cuesj-1226	63	27	basic	basic	ADJ
cuesj-1226	63	28	hygiene	hygiene	NOUN
cuesj-1226	63	29	.	.	PUNCT
cuesj-1226	64	1	in	in	ADP
cuesj-1226	64	2	addition	addition	NOUN
cuesj-1226	64	3	,	,	PUNCT
cuesj-1226	64	4	some	some	DET
cuesj-1226	64	5	research	research	NOUN
cuesj-1226	64	6	indicates	indicate	VERB
cuesj-1226	64	7	that	that	SCONJ
cuesj-1226	64	8	maintaining	maintain	VERB
cuesj-1226	64	9	healthy	healthy	ADJ
cuesj-1226	64	10	vitamin	vitamin	NOUN
cuesj-1226	64	11	d	d	NOUN
cuesj-1226	64	12	levels	level	NOUN
cuesj-1226	64	13	will	will	AUX
cuesj-1226	64	14	strengthen	strengthen	VERB
cuesj-1226	64	15	your	your	PRON
cuesj-1226	64	16	immune	immune	ADJ
cuesj-1226	64	17	system	system	NOUN
cuesj-1226	64	18	and	and	CCONJ
cuesj-1226	64	19	potentially	potentially	ADV
cuesj-1226	64	20	guard	guard	VERB
cuesj-1226	64	21	against	against	ADP
cuesj-1226	64	22	respiratory	respiratory	ADJ
cuesj-1226	64	23	illnesses	illness	NOUN
cuesj-1226	64	24	in	in	ADP
cuesj-1226	64	25	general	general	ADJ
cuesj-1226	64	26	.	.	PUNCT
cuesj-1226	65	1	a	a	DET
cuesj-1226	65	2	recent	recent	ADJ
cuesj-1226	65	3	study	study	NOUN
cuesj-1226	65	4	by	by	ADP
cuesj-1226	65	5	maghbooli	maghbooli	PROPN
cuesj-1226	65	6	et	et	PROPN
cuesj-1226	65	7	al.[8	al.[8	PROPN
cuesj-1226	65	8	]	]	PUNCT
cuesj-1226	65	9	found	find	VERB
cuesj-1226	65	10	that	that	PRON
cuesj-1226	65	11	hospitalized	hospitalize	VERB
cuesj-1226	65	12	covid-19	covid-19	PROPN
cuesj-1226	65	13	patients	patient	NOUN
cuesj-1226	65	14	with	with	ADP
cuesj-1226	65	15	adequate	adequate	ADJ
cuesj-1226	65	16	vitamin	vitamin	NOUN
cuesj-1226	65	17	d	d	NOUN
cuesj-1226	65	18	levels	level	NOUN
cuesj-1226	65	19	had	have	VERB
cuesj-1226	65	20	a	a	DET
cuesj-1226	65	21	decreased	decrease	VERB
cuesj-1226	65	22	risk	risk	NOUN
cuesj-1226	65	23	of	of	ADP
cuesj-1226	65	24	adverse	adverse	ADJ
cuesj-1226	65	25	outcomes	outcome	NOUN
cuesj-1226	65	26	and	and	CCONJ
cuesj-1226	65	27	mortality	mortality	NOUN
cuesj-1226	65	28	.	.	PUNCT
cuesj-1226	66	1	the	the	DET
cuesj-1226	66	2	study	study	NOUN
cuesj-1226	66	3	found	find	VERB
cuesj-1226	66	4	that	that	SCONJ
cuesj-1226	66	5	32.8	32.8	NUM
cuesj-1226	66	6	%	%	NOUN
cuesj-1226	66	7	of	of	ADP
cuesj-1226	66	8	covid-19	covid-19	PROPN
cuesj-1226	66	9	patients	patient	NOUN
cuesj-1226	66	10	at	at	ADP
cuesj-1226	66	11	sina	sina	PROPN
cuesj-1226	66	12	hospital	hospital	PROPN
cuesj-1226	66	13	in	in	ADP
cuesj-1226	66	14	tehran	tehran	PROPN
cuesj-1226	66	15	,	,	PUNCT
cuesj-1226	66	16	iran	iran	PROPN
cuesj-1226	66	17	,	,	PUNCT
cuesj-1226	66	18	had	have	VERB
cuesj-1226	66	19	vitamin	vitamin	NOUN
cuesj-1226	66	20	d	d	NOUN
cuesj-1226	66	21	insufficiency	insufficiency	NOUN
cuesj-1226	66	22	.	.	PUNCT
cuesj-1226	67	1	several	several	ADJ
cuesj-1226	67	2	of	of	ADP
cuesj-1226	67	3	researchers	researcher	NOUN
cuesj-1226	67	4	have	have	AUX
cuesj-1226	67	5	recently	recently	ADV
cuesj-1226	67	6	discussed	discuss	VERB
cuesj-1226	67	7	the	the	DET
cuesj-1226	67	8	role	role	NOUN
cuesj-1226	67	9	that	that	PRON
cuesj-1226	67	10	vitamin	vitamin	NOUN
cuesj-1226	67	11	d	d	NOUN
cuesj-1226	67	12	plays	play	VERB
cuesj-1226	67	13	in	in	ADP
cuesj-1226	67	14	preventing	prevent	VERB
cuesj-1226	67	15	covid-19	covid-19	PROPN
cuesj-1226	67	16	or	or	CCONJ
cuesj-1226	67	17	in	in	ADP
cuesj-1226	67	18	treating	treat	VERB
cuesj-1226	67	19	table	table	NOUN
cuesj-1226	67	20	1	1	NUM
cuesj-1226	67	21	:	:	PUNCT
cuesj-1226	67	22	positive	positive	ADJ
cuesj-1226	67	23	and	and	CCONJ
cuesj-1226	67	24	negative	negative	ADJ
cuesj-1226	67	25	igm	igm	NOUN
cuesj-1226	67	26	and	and	CCONJ
cuesj-1226	67	27	igg	igg	PROPN
cuesj-1226	67	28	among	among	ADP
cuesj-1226	67	29	covid-19	covid-19	PROPN
cuesj-1226	67	30	-	-	PUNCT
cuesj-1226	67	31	recovered	recover	VERB
cuesj-1226	67	32	patients	patient	NOUN
cuesj-1226	67	33	parameter	parameter	INTJ
cuesj-1226	67	34	no	no	INTJ
cuesj-1226	67	35	.	.	PUNCT
cuesj-1226	68	1	positive	positive	ADJ
cuesj-1226	68	2	cases	case	NOUN
cuesj-1226	68	3	negative	negative	ADJ
cuesj-1226	68	4	cases	case	NOUN
cuesj-1226	68	5	(	(	PUNCT
cuesj-1226	68	6	%	%	INTJ
cuesj-1226	68	7	)	)	PUNCT
cuesj-1226	68	8	(	(	PUNCT
cuesj-1226	68	9	%	%	INTJ
cuesj-1226	68	10	)	)	PUNCT
cuesj-1226	68	11	igm	igm	PROPN
cuesj-1226	68	12	(	(	PUNCT
cuesj-1226	68	13	ng	ng	PROPN
cuesj-1226	68	14	/	/	SYM
cuesj-1226	68	15	ml	ml	NOUN
cuesj-1226	68	16	)	)	PUNCT
cuesj-1226	68	17	98	98	NUM
cuesj-1226	68	18	0	0	NUM
cuesj-1226	68	19	100	100	NUM
cuesj-1226	68	20	igg	igg	PROPN
cuesj-1226	68	21	(	(	PUNCT
cuesj-1226	68	22	ng	ng	PROPN
cuesj-1226	68	23	/	/	SYM
cuesj-1226	68	24	ml	ml	NOUN
cuesj-1226	68	25	)	)	PUNCT
cuesj-1226	68	26	98	98	NUM
cuesj-1226	68	27	100	100	NUM
cuesj-1226	68	28	0	0	NUM
cuesj-1226	68	29	table	table	NOUN
cuesj-1226	68	30	4	4	NUM
cuesj-1226	68	31	:	:	PUNCT
cuesj-1226	68	32	mean	mean	ADJ
cuesj-1226	68	33	levels	level	NOUN
cuesj-1226	68	34	of	of	ADP
cuesj-1226	68	35	hematological	hematological	ADJ
cuesj-1226	68	36	parameters	parameter	NOUN
cuesj-1226	68	37	among	among	ADP
cuesj-1226	68	38	covid-19	covid-19	PROPN
cuesj-1226	68	39	-	-	PUNCT
cuesj-1226	68	40	recovered	recover	VERB
cuesj-1226	68	41	patients	patient	NOUN
cuesj-1226	68	42	and	and	CCONJ
cuesj-1226	68	43	healthy	healthy	ADJ
cuesj-1226	68	44	group	group	NOUN
cuesj-1226	68	45	hematological	hematological	NOUN
cuesj-1226	68	46	parameters	parameter	NOUN
cuesj-1226	68	47	covid-19	covid-19	PROPN
cuesj-1226	68	48	-	-	PUNCT
cuesj-1226	68	49	recovered	recover	VERB
cuesj-1226	68	50	patients	patient	NOUN
cuesj-1226	68	51	healthy	healthy	ADJ
cuesj-1226	68	52	group	group	NOUN
cuesj-1226	68	53	t	t	PROPN
cuesj-1226	68	54	-	-	PUNCT
cuesj-1226	68	55	test	test	NOUN
cuesj-1226	68	56	p	p	NOUN
cuesj-1226	68	57	-	-	PUNCT
cuesj-1226	68	58	value	value	NOUN
cuesj-1226	68	59	p	p	NOUN
cuesj-1226	68	60	-	-	PUNCT
cuesj-1226	68	61	value	value	NOUN
cuesj-1226	68	62	no	no	NOUN
cuesj-1226	68	63	.	.	PUNCT
cuesj-1226	69	1	mean±se	mean±se	PROPN
cuesj-1226	69	2	no	no	INTJ
cuesj-1226	69	3	.	.	PUNCT
cuesj-1226	70	1	mean±se	mean±se	PROPN
cuesj-1226	70	2	total	total	ADJ
cuesj-1226	70	3	wbc	wbc	PROPN
cuesj-1226	70	4	103/µl	103/µl	NUM
cuesj-1226	70	5	98	98	NUM
cuesj-1226	70	6	6.77±0.16	6.77±0.16	NUM
cuesj-1226	70	7	20	20	NUM
cuesj-1226	70	8	6.45±0.13	6.45±0.13	NUM
cuesj-1226	70	9	0.010	0.010	NUM
cuesj-1226	70	10	h.s	h.s	PROPN
cuesj-1226	70	11	.	.	PROPN
cuesj-1226	70	12	*	*	PUNCT
cuesj-1226	71	1	*	*	PUNCT
cuesj-1226	71	2	lymphocyte	lymphocyte	ADJ
cuesj-1226	71	3	103/µl	103/µl	NUM
cuesj-1226	71	4	98	98	NUM
cuesj-1226	71	5	2.04±0.06	2.04±0.06	NUM
cuesj-1226	71	6	20	20	NUM
cuesj-1226	71	7	2.85±0.13	2.85±0.13	NUM
cuesj-1226	71	8	0.000	0.000	NUM
cuesj-1226	71	9	h.s	h.s	PROPN
cuesj-1226	71	10	.	.	PROPN
cuesj-1226	71	11	*	*	PUNCT
cuesj-1226	71	12	*	*	PUNCT
cuesj-1226	71	13	monocyte	monocyte	NOUN
cuesj-1226	71	14	103/µl	103/µl	NUM
cuesj-1226	71	15	98	98	NUM
cuesj-1226	71	16	0.49±0.01	0.49±0.01	PROPN
cuesj-1226	71	17	20	20	NUM
cuesj-1226	71	18	0.50±0.06	0.50±0.06	NOUN
cuesj-1226	71	19	0.791	0.791	NUM
cuesj-1226	71	20	n.s	n.s	PROPN
cuesj-1226	71	21	.	.	PROPN
cuesj-1226	71	22	granulocyte	granulocyte	PROPN
cuesj-1226	71	23	103/µl	103/µl	NUM
cuesj-1226	71	24	98	98	NUM
cuesj-1226	71	25	4.22±1.08	4.22±1.08	NUM
cuesj-1226	71	26	20	20	NUM
cuesj-1226	71	27	4.08±0.14	4.08±0.14	NUM
cuesj-1226	71	28	0.491	0.491	NUM
cuesj-1226	71	29	n.s	n.s	PROPN
cuesj-1226	71	30	.	.	PROPN
cuesj-1226	71	31	rbc	rbc	PROPN
cuesj-1226	71	32	106/µl	106/µl	NUM
cuesj-1226	71	33	98	98	NUM
cuesj-1226	71	34	4.99±0.12	4.99±0.12	NUM
cuesj-1226	71	35	20	20	NUM
cuesj-1226	71	36	4.05±0.13	4.05±0.13	NUM
cuesj-1226	71	37	0.703	0.703	NUM
cuesj-1226	71	38	n.s	n.s	PROPN
cuesj-1226	71	39	.	.	PROPN
cuesj-1226	71	40	hb	hb	PROPN
cuesj-1226	72	1	g	g	PROPN
cuesj-1226	72	2	/	/	SYM
cuesj-1226	72	3	dl	dl	PROPN
cuesj-1226	72	4	98	98	NUM
cuesj-1226	72	5	14.66±0.16	14.66±0.16	NUM
cuesj-1226	72	6	20	20	NUM
cuesj-1226	72	7	12.95±0.13	12.95±0.13	NUM
cuesj-1226	72	8	0.000	0.000	NUM
cuesj-1226	72	9	h.s	h.s	PROPN
cuesj-1226	72	10	.	.	PROPN
cuesj-1226	73	1	*	*	PUNCT
cuesj-1226	74	1	*	*	PUNCT
cuesj-1226	75	1	platelet	platelet	NOUN
cuesj-1226	76	1	103/µl	103/µl	NUM
cuesj-1226	76	2	98	98	NUM
cuesj-1226	76	3	223.68±0.30	223.68±0.30	NUM
cuesj-1226	76	4	20	20	NUM
cuesj-1226	76	5	206.75±6.90	206.75±6.90	NUM
cuesj-1226	76	6	0.048	0.048	NUM
cuesj-1226	76	7	s.	s.	PROPN
cuesj-1226	76	8	*	*	PUNCT
cuesj-1226	77	1	p	p	X
cuesj-1226	77	2	:	:	PUNCT
cuesj-1226	77	3	probability	probability	NOUN
cuesj-1226	77	4	;	;	PUNCT
cuesj-1226	77	5	p	p	NOUN
cuesj-1226	77	6	value≥0.05	value≥0.05	NOUN
cuesj-1226	77	7	:	:	PUNCT
cuesj-1226	78	1	non‑significant	non‑significant	ADJ
cuesj-1226	78	2	;	;	PUNCT
cuesj-1226	78	3	*	*	PUNCT
cuesj-1226	78	4	p	p	NOUN
cuesj-1226	78	5	value<0.05	value<0.05	NOUN
cuesj-1226	78	6	:	:	PUNCT
cuesj-1226	78	7	significant	significant	ADJ
cuesj-1226	78	8	;	;	PUNCT
cuesj-1226	78	9	*	*	PUNCT
cuesj-1226	78	10	*	*	PUNCT
cuesj-1226	78	11	p<0.01	p<0.01	ADJ
cuesj-1226	78	12	:	:	PUNCT
cuesj-1226	78	13	highly	highly	ADV
cuesj-1226	78	14	significant	significant	ADJ
cuesj-1226	78	15	table	table	NOUN
cuesj-1226	78	16	2	2	NUM
cuesj-1226	78	17	:	:	PUNCT
cuesj-1226	78	18	mean	mean	VERB
cuesj-1226	78	19	serum	serum	NOUN
cuesj-1226	78	20	levels	level	NOUN
cuesj-1226	78	21	of	of	ADP
cuesj-1226	78	22	ige	ige	PROPN
cuesj-1226	78	23	among	among	ADP
cuesj-1226	78	24	covid-19	covid-19	PROPN
cuesj-1226	78	25	-	-	PUNCT
cuesj-1226	78	26	recovered	recover	VERB
cuesj-1226	78	27	patients	patient	NOUN
cuesj-1226	78	28	in	in	ADP
cuesj-1226	78	29	comparison	comparison	NOUN
cuesj-1226	78	30	to	to	ADP
cuesj-1226	78	31	healthy	healthy	ADJ
cuesj-1226	78	32	control	control	NOUN
cuesj-1226	78	33	group	group	PROPN
cuesj-1226	78	34	parameter	parameter	NOUN
cuesj-1226	78	35	no	no	INTJ
cuesj-1226	78	36	.	.	PUNCT
cuesj-1226	79	1	covid-19	covid-19	NOUN
cuesj-1226	79	2	-	-	PUNCT
cuesj-1226	79	3	recovered	recover	VERB
cuesj-1226	79	4	patients	patient	NOUN
cuesj-1226	79	5	no	no	INTJ
cuesj-1226	79	6	.	.	PUNCT
cuesj-1226	80	1	healthy	healthy	ADJ
cuesj-1226	80	2	group	group	PROPN
cuesj-1226	80	3	t	t	PROPN
cuesj-1226	80	4	-	-	PUNCT
cuesj-1226	80	5	test	test	NOUN
cuesj-1226	80	6	p	p	NOUN
cuesj-1226	80	7	-	-	PUNCT
cuesj-1226	80	8	value	value	NOUN
cuesj-1226	80	9	p	p	NOUN
cuesj-1226	80	10	-	-	PUNCT
cuesj-1226	80	11	value	value	NOUN
cuesj-1226	80	12	mean±se	mean±se	PROPN
cuesj-1226	80	13	mean±se	mean±se	PROPN
cuesj-1226	80	14	ige	ige	PROPN
cuesj-1226	80	15	(	(	PUNCT
cuesj-1226	80	16	ng	ng	PROPN
cuesj-1226	80	17	/	/	SYM
cuesj-1226	80	18	ml	ml	NOUN
cuesj-1226	80	19	)	)	PUNCT
cuesj-1226	80	20	98	98	NUM
cuesj-1226	80	21	142.27±33.80	142.27±33.80	NUM
cuesj-1226	80	22	20	20	NUM
cuesj-1226	80	23	30.61±1.54	30.61±1.54	NUM
cuesj-1226	80	24	0.01	0.01	NUM
cuesj-1226	80	25	h.s	h.s	PROPN
cuesj-1226	80	26	.	.	PUNCT
cuesj-1226	80	27	*	*	PUNCT
cuesj-1226	81	1	*	*	PUNCT
cuesj-1226	81	2	p	p	X
cuesj-1226	81	3	:	:	PUNCT
cuesj-1226	81	4	probability	probability	NOUN
cuesj-1226	81	5	,	,	PUNCT
cuesj-1226	81	6	p	p	NOUN
cuesj-1226	81	7	value≥0.05	value≥0.05	NOUN
cuesj-1226	81	8	:	:	PUNCT
cuesj-1226	81	9	non‑significant	non‑significant	ADJ
cuesj-1226	81	10	;	;	PUNCT
cuesj-1226	81	11	*	*	PUNCT
cuesj-1226	81	12	p	p	NOUN
cuesj-1226	81	13	value<0.05	value<0.05	NOUN
cuesj-1226	81	14	:	:	PUNCT
cuesj-1226	81	15	significant	significant	ADJ
cuesj-1226	81	16	;	;	PUNCT
cuesj-1226	81	17	*	*	PUNCT
cuesj-1226	81	18	*	*	PUNCT
cuesj-1226	81	19	p<0.01	p<0.01	ADJ
cuesj-1226	81	20	:	:	PUNCT
cuesj-1226	81	21	highly	highly	ADV
cuesj-1226	81	22	significant	significant	ADJ
cuesj-1226	81	23	,	,	PUNCT
cuesj-1226	81	24	se	se	ADJ
cuesj-1226	81	25	:	:	PUNCT
cuesj-1226	81	26	stander	stander	NOUN
cuesj-1226	81	27	error	error	NOUN
cuesj-1226	81	28	table	table	NOUN
cuesj-1226	81	29	3	3	NUM
cuesj-1226	81	30	:	:	PUNCT
cuesj-1226	81	31	mean	mean	VERB
cuesj-1226	81	32	serum	serum	NOUN
cuesj-1226	81	33	levels	level	NOUN
cuesj-1226	81	34	of	of	ADP
cuesj-1226	81	35	vitamin	vitamin	NOUN
cuesj-1226	81	36	d3	d3	PROPN
cuesj-1226	81	37	among	among	ADP
cuesj-1226	81	38	covid-19	covid-19	PROPN
cuesj-1226	81	39	-	-	PUNCT
cuesj-1226	81	40	recovered	recover	VERB
cuesj-1226	81	41	patients	patient	NOUN
cuesj-1226	81	42	in	in	ADP
cuesj-1226	81	43	comparison	comparison	NOUN
cuesj-1226	81	44	to	to	ADP
cuesj-1226	81	45	the	the	DET
cuesj-1226	81	46	healthy	healthy	ADJ
cuesj-1226	81	47	control	control	PROPN
cuesj-1226	81	48	group	group	PROPN
cuesj-1226	81	49	parameter	parameter	NOUN
cuesj-1226	82	1	no	no	INTJ
cuesj-1226	82	2	.	.	PUNCT
cuesj-1226	83	1	covid-19	covid-19	NOUN
cuesj-1226	83	2	-	-	PUNCT
cuesj-1226	83	3	recovered	recover	VERB
cuesj-1226	83	4	patients	patient	NOUN
cuesj-1226	83	5	no	no	INTJ
cuesj-1226	83	6	.	.	PUNCT
cuesj-1226	84	1	healthy	healthy	ADJ
cuesj-1226	84	2	group	group	PROPN
cuesj-1226	84	3	t	t	PROPN
cuesj-1226	84	4	-	-	PUNCT
cuesj-1226	84	5	test	test	NOUN
cuesj-1226	84	6	p	p	NOUN
cuesj-1226	84	7	-	-	PUNCT
cuesj-1226	84	8	value	value	NOUN
cuesj-1226	84	9	p	p	NOUN
cuesj-1226	84	10	-	-	PUNCT
cuesj-1226	84	11	value	value	NOUN
cuesj-1226	84	12	mean±se	mean±se	NOUN
cuesj-1226	84	13	mean±se	mean±se	PROPN
cuesj-1226	84	14	vitamin	vitamin	PROPN
cuesj-1226	84	15	d3	d3	PROPN
cuesj-1226	84	16	(	(	PUNCT
cuesj-1226	84	17	ng	ng	PROPN
cuesj-1226	84	18	/	/	SYM
cuesj-1226	84	19	ml	ml	NOUN
cuesj-1226	84	20	)	)	PUNCT
cuesj-1226	84	21	98	98	NUM
cuesj-1226	84	22	17.99±1.34	17.99±1.34	NUM
cuesj-1226	84	23	20	20	NUM
cuesj-1226	84	24	38.62±1.47	38.62±1.47	NUM
cuesj-1226	84	25	0.01	0.01	NUM
cuesj-1226	84	26	h.s	h.s	PROPN
cuesj-1226	84	27	.	.	PUNCT
cuesj-1226	84	28	*	*	PUNCT
cuesj-1226	85	1	*	*	PUNCT
cuesj-1226	85	2	p	p	X
cuesj-1226	85	3	:	:	PUNCT
cuesj-1226	85	4	probability	probability	NOUN
cuesj-1226	85	5	;	;	PUNCT
cuesj-1226	85	6	p	p	NOUN
cuesj-1226	85	7	value≥0.05	value≥0.05	NOUN
cuesj-1226	85	8	:	:	PUNCT
cuesj-1226	86	1	non‑significant	non‑significant	ADJ
cuesj-1226	86	2	;	;	PUNCT
cuesj-1226	86	3	*	*	PUNCT
cuesj-1226	86	4	p	p	NOUN
cuesj-1226	86	5	value<0.05	value<0.05	NOUN
cuesj-1226	86	6	:	:	PUNCT
cuesj-1226	86	7	significant	significant	ADJ
cuesj-1226	86	8	;	;	PUNCT
cuesj-1226	86	9	*	*	PUNCT
cuesj-1226	86	10	*	*	PUNCT
cuesj-1226	86	11	p<0.01	p<0.01	ADJ
cuesj-1226	86	12	:	:	PUNCT
cuesj-1226	86	13	highly	highly	ADV
cuesj-1226	86	14	significant	significant	ADJ
cuesj-1226	86	15	,	,	PUNCT
cuesj-1226	86	16	se	se	ADJ
cuesj-1226	86	17	:	:	PUNCT
cuesj-1226	86	18	stander	stander	NOUN
cuesj-1226	86	19	error	error	NOUN
cuesj-1226	86	20	ubeid	ubeid	NOUN
cuesj-1226	86	21	,	,	PUNCT
cuesj-1226	86	22	et	et	PROPN
cuesj-1226	86	23	al	al	PROPN
cuesj-1226	86	24	.	.	PUNCT
cuesj-1226	86	25	:	:	PUNCT
cuesj-1226	87	1	vitamin	vitamin	NOUN
cuesj-1226	87	2	d	d	PROPN
cuesj-1226	87	3	levels	level	NOUN
cuesj-1226	87	4	in	in	ADP
cuesj-1226	87	5	coronavirus	coronavirus	NOUN
cuesj-1226	87	6	-	-	PUNCT
cuesj-1226	87	7	infected	infect	VERB
cuesj-1226	87	8	individuals	individual	NOUN
cuesj-1226	87	9	34	34	NUM
cuesj-1226	87	10	http://journals.cihanuniversity.edu.iq/index.php/cuesj	http://journals.cihanuniversity.edu.iq/index.php/cuesj	ADJ
cuesj-1226	87	11	cuesj	cuesj	NOUN
cuesj-1226	87	12	2024	2024	NUM
cuesj-1226	87	13	,	,	PUNCT
cuesj-1226	87	14	8	8	NUM
cuesj-1226	87	15	(	(	PUNCT
cuesj-1226	87	16	2	2	NUM
cuesj-1226	87	17	):	):	PUNCT
cuesj-1226	87	18	31	31	NUM
cuesj-1226	87	19	-	-	SYM
cuesj-1226	87	20	35	35	NUM
cuesj-1226	87	21	sars	sar	NOUN
cuesj-1226	87	22	-	-	PUNCT
cuesj-1226	87	23	cov2	cov2	PROPN
cuesj-1226	87	24	patients	patient	NOUN
cuesj-1226	87	25	using	use	VERB
cuesj-1226	87	26	vitamin	vitamin	NOUN
cuesj-1226	87	27	d	d	NOUN
cuesj-1226	87	28	as	as	ADP
cuesj-1226	87	29	an	an	DET
cuesj-1226	87	30	intervention	intervention	NOUN
cuesj-1226	87	31	.	.	PUNCT
cuesj-1226	88	1	the	the	DET
cuesj-1226	88	2	recommendation	recommendation	NOUN
cuesj-1226	88	3	is	be	AUX
cuesj-1226	88	4	mostly	mostly	ADV
cuesj-1226	88	5	predicated	predicate	VERB
cuesj-1226	88	6	on	on	ADP
cuesj-1226	88	7	how	how	SCONJ
cuesj-1226	88	8	vitamin	vitamin	NOUN
cuesj-1226	88	9	d	d	NOUN
cuesj-1226	88	10	level	level	NOUN
cuesj-1226	88	11	affects	affect	VERB
cuesj-1226	88	12	influenza	influenza	NOUN
cuesj-1226	88	13	infectious	infectious	ADJ
cuesj-1226	88	14	illness.[8	illness.[8	NOUN
cuesj-1226	88	15	-	-	SYM
cuesj-1226	88	16	11	11	NUM
cuesj-1226	88	17	]	]	PUNCT
cuesj-1226	88	18	other	other	ADJ
cuesj-1226	88	19	researchers	researcher	NOUN
cuesj-1226	88	20	affirmed	affirm	VERB
cuesj-1226	88	21	that	that	SCONJ
cuesj-1226	88	22	the	the	DET
cuesj-1226	88	23	immune	immune	ADJ
cuesj-1226	88	24	system	system	NOUN
cuesj-1226	88	25	is	be	AUX
cuesj-1226	88	26	the	the	DET
cuesj-1226	88	27	first	first	ADJ
cuesj-1226	88	28	defensive	defensive	ADJ
cuesj-1226	88	29	line	line	NOUN
cuesj-1226	88	30	in	in	ADP
cuesj-1226	88	31	our	our	PRON
cuesj-1226	88	32	bodies	body	NOUN
cuesj-1226	88	33	which	which	PRON
cuesj-1226	88	34	requires	require	VERB
cuesj-1226	88	35	vitamin	vitamin	NOUN
cuesj-1226	88	36	d	d	NOUN
cuesj-1226	88	37	to	to	PART
cuesj-1226	88	38	sustain	sustain	VERB
cuesj-1226	88	39	our	our	PRON
cuesj-1226	88	40	protection	protection	NOUN
cuesj-1226	88	41	against	against	ADP
cuesj-1226	88	42	infection	infection	NOUN
cuesj-1226	88	43	and	and	CCONJ
cuesj-1226	88	44	diseases	disease	NOUN
cuesj-1226	88	45	by	by	ADP
cuesj-1226	88	46	increasing	increase	VERB
cuesj-1226	88	47	immunological	immunological	ADJ
cuesj-1226	88	48	response	response	NOUN
cuesj-1226	88	49	.	.	PUNCT
cuesj-1226	89	1	it	it	PRON
cuesj-1226	89	2	retains	retain	VERB
cuesj-1226	89	3	anti	anti	ADJ
cuesj-1226	89	4	-	-	ADJ
cuesj-1226	89	5	inflammatory	inflammatory	ADJ
cuesj-1226	89	6	and	and	CCONJ
cuesj-1226	89	7	immunoregulatory	immunoregulatory	ADJ
cuesj-1226	89	8	effects	effect	NOUN
cuesj-1226	89	9	to	to	PART
cuesj-1226	89	10	trigger	trigger	VERB
cuesj-1226	89	11	the	the	DET
cuesj-1226	89	12	activation	activation	NOUN
cuesj-1226	89	13	to	to	PART
cuesj-1226	89	14	protect.[8,12,13	protect.[8,12,13	VERB
cuesj-1226	89	15	]	]	PUNCT
cuesj-1226	89	16	while	while	SCONJ
cuesj-1226	89	17	others	other	NOUN
cuesj-1226	89	18	mentioned	mention	VERB
cuesj-1226	89	19	,	,	PUNCT
cuesj-1226	89	20	vitamin	vitamin	NOUN
cuesj-1226	89	21	d	d	NOUN
cuesj-1226	89	22	has	have	AUX
cuesj-1226	89	23	improved	improve	VERB
cuesj-1226	89	24	immune	immune	ADJ
cuesj-1226	89	25	cell	cell	NOUN
cuesj-1226	89	26	activity	activity	NOUN
cuesj-1226	89	27	and	and	CCONJ
cuesj-1226	89	28	consequently	consequently	ADV
cuesj-1226	89	29	our	our	PRON
cuesj-1226	89	30	defensive	defensive	ADJ
cuesj-1226	89	31	system	system	NOUN
cuesj-1226	89	32	,	,	PUNCT
cuesj-1226	89	33	i.e.	i.e.	X
cuesj-1226	89	34	,	,	PUNCT
cuesj-1226	89	35	t	t	NOUN
cuesj-1226	89	36	-	-	PUNCT
cuesj-1226	89	37	cells	cell	NOUN
cuesj-1226	89	38	and	and	CCONJ
cuesj-1226	89	39	macrophages.[14	macrophages.[14	PROPN
cuesj-1226	89	40	-	-	SYM
cuesj-1226	89	41	17	17	NUM
cuesj-1226	89	42	]	]	PUNCT
cuesj-1226	89	43	hematological	hematological	ADJ
cuesj-1226	89	44	parameter	parameter	NOUN
cuesj-1226	89	45	results	result	NOUN
cuesj-1226	89	46	showed	show	VERB
cuesj-1226	89	47	that	that	SCONJ
cuesj-1226	89	48	the	the	DET
cuesj-1226	89	49	total	total	ADJ
cuesj-1226	89	50	wbc	wbc	ADJ
cuesj-1226	89	51	count	count	NOUN
cuesj-1226	89	52	among	among	ADP
cuesj-1226	89	53	covid-19	covid-19	PROPN
cuesj-1226	89	54	-	-	PUNCT
cuesj-1226	89	55	recovered	recover	VERB
cuesj-1226	89	56	patients	patient	NOUN
cuesj-1226	89	57	was	be	AUX
cuesj-1226	89	58	highly	highly	ADV
cuesj-1226	89	59	significantly	significantly	ADV
cuesj-1226	89	60	increased	increase	VERB
cuesj-1226	89	61	(	(	PUNCT
cuesj-1226	89	62	mean	mean	PROPN
cuesj-1226	89	63	±	±	NUM
cuesj-1226	89	64	se	se	X
cuesj-1226	89	65	6.77	6.77	NUM
cuesj-1226	89	66	±	±	NUM
cuesj-1226	89	67	0.16	0.16	NUM
cuesj-1226	89	68	)	)	PUNCT
cuesj-1226	89	69	(	(	PUNCT
cuesj-1226	89	70	p	p	X
cuesj-1226	89	71	<	<	X
cuesj-1226	89	72	0.01	0.01	NUM
cuesj-1226	89	73	)	)	PUNCT
cuesj-1226	89	74	.	.	PUNCT
cuesj-1226	90	1	furthermore	furthermore	ADV
cuesj-1226	90	2	,	,	PUNCT
cuesj-1226	90	3	the	the	DET
cuesj-1226	90	4	mean	mean	ADJ
cuesj-1226	90	5	level	level	NOUN
cuesj-1226	90	6	of	of	ADP
cuesj-1226	90	7	lymphocyte	lymphocyte	ADJ
cuesj-1226	90	8	counts	count	NOUN
cuesj-1226	90	9	reveals	reveal	VERB
cuesj-1226	90	10	a	a	DET
cuesj-1226	90	11	highly	highly	ADV
cuesj-1226	90	12	significant	significant	ADJ
cuesj-1226	90	13	decrease	decrease	NOUN
cuesj-1226	90	14	(	(	PUNCT
cuesj-1226	90	15	mean	mean	NOUN
cuesj-1226	90	16	±	±	NUM
cuesj-1226	90	17	se	se	X
cuesj-1226	90	18	2.04	2.04	NUM
cuesj-1226	90	19	±	±	NUM
cuesj-1226	90	20	0.06	0.06	NUM
cuesj-1226	90	21	)	)	PUNCT
cuesj-1226	90	22	when	when	SCONJ
cuesj-1226	90	23	compared	compare	VERB
cuesj-1226	90	24	to	to	ADP
cuesj-1226	90	25	the	the	DET
cuesj-1226	90	26	healthy	healthy	ADJ
cuesj-1226	90	27	group	group	NOUN
cuesj-1226	90	28	(	(	PUNCT
cuesj-1226	90	29	mean	mean	PROPN
cuesj-1226	90	30	±	±	NUM
cuesj-1226	90	31	se	se	X
cuesj-1226	90	32	2.85	2.85	NUM
cuesj-1226	90	33	±	±	NUM
cuesj-1226	90	34	0.13	0.13	NUM
cuesj-1226	90	35	)	)	PUNCT
cuesj-1226	90	36	(	(	PUNCT
cuesj-1226	90	37	p	p	X
cuesj-1226	90	38	<	<	X
cuesj-1226	90	39	0.01	0.01	NUM
cuesj-1226	90	40	)	)	PUNCT
cuesj-1226	90	41	.	.	PUNCT
cuesj-1226	91	1	while	while	SCONJ
cuesj-1226	91	2	these	these	DET
cuesj-1226	91	3	results	result	NOUN
cuesj-1226	91	4	showed	show	VERB
cuesj-1226	91	5	the	the	DET
cuesj-1226	91	6	mean	mean	ADJ
cuesj-1226	91	7	monocyte	monocyte	NOUN
cuesj-1226	91	8	count	count	NOUN
cuesj-1226	91	9	there	there	PRON
cuesj-1226	91	10	was	be	VERB
cuesj-1226	91	11	no	no	DET
cuesj-1226	91	12	significant	significant	ADJ
cuesj-1226	91	13	difference	difference	NOUN
cuesj-1226	91	14	between	between	ADP
cuesj-1226	91	15	those	those	PRON
cuesj-1226	91	16	recovering	recover	VERB
cuesj-1226	91	17	from	from	ADP
cuesj-1226	91	18	covid-19	covid-19	PROPN
cuesj-1226	91	19	patients	patient	NOUN
cuesj-1226	91	20	and	and	CCONJ
cuesj-1226	91	21	the	the	DET
cuesj-1226	91	22	healthy	healthy	ADJ
cuesj-1226	91	23	group	group	NOUN
cuesj-1226	91	24	(	(	PUNCT
cuesj-1226	91	25	p	p	X
cuesj-1226	91	26	≥	≥	NOUN
cuesj-1226	91	27	0.05	0.05	NUM
cuesj-1226	91	28	)	)	PUNCT
cuesj-1226	91	29	.	.	PUNCT
cuesj-1226	92	1	the	the	DET
cuesj-1226	92	2	mean	mean	ADJ
cuesj-1226	92	3	count	count	NOUN
cuesj-1226	92	4	of	of	ADP
cuesj-1226	92	5	total	total	ADJ
cuesj-1226	92	6	rbc	rbc	PROPN
cuesj-1226	92	7	counts	count	NOUN
cuesj-1226	92	8	in	in	ADP
cuesj-1226	92	9	covid-19	covid-19	PROPN
cuesj-1226	92	10	-	-	PUNCT
cuesj-1226	92	11	recovered	recover	VERB
cuesj-1226	92	12	patients	patient	NOUN
cuesj-1226	92	13	showed	show	VERB
cuesj-1226	92	14	a	a	DET
cuesj-1226	92	15	non	non	ADJ
cuesj-1226	92	16	-	-	ADJ
cuesj-1226	92	17	significant	significant	ADJ
cuesj-1226	92	18	rise	rise	NOUN
cuesj-1226	92	19	when	when	SCONJ
cuesj-1226	92	20	compared	compare	VERB
cuesj-1226	92	21	to	to	ADP
cuesj-1226	92	22	the	the	DET
cuesj-1226	92	23	healthy	healthy	ADJ
cuesj-1226	92	24	group	group	NOUN
cuesj-1226	92	25	(	(	PUNCT
cuesj-1226	92	26	p	p	X
cuesj-1226	92	27	≥	≥	NOUN
cuesj-1226	92	28	0.05	0.05	NUM
cuesj-1226	92	29	)	)	PUNCT
cuesj-1226	92	30	.	.	PUNCT
cuesj-1226	93	1	however	however	ADV
cuesj-1226	93	2	,	,	PUNCT
cuesj-1226	93	3	the	the	DET
cuesj-1226	93	4	mean	mean	ADJ
cuesj-1226	93	5	concentration	concentration	NOUN
cuesj-1226	93	6	of	of	ADP
cuesj-1226	93	7	hb	hb	PROPN
cuesj-1226	93	8	reveals	reveal	VERB
cuesj-1226	93	9	a	a	DET
cuesj-1226	93	10	highly	highly	ADV
cuesj-1226	93	11	significant	significant	ADJ
cuesj-1226	93	12	increase	increase	NOUN
cuesj-1226	93	13	(	(	PUNCT
cuesj-1226	93	14	mean	mean	NOUN
cuesj-1226	93	15	±	±	NUM
cuesj-1226	93	16	se	se	X
cuesj-1226	93	17	14.66	14.66	NUM
cuesj-1226	93	18	±	±	NUM
cuesj-1226	93	19	0.16	0.16	NUM
cuesj-1226	93	20	)	)	PUNCT
cuesj-1226	93	21	compared	compare	VERB
cuesj-1226	93	22	to	to	ADP
cuesj-1226	93	23	the	the	DET
cuesj-1226	93	24	healthy	healthy	ADJ
cuesj-1226	93	25	group	group	NOUN
cuesj-1226	93	26	(	(	PUNCT
cuesj-1226	93	27	p	p	X
cuesj-1226	93	28	<	<	X
cuesj-1226	93	29	0.01	0.01	NUM
cuesj-1226	93	30	)	)	PUNCT
cuesj-1226	93	31	.	.	PUNCT
cuesj-1226	94	1	finally	finally	ADV
cuesj-1226	94	2	,	,	PUNCT
cuesj-1226	94	3	the	the	DET
cuesj-1226	94	4	platelet	platelet	NOUN
cuesj-1226	94	5	mean	mean	NOUN
cuesj-1226	94	6	counts	count	NOUN
cuesj-1226	94	7	present	present	VERB
cuesj-1226	94	8	a	a	DET
cuesj-1226	94	9	significant	significant	ADJ
cuesj-1226	94	10	rise	rise	NOUN
cuesj-1226	94	11	when	when	SCONJ
cuesj-1226	94	12	compared	compare	VERB
cuesj-1226	94	13	to	to	ADP
cuesj-1226	94	14	the	the	DET
cuesj-1226	94	15	healthy	healthy	ADJ
cuesj-1226	94	16	group	group	NOUN
cuesj-1226	94	17	(	(	PUNCT
cuesj-1226	94	18	p	p	X
cuesj-1226	94	19	<	<	X
cuesj-1226	94	20	0.05	0.05	NUM
cuesj-1226	94	21	)	)	PUNCT
cuesj-1226	94	22	.	.	PUNCT
cuesj-1226	95	1	a	a	DET
cuesj-1226	95	2	study	study	NOUN
cuesj-1226	95	3	by	by	ADP
cuesj-1226	95	4	maghbooli	maghbooli	PROPN
cuesj-1226	95	5	et	et	PROPN
cuesj-1226	95	6	al.[8	al.[8	PROPN
cuesj-1226	95	7	]	]	PUNCT
cuesj-1226	95	8	recorded	record	VERB
cuesj-1226	95	9	severe	severe	ADJ
cuesj-1226	95	10	leukocytosis	leukocytosis	NOUN
cuesj-1226	95	11	(	(	PUNCT
cuesj-1226	95	12	29.2	29.2	NUM
cuesj-1226	95	13	%	%	NOUN
cuesj-1226	95	14	)	)	PUNCT
cuesj-1226	95	15	in	in	ADP
cuesj-1226	95	16	patients	patient	NOUN
cuesj-1226	95	17	,	,	PUNCT
cuesj-1226	95	18	with	with	ADP
cuesj-1226	95	19	only	only	ADV
cuesj-1226	95	20	one	one	NUM
cuesj-1226	95	21	patient	patient	NOUN
cuesj-1226	95	22	presenting	presenting	NOUN
cuesj-1226	95	23	with	with	ADP
cuesj-1226	95	24	severe	severe	ADJ
cuesj-1226	95	25	leukopenia	leukopenia	NOUN
cuesj-1226	95	26	(	(	PUNCT
cuesj-1226	95	27	wbc	wbc	INTJ
cuesj-1226	95	28	<	<	X
cuesj-1226	95	29	2	2	NUM
cuesj-1226	95	30	×	×	NOUN
cuesj-1226	95	31	109	109	NUM
cuesj-1226	95	32	/	/	SYM
cuesj-1226	95	33	l	l	NOUN
cuesj-1226	95	34	)	)	PUNCT
cuesj-1226	95	35	.	.	PUNCT
cuesj-1226	96	1	it	it	PRON
cuesj-1226	96	2	was	be	AUX
cuesj-1226	96	3	also	also	ADV
cuesj-1226	96	4	mentioned	mention	VERB
cuesj-1226	96	5	that	that	SCONJ
cuesj-1226	96	6	lymphopenia	lymphopenia	NOUN
cuesj-1226	96	7	was	be	AUX
cuesj-1226	96	8	featured	feature	VERB
cuesj-1226	96	9	in	in	ADP
cuesj-1226	96	10	36.9	36.9	NUM
cuesj-1226	96	11	%	%	NOUN
cuesj-1226	96	12	of	of	ADP
cuesj-1226	96	13	patients	patient	NOUN
cuesj-1226	96	14	(	(	PUNCT
cuesj-1226	96	15	absolute	absolute	ADJ
cuesj-1226	96	16	lymphocyte	lymphocyte	ADJ
cuesj-1226	96	17	count	count	NOUN
cuesj-1226	96	18	,	,	PUNCT
cuesj-1226	96	19	0.5	0.5	NUM
cuesj-1226	96	20	-	-	SYM
cuesj-1226	96	21	1	1	NUM
cuesj-1226	96	22	×	×	NOUN
cuesj-1226	96	23	109	109	NUM
cuesj-1226	96	24	/	/	SYM
cuesj-1226	96	25	l	l	NOUN
cuesj-1226	96	26	)	)	PUNCT
cuesj-1226	96	27	,	,	PUNCT
cuesj-1226	96	28	which	which	PRON
cuesj-1226	96	29	indicates	indicate	VERB
cuesj-1226	96	30	that	that	SCONJ
cuesj-1226	96	31	our	our	PRON
cuesj-1226	96	32	current	current	ADJ
cuesj-1226	96	33	results	result	NOUN
cuesj-1226	96	34	are	be	AUX
cuesj-1226	96	35	in	in	ADP
cuesj-1226	96	36	agreement	agreement	NOUN
cuesj-1226	96	37	with	with	ADP
cuesj-1226	96	38	maghbooli	maghbooli	NOUN
cuesj-1226	96	39	et	et	ADP
cuesj-1226	96	40	al.[8	al.[8	PROPN
cuesj-1226	96	41	]	]	PUNCT
cuesj-1226	96	42	alteration	alteration	NOUN
cuesj-1226	96	43	in	in	ADP
cuesj-1226	96	44	the	the	DET
cuesj-1226	96	45	immune	immune	ADJ
cuesj-1226	96	46	response	response	NOUN
cuesj-1226	96	47	was	be	AUX
cuesj-1226	96	48	clear	clear	ADJ
cuesj-1226	96	49	from	from	ADP
cuesj-1226	96	50	other	other	ADJ
cuesj-1226	96	51	studies	study	NOUN
cuesj-1226	96	52	concerning	concern	VERB
cuesj-1226	96	53	cytokines	cytokine	NOUN
cuesj-1226	96	54	in	in	ADP
cuesj-1226	96	55	covid-19	covid-19	PROPN
cuesj-1226	96	56	patients.[17	patients.[17	PROPN
cuesj-1226	96	57	-	-	PUNCT
cuesj-1226	96	58	19	19	NUM
cuesj-1226	96	59	]	]	PUNCT
cuesj-1226	96	60	conclusion	conclusion	NOUN
cuesj-1226	96	61	this	this	DET
cuesj-1226	96	62	study	study	NOUN
cuesj-1226	96	63	showed	show	VERB
cuesj-1226	96	64	that	that	SCONJ
cuesj-1226	96	65	most	most	ADJ
cuesj-1226	96	66	covid-19	covid-19	PROPN
cuesj-1226	96	67	-	-	PUNCT
cuesj-1226	96	68	recovered	recover	VERB
cuesj-1226	96	69	patients	patient	NOUN
cuesj-1226	96	70	were	be	AUX
cuesj-1226	96	71	men	man	NOUN
cuesj-1226	96	72	.	.	PUNCT
cuesj-1226	97	1	elisa	elisa	PROPN
cuesj-1226	97	2	detection	detection	NOUN
cuesj-1226	97	3	for	for	ADP
cuesj-1226	97	4	igm	igm	PROPN
cuesj-1226	97	5	revealed	reveal	VERB
cuesj-1226	97	6	that	that	SCONJ
cuesj-1226	97	7	all	all	DET
cuesj-1226	97	8	samples	sample	NOUN
cuesj-1226	97	9	were	be	AUX
cuesj-1226	97	10	negative	negative	ADJ
cuesj-1226	97	11	.	.	PUNCT
cuesj-1226	98	1	at	at	ADP
cuesj-1226	98	2	the	the	DET
cuesj-1226	98	3	same	same	ADJ
cuesj-1226	98	4	time	time	NOUN
cuesj-1226	98	5	,	,	PUNCT
cuesj-1226	98	6	for	for	ADP
cuesj-1226	98	7	igg	igg	PROPN
cuesj-1226	98	8	,	,	PUNCT
cuesj-1226	98	9	all	all	DET
cuesj-1226	98	10	samples	sample	NOUN
cuesj-1226	98	11	were	be	AUX
cuesj-1226	98	12	positive	positive	ADJ
cuesj-1226	98	13	.	.	PUNCT
cuesj-1226	99	1	vitamin	vitamin	NOUN
cuesj-1226	99	2	d	d	NOUN
cuesj-1226	99	3	among	among	ADP
cuesj-1226	99	4	recovered	recovered	ADJ
cuesj-1226	99	5	patients	patient	NOUN
cuesj-1226	99	6	with	with	ADP
cuesj-1226	99	7	covid-19	covid-19	PROPN
cuesj-1226	99	8	has	have	AUX
cuesj-1226	99	9	decreased	decrease	VERB
cuesj-1226	99	10	significantly	significantly	ADV
cuesj-1226	99	11	,	,	PUNCT
cuesj-1226	99	12	requiring	require	VERB
cuesj-1226	99	13	taking	take	VERB
cuesj-1226	99	14	vitamin	vitamin	NOUN
cuesj-1226	99	15	d	d	NOUN
cuesj-1226	99	16	supplementation	supplementation	NOUN
cuesj-1226	99	17	to	to	PART
cuesj-1226	99	18	avoid	avoid	VERB
cuesj-1226	99	19	immune	immune	ADJ
cuesj-1226	99	20	deficiency	deficiency	NOUN
cuesj-1226	99	21	.	.	PUNCT
cuesj-1226	100	1	all	all	DET
cuesj-1226	100	2	recovered	recover	VERB
cuesj-1226	100	3	patients	patient	NOUN
cuesj-1226	100	4	have	have	VERB
cuesj-1226	100	5	various	various	ADJ
cuesj-1226	100	6	hematological	hematological	ADJ
cuesj-1226	100	7	parameters	parameter	NOUN
cuesj-1226	100	8	that	that	PRON
cuesj-1226	100	9	revealed	reveal	VERB
cuesj-1226	100	10	a	a	DET
cuesj-1226	100	11	significant	significant	ADJ
cuesj-1226	100	12	increase	increase	NOUN
cuesj-1226	100	13	in	in	ADP
cuesj-1226	100	14	total	total	ADJ
cuesj-1226	100	15	wbc	wbc	PROPN
cuesj-1226	100	16	,	,	PUNCT
cuesj-1226	100	17	hb	hb	PROPN
cuesj-1226	100	18	,	,	PUNCT
cuesj-1226	100	19	and	and	CCONJ
cuesj-1226	100	20	platelets	platelet	NOUN
cuesj-1226	100	21	.	.	PUNCT
cuesj-1226	101	1	in	in	ADP
cuesj-1226	101	2	contrast	contrast	NOUN
cuesj-1226	101	3	,	,	PUNCT
cuesj-1226	101	4	the	the	DET
cuesj-1226	101	5	rbc	rbc	PROPN
cuesj-1226	101	6	count	count	NOUN
cuesj-1226	101	7	had	have	VERB
cuesj-1226	101	8	a	a	DET
cuesj-1226	101	9	non	non	ADJ
cuesj-1226	101	10	-	-	ADJ
cuesj-1226	101	11	significant	significant	ADJ
cuesj-1226	101	12	rise	rise	NOUN
cuesj-1226	101	13	in	in	ADP
cuesj-1226	101	14	comparison	comparison	NOUN
cuesj-1226	101	15	with	with	ADP
cuesj-1226	101	16	the	the	DET
cuesj-1226	101	17	healthy	healthy	ADJ
cuesj-1226	101	18	group	group	NOUN
cuesj-1226	101	19	.	.	PUNCT
cuesj-1226	102	1	the	the	DET
cuesj-1226	102	2	total	total	ADJ
cuesj-1226	102	3	means	mean	NOUN
cuesj-1226	102	4	of	of	ADP
cuesj-1226	102	5	serum	serum	NOUN
cuesj-1226	102	6	vitamin	vitamin	NOUN
cuesj-1226	102	7	d3	d3	PROPN
cuesj-1226	102	8	levels	level	NOUN
cuesj-1226	102	9	in	in	ADP
cuesj-1226	102	10	covid-19	covid-19	PROPN
cuesj-1226	102	11	-	-	PUNCT
cuesj-1226	102	12	recovered	recover	VERB
cuesj-1226	102	13	patients	patient	NOUN
cuesj-1226	102	14	were	be	AUX
cuesj-1226	102	15	highly	highly	ADV
cuesj-1226	102	16	significantly	significantly	ADV
cuesj-1226	102	17	declined	decline	VERB
cuesj-1226	102	18	when	when	SCONJ
cuesj-1226	102	19	compared	compare	VERB
cuesj-1226	102	20	to	to	ADP
cuesj-1226	102	21	the	the	DET
cuesj-1226	102	22	healthy	healthy	ADJ
cuesj-1226	102	23	group	group	NOUN
cuesj-1226	102	24	.	.	PUNCT
cuesj-1226	103	1	references	reference	NOUN
cuesj-1226	103	2	1	1	NUM
cuesj-1226	103	3	.	.	PUNCT
cuesj-1226	103	4	z.	z.	PROPN
cuesj-1226	103	5	song	song	PROPN
cuesj-1226	103	6	,	,	PUNCT
cuesj-1226	103	7	y.	y.	PROPN
cuesj-1226	103	8	xu	xu	PROPN
cuesj-1226	103	9	,	,	PUNCT
cuesj-1226	103	10	l.	l.	PROPN
cuesj-1226	103	11	bao	bao	PROPN
cuesj-1226	103	12	,	,	PUNCT
cuesj-1226	103	13	l.	l.	PROPN
cuesj-1226	103	14	zhang	zhang	PROPN
cuesj-1226	103	15	,	,	PUNCT
cuesj-1226	103	16	p.	p.	PROPN
cuesj-1226	103	17	yu	yu	PROPN
cuesj-1226	103	18	,	,	PUNCT
cuesj-1226	103	19	y.	y.	PROPN
cuesj-1226	103	20	qu	qu	PROPN
cuesj-1226	103	21	,	,	PUNCT
cuesj-1226	103	22	h.	h.	PROPN
cuesj-1226	103	23	zhu	zhu	PROPN
cuesj-1226	103	24	,	,	PUNCT
cuesj-1226	103	25	w.	w.	PROPN
cuesj-1226	103	26	zhao	zhao	PROPN
cuesj-1226	103	27	,	,	PUNCT
cuesj-1226	103	28	y.	y.	PROPN
cuesj-1226	103	29	han	han	PROPN
cuesj-1226	103	30	and	and	CCONJ
cuesj-1226	103	31	c.	c.	PROPN
cuesj-1226	103	32	qin	qin	PROPN
cuesj-1226	103	33	.	.	PROPN
cuesj-1226	104	1	from	from	ADP
cuesj-1226	104	2	sars	sars	PROPN
cuesj-1226	104	3	to	to	ADP
cuesj-1226	104	4	mers	mer	NOUN
cuesj-1226	104	5	,	,	PUNCT
cuesj-1226	104	6	thrusting	thrust	VERB
cuesj-1226	104	7	coronaviruses	coronaviruse	NOUN
cuesj-1226	104	8	into	into	ADP
cuesj-1226	104	9	the	the	DET
cuesj-1226	104	10	spotlight	spotlight	NOUN
cuesj-1226	104	11	.	.	PUNCT
cuesj-1226	105	1	viruses	virus	NOUN
cuesj-1226	105	2	,	,	PUNCT
cuesj-1226	105	3	vol	vol	NOUN
cuesj-1226	105	4	.	.	PROPN
cuesj-1226	105	5	11	11	NUM
cuesj-1226	105	6	,	,	PUNCT
cuesj-1226	105	7	no	no	INTJ
cuesj-1226	105	8	.	.	NOUN
cuesj-1226	105	9	1	1	NUM
cuesj-1226	105	10	,	,	PUNCT
cuesj-1226	105	11	p.	p.	NOUN
cuesj-1226	105	12	59	59	NUM
cuesj-1226	105	13	,	,	PUNCT
cuesj-1226	105	14	2019	2019	NUM
cuesj-1226	105	15	.	.	PUNCT
cuesj-1226	106	1	2	2	X
cuesj-1226	106	2	.	.	X
cuesj-1226	106	3	c.	c.	PROPN
cuesj-1226	106	4	drosten	drosten	PROPN
cuesj-1226	106	5	,	,	PUNCT
cuesj-1226	106	6	s.	s.	PROPN
cuesj-1226	106	7	günther	günther	PROPN
cuesj-1226	106	8	,	,	PUNCT
cuesj-1226	106	9	w.	w.	PROPN
cuesj-1226	106	10	preiser	preiser	PROPN
cuesj-1226	106	11	,	,	PUNCT
cuesj-1226	106	12	s.	s.	PROPN
cuesj-1226	106	13	van	van	PROPN
cuesj-1226	106	14	der	der	PROPN
cuesj-1226	106	15	werf	werf	PROPN
cuesj-1226	106	16	,	,	PUNCT
cuesj-1226	106	17	h.	h.	PROPN
cuesj-1226	106	18	r.	r.	PROPN
cuesj-1226	106	19	brodt	brodt	PROPN
cuesj-1226	106	20	,	,	PUNCT
cuesj-1226	106	21	s.	s.	PROPN
cuesj-1226	106	22	becker	becker	PROPN
cuesj-1226	106	23	,	,	PUNCT
cuesj-1226	106	24	h.	h.	PROPN
cuesj-1226	106	25	rabenau	rabenau	PROPN
cuesj-1226	106	26	,	,	PUNCT
cuesj-1226	106	27	m.	m.	NOUN
cuesj-1226	106	28	panning	panning	NOUN
cuesj-1226	106	29	,	,	PUNCT
cuesj-1226	106	30	l.	l.	PROPN
cuesj-1226	106	31	kolesnikova	kolesnikova	PROPN
cuesj-1226	106	32	,	,	PUNCT
cuesj-1226	106	33	r.	r.	PROPN
cuesj-1226	106	34	a.	a.	NOUN
cuesj-1226	106	35	fouchier	fouchier	PROPN
cuesj-1226	106	36	,	,	PUNCT
cuesj-1226	106	37	a.	a.	NOUN
cuesj-1226	106	38	berger	berger	PROPN
cuesj-1226	106	39	,	,	PUNCT
cuesj-1226	106	40	a.	a.	PROPN
cuesj-1226	106	41	m.	m.	PROPN
cuesj-1226	106	42	burguière	burguière	PROPN
cuesj-1226	106	43	,	,	PUNCT
cuesj-1226	106	44	j.	j.	PROPN
cuesj-1226	106	45	cinatl	cinatl	PROPN
cuesj-1226	106	46	,	,	PUNCT
cuesj-1226	106	47	m.	m.	NOUN
cuesj-1226	106	48	eickmann	eickmann	NOUN
cuesj-1226	106	49	,	,	PUNCT
cuesj-1226	106	50	n.	n.	PROPN
cuesj-1226	106	51	escriou	escriou	PROPN
cuesj-1226	106	52	,	,	PUNCT
cuesj-1226	106	53	k.	k.	PROPN
cuesj-1226	106	54	grywna	grywna	PROPN
cuesj-1226	106	55	,	,	PUNCT
cuesj-1226	106	56	s.	s.	PROPN
cuesj-1226	106	57	kramme	kramme	PROPN
cuesj-1226	106	58	,	,	PUNCT
cuesj-1226	106	59	j.	j.	PROPN
cuesj-1226	106	60	c.	c.	PROPN
cuesj-1226	106	61	manuguerra	manuguerra	PROPN
cuesj-1226	106	62	,	,	PUNCT
cuesj-1226	106	63	s.	s.	PROPN
cuesj-1226	106	64	müller	müller	PROPN
cuesj-1226	106	65	,	,	PUNCT
cuesj-1226	106	66	…	…	PUNCT
cuesj-1226	106	67	and	and	CCONJ
cuesj-1226	106	68	v.	v.	ADP
cuesj-1226	106	69	rickerts	rickert	NOUN
cuesj-1226	106	70	.	.	PUNCT
cuesj-1226	107	1	identification	identification	NOUN
cuesj-1226	107	2	of	of	ADP
cuesj-1226	107	3	a	a	DET
cuesj-1226	107	4	novel	novel	ADJ
cuesj-1226	107	5	coronavirus	coronavirus	NOUN
cuesj-1226	107	6	in	in	ADP
cuesj-1226	107	7	patients	patient	NOUN
cuesj-1226	107	8	with	with	ADP
cuesj-1226	107	9	severe	severe	ADJ
cuesj-1226	107	10	acute	acute	ADJ
cuesj-1226	107	11	respiratory	respiratory	ADJ
cuesj-1226	107	12	syndrome	syndrome	NOUN
cuesj-1226	107	13	.	.	PUNCT
cuesj-1226	108	1	new	new	PROPN
cuesj-1226	108	2	england	england	PROPN
cuesj-1226	108	3	journal	journal	PROPN
cuesj-1226	108	4	of	of	ADP
cuesj-1226	108	5	medicine	medicine	NOUN
cuesj-1226	108	6	,	,	PUNCT
cuesj-1226	108	7	vol	vol	NOUN
cuesj-1226	108	8	.	.	PROPN
cuesj-1226	109	1	348	348	NUM
cuesj-1226	109	2	,	,	PUNCT
cuesj-1226	109	3	no	no	INTJ
cuesj-1226	109	4	.	.	NOUN
cuesj-1226	109	5	20	20	NUM
cuesj-1226	109	6	,	,	PUNCT
cuesj-1226	109	7	pp	pp	ADJ
cuesj-1226	109	8	.	.	PUNCT
cuesj-1226	110	1	1967	1967	NUM
cuesj-1226	110	2	-	-	SYM
cuesj-1226	110	3	1976	1976	NUM
cuesj-1226	110	4	,	,	PUNCT
cuesj-1226	110	5	2003	2003	NUM
cuesj-1226	110	6	.	.	PUNCT
cuesj-1226	111	1	3	3	X
cuesj-1226	111	2	.	.	X
cuesj-1226	111	3	s.	s.	PROPN
cuesj-1226	111	4	felsenstein	felsenstein	PROPN
cuesj-1226	111	5	,	,	PUNCT
cuesj-1226	111	6	j.	j.	PROPN
cuesj-1226	111	7	a.	a.	PROPN
cuesj-1226	111	8	herbert	herbert	PROPN
cuesj-1226	111	9	,	,	PUNCT
cuesj-1226	111	10	p.	p.	PROPN
cuesj-1226	111	11	s.	s.	PROPN
cuesj-1226	111	12	mcnamara	mcnamara	PROPN
cuesj-1226	111	13	and	and	CCONJ
cuesj-1226	111	14	c.	c.	PROPN
cuesj-1226	111	15	m.	m.	PROPN
cuesj-1226	111	16	hedrich	hedrich	PROPN
cuesj-1226	111	17	.	.	PUNCT
cuesj-1226	112	1	covid-19	covid-19	PROPN
cuesj-1226	112	2	:	:	PUNCT
cuesj-1226	112	3	immunology	immunology	NOUN
cuesj-1226	112	4	and	and	CCONJ
cuesj-1226	112	5	treatment	treatment	NOUN
cuesj-1226	112	6	options	option	NOUN
cuesj-1226	112	7	.	.	PUNCT
cuesj-1226	113	1	clinical	clinical	ADJ
cuesj-1226	113	2	immunology	immunology	NOUN
cuesj-1226	113	3	,	,	PUNCT
cuesj-1226	113	4	vol	vol	NOUN
cuesj-1226	113	5	.	.	PROPN
cuesj-1226	113	6	215	215	NUM
cuesj-1226	113	7	,	,	PUNCT
cuesj-1226	113	8	p.	p.	NOUN
cuesj-1226	113	9	108448	108448	NUM
cuesj-1226	113	10	,	,	PUNCT
cuesj-1226	113	11	2020	2020	NUM
cuesj-1226	113	12	.	.	PUNCT
cuesj-1226	114	1	4	4	X
cuesj-1226	114	2	.	.	X
cuesj-1226	114	3	a.	a.	NOUN
cuesj-1226	114	4	m.	m.	PROPN
cuesj-1226	114	5	rasheed	rasheed	PROPN
cuesj-1226	114	6	,	,	PUNCT
cuesj-1226	114	7	d.	d.	PROPN
cuesj-1226	114	8	f.	f.	PROPN
cuesj-1226	114	9	fatak	fatak	PROPN
cuesj-1226	114	10	,	,	PUNCT
cuesj-1226	114	11	h.	h.	PROPN
cuesj-1226	114	12	a.	a.	PROPN
cuesj-1226	114	13	hashim	hashim	PROPN
cuesj-1226	114	14	,	,	PUNCT
cuesj-1226	114	15	m.	m.	PROPN
cuesj-1226	114	16	f.	f.	PROPN
cuesj-1226	114	17	maulood	maulood	PROPN
cuesj-1226	114	18	,	,	PUNCT
cuesj-1226	114	19	k.	k.	PROPN
cuesj-1226	114	20	k.	k.	PROPN
cuesj-1226	114	21	kabah	kabah	PROPN
cuesj-1226	114	22	,	,	PUNCT
cuesj-1226	114	23	y.	y.	PROPN
cuesj-1226	114	24	a.	a.	PROPN
cuesj-1226	114	25	almusawi	almusawi	PROPN
cuesj-1226	114	26	and	and	CCONJ
cuesj-1226	114	27	a.	a.	PROPN
cuesj-1226	114	28	s.	s.	PROPN
cuesj-1226	114	29	abdulamir	abdulamir	PROPN
cuesj-1226	114	30	.	.	PUNCT
cuesj-1226	115	1	the	the	DET
cuesj-1226	115	2	therapeutic	therapeutic	ADJ
cuesj-1226	115	3	effectiveness	effectiveness	NOUN
cuesj-1226	115	4	of	of	ADP
cuesj-1226	115	5	convalescent	convalescent	NOUN
cuesj-1226	115	6	plasma	plasma	NOUN
cuesj-1226	115	7	therapy	therapy	NOUN
cuesj-1226	115	8	on	on	ADP
cuesj-1226	115	9	treating	treat	VERB
cuesj-1226	115	10	covid-19	covid-19	PROPN
cuesj-1226	115	11	patients	patient	NOUN
cuesj-1226	115	12	residing	reside	VERB
cuesj-1226	115	13	in	in	ADP
cuesj-1226	115	14	respiratory	respiratory	ADJ
cuesj-1226	115	15	care	care	NOUN
cuesj-1226	115	16	units	unit	NOUN
cuesj-1226	115	17	in	in	ADP
cuesj-1226	115	18	baghdad	baghdad	PROPN
cuesj-1226	115	19	,	,	PUNCT
cuesj-1226	115	20	iraq	iraq	PROPN
cuesj-1226	115	21	.	.	PUNCT
cuesj-1226	116	1	le	le	PROPN
cuesj-1226	116	2	infezioni	infezioni	PROPN
cuesj-1226	116	3	in	in	ADP
cuesj-1226	116	4	medicina	medicina	PROPN
cuesj-1226	116	5	,	,	PUNCT
cuesj-1226	116	6	vol	vol	NOUN
cuesj-1226	116	7	.	.	PROPN
cuesj-1226	116	8	28	28	NUM
cuesj-1226	116	9	,	,	PUNCT
cuesj-1226	116	10	pp	pp	PROPN
cuesj-1226	116	11	.	.	PUNCT
cuesj-1226	117	1	357	357	NUM
cuesj-1226	117	2	-	-	SYM
cuesj-1226	117	3	366	366	NUM
cuesj-1226	117	4	,	,	PUNCT
cuesj-1226	117	5	2020	2020	NUM
cuesj-1226	117	6	.	.	PUNCT
cuesj-1226	118	1	5	5	X
cuesj-1226	118	2	.	.	PUNCT
cuesj-1226	118	3	o.	o.	PROPN
cuesj-1226	118	4	s.	s.	PROPN
cuesj-1226	118	5	habib	habib	PROPN
cuesj-1226	118	6	,	,	PUNCT
cuesj-1226	118	7	a.	a.	PROPN
cuesj-1226	118	8	k.	k.	PROPN
cuesj-1226	118	9	alkanan	alkanan	PROPN
cuesj-1226	118	10	and	and	CCONJ
cuesj-1226	118	11	n.	n.	PROPN
cuesj-1226	118	12	q.	q.	PROPN
cuesj-1226	118	13	mohammed	mohammed	PROPN
cuesj-1226	118	14	.	.	PUNCT
cuesj-1226	119	1	epidemiological	epidemiological	ADJ
cuesj-1226	119	2	features	feature	NOUN
cuesj-1226	119	3	of	of	ADP
cuesj-1226	119	4	covid-19	covid-19	PROPN
cuesj-1226	119	5	epidemic	epidemic	NOUN
cuesj-1226	119	6	in	in	ADP
cuesj-1226	119	7	basrah	basrah	PROPN
cuesj-1226	119	8	-	-	PUNCT
cuesj-1226	119	9	southern	southern	ADJ
cuesj-1226	119	10	iraq	iraq	PROPN
cuesj-1226	119	11	-	-	PUNCT
cuesj-1226	119	12	first	first	ADJ
cuesj-1226	119	13	report	report	NOUN
cuesj-1226	119	14	.	.	PUNCT
cuesj-1226	120	1	the	the	DET
cuesj-1226	120	2	medical	medical	ADJ
cuesj-1226	120	3	journal	journal	PROPN
cuesj-1226	120	4	of	of	ADP
cuesj-1226	120	5	basrah	basrah	PROPN
cuesj-1226	120	6	university	university	PROPN
cuesj-1226	120	7	,	,	PUNCT
cuesj-1226	120	8	vol	vol	NOUN
cuesj-1226	120	9	.	.	PROPN
cuesj-1226	120	10	38	38	NUM
cuesj-1226	120	11	,	,	PUNCT
cuesj-1226	120	12	no	no	INTJ
cuesj-1226	120	13	.	.	NOUN
cuesj-1226	120	14	1	1	NUM
cuesj-1226	120	15	,	,	PUNCT
cuesj-1226	120	16	pp	pp	ADJ
cuesj-1226	120	17	.	.	PUNCT
cuesj-1226	121	1	7	7	NUM
cuesj-1226	121	2	-	-	SYM
cuesj-1226	121	3	18	18	NUM
cuesj-1226	121	4	,	,	PUNCT
cuesj-1226	121	5	2020	2020	NUM
cuesj-1226	121	6	.	.	PUNCT
cuesj-1226	122	1	6	6	X
cuesj-1226	122	2	.	.	X
cuesj-1226	122	3	m.	m.	NOUN
cuesj-1226	122	4	a.	a.	PROPN
cuesj-1226	122	5	ibrahim	ibrahim	PROPN
cuesj-1226	122	6	and	and	CCONJ
cuesj-1226	122	7	a.	a.	PROPN
cuesj-1226	122	8	al	al	PROPN
cuesj-1226	122	9	-	-	PUNCT
cuesj-1226	122	10	najafi	najafi	PROPN
cuesj-1226	122	11	.	.	PUNCT
cuesj-1226	123	1	modeling	modeling	NOUN
cuesj-1226	123	2	,	,	PUNCT
cuesj-1226	123	3	control	control	NOUN
cuesj-1226	123	4	,	,	PUNCT
cuesj-1226	123	5	and	and	CCONJ
cuesj-1226	123	6	prediction	prediction	NOUN
cuesj-1226	123	7	of	of	ADP
cuesj-1226	123	8	the	the	DET
cuesj-1226	123	9	spread	spread	NOUN
cuesj-1226	123	10	of	of	ADP
cuesj-1226	123	11	covid-19	covid-19	PROPN
cuesj-1226	123	12	using	use	VERB
cuesj-1226	123	13	compartmental	compartmental	NOUN
cuesj-1226	123	14	,	,	PUNCT
cuesj-1226	123	15	logistic	logistic	ADJ
cuesj-1226	123	16	,	,	PUNCT
cuesj-1226	123	17	and	and	CCONJ
cuesj-1226	123	18	gauss	gauss	ADJ
cuesj-1226	123	19	models	model	NOUN
cuesj-1226	123	20	:	:	PUNCT
cuesj-1226	123	21	a	a	DET
cuesj-1226	123	22	case	case	NOUN
cuesj-1226	123	23	study	study	NOUN
cuesj-1226	123	24	in	in	ADP
cuesj-1226	123	25	iraq	iraq	PROPN
cuesj-1226	123	26	and	and	CCONJ
cuesj-1226	123	27	egypt	egypt	PROPN
cuesj-1226	123	28	.	.	PUNCT
cuesj-1226	124	1	processes	process	NOUN
cuesj-1226	124	2	,	,	PUNCT
cuesj-1226	124	3	vol	vol	NOUN
cuesj-1226	124	4	.	.	PROPN
cuesj-1226	124	5	8	8	NUM
cuesj-1226	124	6	,	,	PUNCT
cuesj-1226	124	7	no	no	INTJ
cuesj-1226	124	8	.	.	NOUN
cuesj-1226	124	9	11	11	NUM
cuesj-1226	124	10	,	,	PUNCT
cuesj-1226	124	11	p.	p.	NOUN
cuesj-1226	124	12	1400	1400	NUM
cuesj-1226	124	13	,	,	PUNCT
cuesj-1226	124	14	2020	2020	NUM
cuesj-1226	124	15	.	.	PUNCT
cuesj-1226	125	1	7	7	X
cuesj-1226	125	2	.	.	X
cuesj-1226	125	3	n.	n.	PROPN
cuesj-1226	125	4	ali	ali	PROPN
cuesj-1226	125	5	.	.	PUNCT
cuesj-1226	126	1	role	role	NOUN
cuesj-1226	126	2	of	of	ADP
cuesj-1226	126	3	vitamin	vitamin	NOUN
cuesj-1226	126	4	d	d	NOUN
cuesj-1226	126	5	in	in	ADP
cuesj-1226	126	6	preventing	preventing	NOUN
cuesj-1226	126	7	of	of	ADP
cuesj-1226	126	8	covid-19	covid-19	PROPN
cuesj-1226	126	9	infection	infection	NOUN
cuesj-1226	126	10	,	,	PUNCT
cuesj-1226	126	11	progression	progression	NOUN
cuesj-1226	126	12	and	and	CCONJ
cuesj-1226	126	13	severity	severity	NOUN
cuesj-1226	126	14	.	.	PUNCT
cuesj-1226	127	1	journal	journal	NOUN
cuesj-1226	127	2	of	of	ADP
cuesj-1226	127	3	infection	infection	NOUN
cuesj-1226	127	4	and	and	CCONJ
cuesj-1226	127	5	public	public	ADJ
cuesj-1226	127	6	health	health	NOUN
cuesj-1226	127	7	,	,	PUNCT
cuesj-1226	127	8	vol	vol	NOUN
cuesj-1226	127	9	.	.	PROPN
cuesj-1226	127	10	13	13	NUM
cuesj-1226	127	11	,	,	PUNCT
cuesj-1226	127	12	no	no	INTJ
cuesj-1226	127	13	.	.	NOUN
cuesj-1226	127	14	10	10	NUM
cuesj-1226	127	15	,	,	PUNCT
cuesj-1226	127	16	pp	pp	ADJ
cuesj-1226	127	17	.	.	PUNCT
cuesj-1226	128	1	1373	1373	NUM
cuesj-1226	128	2	-	-	SYM
cuesj-1226	128	3	1380	1380	NUM
cuesj-1226	128	4	,	,	PUNCT
cuesj-1226	128	5	2020	2020	NUM
cuesj-1226	128	6	.	.	PUNCT
cuesj-1226	129	1	8	8	NUM
cuesj-1226	129	2	.	.	PUNCT
cuesj-1226	129	3	z.	z.	PROPN
cuesj-1226	129	4	maghbooli	maghbooli	PROPN
cuesj-1226	129	5	,	,	PUNCT
cuesj-1226	129	6	m.	m.	NOUN
cuesj-1226	129	7	a.	a.	NOUN
cuesj-1226	129	8	sahraian	sahraian	PROPN
cuesj-1226	129	9	,	,	PUNCT
cuesj-1226	129	10	m.	m.	PROPN
cuesj-1226	129	11	ebrahimi	ebrahimi	PROPN
cuesj-1226	129	12	,	,	PUNCT
cuesj-1226	129	13	m.	m.	NOUN
cuesj-1226	129	14	pazoki	pazoki	NOUN
cuesj-1226	129	15	,	,	PUNCT
cuesj-1226	129	16	s.	s.	PROPN
cuesj-1226	129	17	kafan	kafan	PROPN
cuesj-1226	129	18	,	,	PUNCT
cuesj-1226	129	19	h.	h.	PROPN
cuesj-1226	129	20	m.	m.	PROPN
cuesj-1226	129	21	tabriz	tabriz	PROPN
cuesj-1226	129	22	,	,	PUNCT
cuesj-1226	129	23	a.	a.	NOUN
cuesj-1226	129	24	hadadi	hadadi	PROPN
cuesj-1226	129	25	,	,	PUNCT
cuesj-1226	129	26	m.	m.	NOUN
cuesj-1226	129	27	montazeri	montazeri	PROPN
cuesj-1226	129	28	,	,	PUNCT
cuesj-1226	129	29	m.	m.	NOUN
cuesj-1226	129	30	nasiri	nasiri	ADV
cuesj-1226	129	31	,	,	PUNCT
cuesj-1226	129	32	a.	a.	PROPN
cuesj-1226	129	33	shirvani	shirvani	PROPN
cuesj-1226	129	34	and	and	CCONJ
cuesj-1226	129	35	m.	m.	PROPN
cuesj-1226	129	36	f.	f.	PROPN
cuesj-1226	129	37	holick	holick	PROPN
cuesj-1226	129	38	.	.	PUNCT
cuesj-1226	130	1	vitamin	vitamin	NOUN
cuesj-1226	130	2	d	d	X
cuesj-1226	130	3	sufficiency	sufficiency	NOUN
cuesj-1226	130	4	,	,	PUNCT
cuesj-1226	130	5	a	a	DET
cuesj-1226	130	6	serum	serum	NOUN
cuesj-1226	130	7	25	25	NUM
cuesj-1226	130	8	-	-	PUNCT
cuesj-1226	130	9	hydroxyvitamin	hydroxyvitamin	NOUN
cuesj-1226	130	10	d	d	NOUN
cuesj-1226	130	11	at	at	ADV
cuesj-1226	130	12	least	least	ADV
cuesj-1226	130	13	30	30	NUM
cuesj-1226	130	14	ng	ng	NOUN
cuesj-1226	130	15	/	/	SYM
cuesj-1226	130	16	ml	ml	ADV
cuesj-1226	130	17	reduced	reduce	VERB
cuesj-1226	130	18	risk	risk	NOUN
cuesj-1226	130	19	for	for	ADP
cuesj-1226	130	20	adverse	adverse	ADJ
cuesj-1226	130	21	clinical	clinical	ADJ
cuesj-1226	130	22	outcomes	outcome	NOUN
cuesj-1226	130	23	in	in	ADP
cuesj-1226	130	24	patients	patient	NOUN
cuesj-1226	130	25	with	with	ADP
cuesj-1226	130	26	covid-19	covid-19	PROPN
cuesj-1226	130	27	infection	infection	NOUN
cuesj-1226	130	28	.	.	PUNCT
cuesj-1226	131	1	plos	plos	PROPN
cuesj-1226	131	2	one	one	NUM
cuesj-1226	131	3	,	,	PUNCT
cuesj-1226	131	4	vol	vol	NOUN
cuesj-1226	131	5	.	.	PROPN
cuesj-1226	131	6	15	15	NUM
cuesj-1226	131	7	,	,	PUNCT
cuesj-1226	131	8	no	no	INTJ
cuesj-1226	131	9	.	.	NOUN
cuesj-1226	131	10	9	9	NUM
cuesj-1226	131	11	,	,	PUNCT
cuesj-1226	131	12	p.	p.	NOUN
cuesj-1226	131	13	e0239799	e0239799	PROPN
cuesj-1226	131	14	,	,	PUNCT
cuesj-1226	131	15	2020	2020	NUM
cuesj-1226	131	16	.	.	PUNCT
cuesj-1226	132	1	9	9	NUM
cuesj-1226	132	2	.	.	PUNCT
cuesj-1226	132	3	a.	a.	PROPN
cuesj-1226	132	4	mittal	mittal	PROPN
cuesj-1226	132	5	,	,	PUNCT
cuesj-1226	132	6	k.	k.	PROPN
cuesj-1226	132	7	manjunath	manjunath	PROPN
cuesj-1226	132	8	,	,	PUNCT
cuesj-1226	132	9	r.	r.	PROPN
cuesj-1226	132	10	k.	k.	PROPN
cuesj-1226	132	11	ranjan	ranjan	PROPN
cuesj-1226	132	12	,	,	PUNCT
cuesj-1226	132	13	s.	s.	PROPN
cuesj-1226	132	14	kaushik	kaushik	PROPN
cuesj-1226	132	15	,	,	PUNCT
cuesj-1226	132	16	s.	s.	PROPN
cuesj-1226	132	17	kumar	kumar	PROPN
cuesj-1226	132	18	and	and	CCONJ
cuesj-1226	132	19	v.	v.	PROPN
cuesj-1226	132	20	verma	verma	PROPN
cuesj-1226	132	21	.	.	PUNCT
cuesj-1226	133	1	covid-19	covid-19	PROPN
cuesj-1226	133	2	pandemic	pandemic	NOUN
cuesj-1226	133	3	:	:	PUNCT
cuesj-1226	133	4	insights	insight	NOUN
cuesj-1226	133	5	into	into	ADP
cuesj-1226	133	6	structure	structure	NOUN
cuesj-1226	133	7	,	,	PUNCT
cuesj-1226	133	8	function	function	NOUN
cuesj-1226	133	9	,	,	PUNCT
cuesj-1226	133	10	and	and	CCONJ
cuesj-1226	133	11	hace2	hace2	NOUN
cuesj-1226	133	12	receptor	receptor	NOUN
cuesj-1226	133	13	recognition	recognition	NOUN
cuesj-1226	133	14	by	by	ADP
cuesj-1226	133	15	sars	sar	NOUN
cuesj-1226	133	16	-	-	PUNCT
cuesj-1226	133	17	cov-2	cov-2	NOUN
cuesj-1226	133	18	.	.	PUNCT
cuesj-1226	134	1	plos	plos	PROPN
cuesj-1226	134	2	pathogens	pathogens	PROPN
cuesj-1226	134	3	,	,	PUNCT
cuesj-1226	134	4	vol	vol	NOUN
cuesj-1226	134	5	.	.	PROPN
cuesj-1226	134	6	16	16	NUM
cuesj-1226	134	7	,	,	PUNCT
cuesj-1226	134	8	no	no	INTJ
cuesj-1226	134	9	.	.	NOUN
cuesj-1226	134	10	8	8	NUM
cuesj-1226	134	11	,	,	PUNCT
cuesj-1226	134	12	p.	p.	NOUN
cuesj-1226	134	13	e1008762	e1008762	PROPN
cuesj-1226	134	14	,	,	PUNCT
cuesj-1226	134	15	2020	2020	NUM
cuesj-1226	134	16	.	.	PUNCT
cuesj-1226	135	1	10	10	NUM
cuesj-1226	135	2	.	.	PUNCT
cuesj-1226	135	3	n.	n.	NOUN
cuesj-1226	135	4	vankadari	vankadari	PROPN
cuesj-1226	136	1	and	and	CCONJ
cuesj-1226	136	2	j.	j.	PROPN
cuesj-1226	136	3	a.	a.	PROPN
cuesj-1226	136	4	wilce	wilce	PROPN
cuesj-1226	136	5	.	.	PUNCT
cuesj-1226	137	1	emerging	emerge	VERB
cuesj-1226	137	2	covid-19	covid-19	PROPN
cuesj-1226	137	3	coronavirus	coronavirus	NOUN
cuesj-1226	137	4	:	:	PUNCT
cuesj-1226	137	5	glycan	glycan	NOUN
cuesj-1226	137	6	shield	shield	VERB
cuesj-1226	137	7	and	and	CCONJ
cuesj-1226	137	8	structure	structure	NOUN
cuesj-1226	137	9	prediction	prediction	NOUN
cuesj-1226	137	10	of	of	ADP
cuesj-1226	137	11	spike	spike	ADJ
cuesj-1226	137	12	glycoprotein	glycoprotein	NOUN
cuesj-1226	137	13	and	and	CCONJ
cuesj-1226	137	14	its	its	PRON
cuesj-1226	137	15	interaction	interaction	NOUN
cuesj-1226	137	16	with	with	ADP
cuesj-1226	137	17	human	human	ADJ
cuesj-1226	137	18	cd26	cd26	PROPN
cuesj-1226	137	19	.	.	PUNCT
cuesj-1226	138	1	emerging	emerge	VERB
cuesj-1226	138	2	microbes	microbe	NOUN
cuesj-1226	138	3	and	and	CCONJ
cuesj-1226	138	4	infections	infection	NOUN
cuesj-1226	138	5	,	,	PUNCT
cuesj-1226	138	6	vol	vol	NOUN
cuesj-1226	138	7	.	.	PROPN
cuesj-1226	138	8	9	9	NUM
cuesj-1226	138	9	,	,	PUNCT
cuesj-1226	138	10	no	no	INTJ
cuesj-1226	138	11	.	.	NOUN
cuesj-1226	138	12	1	1	NUM
cuesj-1226	138	13	,	,	PUNCT
cuesj-1226	138	14	pp	pp	ADJ
cuesj-1226	138	15	.	.	PUNCT
cuesj-1226	139	1	601	601	NUM
cuesj-1226	139	2	-	-	SYM
cuesj-1226	139	3	604	604	NUM
cuesj-1226	139	4	,	,	PUNCT
cuesj-1226	139	5	2020	2020	NUM
cuesj-1226	139	6	.	.	PUNCT
cuesj-1226	140	1	11	11	NUM
cuesj-1226	140	2	.	.	PUNCT
cuesj-1226	141	1	g.	g.	PROPN
cuesj-1226	141	2	feketea	feketea	PROPN
cuesj-1226	141	3	,	,	PUNCT
cuesj-1226	141	4	v.	v.	ADP
cuesj-1226	141	5	vlacha	vlacha	PROPN
cuesj-1226	141	6	,	,	PUNCT
cuesj-1226	141	7	i.	i.	PROPN
cuesj-1226	141	8	c.	c.	PROPN
cuesj-1226	141	9	bocsan	bocsan	PROPN
cuesj-1226	141	10	,	,	PUNCT
cuesj-1226	141	11	e.	e.	PROPN
cuesj-1226	141	12	vassilopoulou	vassilopoulou	PROPN
cuesj-1226	141	13	,	,	PUNCT
cuesj-1226	141	14	l.	l.	PROPN
cuesj-1226	141	15	a.	a.	PROPN
cuesj-1226	141	16	stanciu	stanciu	PROPN
cuesj-1226	141	17	and	and	CCONJ
cuesj-1226	141	18	m.	m.	PROPN
cuesj-1226	141	19	zdrenghea	zdrenghea	PROPN
cuesj-1226	141	20	.	.	PUNCT
cuesj-1226	142	1	vitamin	vitamin	NOUN
cuesj-1226	142	2	d	d	PROPN
cuesj-1226	142	3	in	in	ADP
cuesj-1226	142	4	corona	corona	NOUN
cuesj-1226	142	5	virus	virus	NOUN
cuesj-1226	142	6	disease	disease	NOUN
cuesj-1226	142	7	2019	2019	NUM
cuesj-1226	142	8	(	(	PUNCT
cuesj-1226	142	9	covid-19	covid-19	PROPN
cuesj-1226	142	10	)	)	PUNCT
cuesj-1226	142	11	related	relate	VERB
cuesj-1226	142	12	multisystem	multisystem	NOUN
cuesj-1226	142	13	inflammatory	inflammatory	ADJ
cuesj-1226	142	14	syndrome	syndrome	NOUN
cuesj-1226	142	15	in	in	ADP
cuesj-1226	142	16	children	child	NOUN
cuesj-1226	142	17	(	(	PUNCT
cuesj-1226	142	18	mis	mis	X
cuesj-1226	142	19	-	-	PUNCT
cuesj-1226	142	20	c	c	NOUN
cuesj-1226	142	21	)	)	PUNCT
cuesj-1226	142	22	.	.	PUNCT
cuesj-1226	143	1	frontiers	frontier	NOUN
cuesj-1226	143	2	in	in	ADP
cuesj-1226	143	3	immunology	immunology	NOUN
cuesj-1226	143	4	,	,	PUNCT
cuesj-1226	143	5	vol	vol	NOUN
cuesj-1226	143	6	.	.	PROPN
cuesj-1226	143	7	12	12	NUM
cuesj-1226	143	8	,	,	PUNCT
cuesj-1226	143	9	p.	p.	NOUN
cuesj-1226	143	10	648546	648546	NUM
cuesj-1226	143	11	,	,	PUNCT
cuesj-1226	143	12	2021	2021	NUM
cuesj-1226	143	13	.	.	PUNCT
cuesj-1226	144	1	12	12	NUM
cuesj-1226	144	2	.	.	PUNCT
cuesj-1226	144	3	w.	w.	PROPN
cuesj-1226	144	4	b.	b.	PROPN
cuesj-1226	144	5	grant	grant	PROPN
cuesj-1226	144	6	,	,	PUNCT
cuesj-1226	144	7	h.	h.	PROPN
cuesj-1226	144	8	lahore	lahore	PROPN
cuesj-1226	144	9	,	,	PUNCT
cuesj-1226	144	10	s.	s.	PROPN
cuesj-1226	144	11	l.	l.	PROPN
cuesj-1226	144	12	mcdonnell	mcdonnell	PROPN
cuesj-1226	144	13	,	,	PUNCT
cuesj-1226	144	14	c.	c.	PROPN
cuesj-1226	144	15	a.	a.	PROPN
cuesj-1226	145	1	baggerly	baggerly	ADV
cuesj-1226	145	2	,	,	PUNCT
cuesj-1226	145	3	c.	c.	PROPN
cuesj-1226	145	4	b.	b.	PROPN
cuesj-1226	145	5	french	french	PROPN
cuesj-1226	145	6	,	,	PUNCT
cuesj-1226	145	7	j.	j.	PROPN
cuesj-1226	145	8	l.	l.	PROPN
cuesj-1226	145	9	aliano	aliano	PROPN
cuesj-1226	145	10	and	and	CCONJ
cuesj-1226	145	11	h.	h.	PROPN
cuesj-1226	145	12	p.	p.	PROPN
cuesj-1226	145	13	bhattoa	bhattoa	PROPN
cuesj-1226	145	14	.	.	PUNCT
cuesj-1226	146	1	evidence	evidence	NOUN
cuesj-1226	146	2	that	that	SCONJ
cuesj-1226	146	3	vitamin	vitamin	NOUN
cuesj-1226	146	4	d	d	NOUN
cuesj-1226	146	5	supplementation	supplementation	NOUN
cuesj-1226	146	6	could	could	AUX
cuesj-1226	146	7	reduce	reduce	VERB
cuesj-1226	146	8	risk	risk	NOUN
cuesj-1226	146	9	of	of	ADP
cuesj-1226	146	10	influenza	influenza	NOUN
cuesj-1226	146	11	and	and	CCONJ
cuesj-1226	146	12	covid-19	covid-19	PROPN
cuesj-1226	146	13	infections	infection	NOUN
cuesj-1226	146	14	and	and	CCONJ
cuesj-1226	146	15	deaths	death	NOUN
cuesj-1226	146	16	.	.	PUNCT
cuesj-1226	147	1	nutrients	nutrient	NOUN
cuesj-1226	147	2	,	,	PUNCT
cuesj-1226	147	3	vol	vol	NOUN
cuesj-1226	147	4	.	.	PROPN
cuesj-1226	147	5	12	12	NUM
cuesj-1226	147	6	,	,	PUNCT
cuesj-1226	147	7	no	no	INTJ
cuesj-1226	147	8	.	.	NOUN
cuesj-1226	147	9	4	4	NUM
cuesj-1226	147	10	,	,	PUNCT
cuesj-1226	147	11	p.	p.	NOUN
cuesj-1226	147	12	988	988	NUM
cuesj-1226	147	13	,	,	PUNCT
cuesj-1226	147	14	2020	2020	NUM
cuesj-1226	147	15	.	.	PUNCT
cuesj-1226	148	1	13	13	NUM
cuesj-1226	148	2	.	.	PUNCT
cuesj-1226	148	3	t.	t.	PROPN
cuesj-1226	148	4	s.	s.	PROPN
cuesj-1226	148	5	salih	salih	PROPN
cuesj-1226	148	6	,	,	PUNCT
cuesj-1226	148	7	a.	a.	PROPN
cuesj-1226	148	8	s.	s.	PROPN
cuesj-1226	148	9	m.	m.	PROPN
cuesj-1226	148	10	juma	juma	PROPN
cuesj-1226	148	11	and	and	CCONJ
cuesj-1226	148	12	m.	m.	PROPN
cuesj-1226	148	13	h.	h.	PROPN
cuesj-1226	148	14	ubeid	ubeid	PROPN
cuesj-1226	148	15	.	.	PUNCT
cuesj-1226	149	1	occupational	occupational	ADJ
cuesj-1226	149	2	exposures	exposure	NOUN
cuesj-1226	149	3	and	and	CCONJ
cuesj-1226	149	4	associated	associated	ADJ
cuesj-1226	149	5	health	health	NOUN
cuesj-1226	149	6	effects	effect	NOUN
cuesj-1226	149	7	among	among	ADP
cuesj-1226	149	8	dumpsite	dumpsite	ADJ
cuesj-1226	149	9	workers	worker	NOUN
cuesj-1226	149	10	.	.	PUNCT
cuesj-1226	150	1	cihan	cihan	VERB
cuesj-1226	150	2	university	university	NOUN
cuesj-1226	150	3	-	-	PUNCT
cuesj-1226	150	4	erbil	erbil	PROPN
cuesj-1226	150	5	scientific	scientific	ADJ
cuesj-1226	150	6	journal	journal	NOUN
cuesj-1226	150	7	,	,	PUNCT
cuesj-1226	150	8	vol	vol	NOUN
cuesj-1226	150	9	.	.	PROPN
cuesj-1226	150	10	5	5	NUM
cuesj-1226	150	11	,	,	PUNCT
cuesj-1226	150	12	no	no	INTJ
cuesj-1226	150	13	.	.	NOUN
cuesj-1226	150	14	2	2	NUM
cuesj-1226	150	15	,	,	PUNCT
cuesj-1226	150	16	pp	pp	ADJ
cuesj-1226	150	17	.	.	PUNCT
cuesj-1226	151	1	1	1	NUM
cuesj-1226	151	2	-	-	SYM
cuesj-1226	151	3	5	5	NUM
cuesj-1226	151	4	,	,	PUNCT
cuesj-1226	151	5	2021	2021	NUM
cuesj-1226	151	6	.	.	PUNCT
cuesj-1226	152	1	14	14	NUM
cuesj-1226	152	2	.	.	PUNCT
cuesj-1226	153	1	j.	j.	PROPN
cuesj-1226	153	2	cannell	cannell	PROPN
cuesj-1226	153	3	,	,	PUNCT
cuesj-1226	153	4	r.	r.	PROPN
cuesj-1226	153	5	vieth	vieth	PROPN
cuesj-1226	153	6	,	,	PUNCT
cuesj-1226	153	7	j.	j.	PROPN
cuesj-1226	153	8	c.	c.	PROPN
cuesj-1226	153	9	umhau	umhau	PROPN
cuesj-1226	153	10	,	,	PUNCT
cuesj-1226	153	11	m.	m.	PROPN
cuesj-1226	153	12	f.	f.	PROPN
cuesj-1226	153	13	holick	holick	PROPN
cuesj-1226	153	14	,	,	PUNCT
cuesj-1226	153	15	w.	w.	PROPN
cuesj-1226	153	16	b.	b.	PROPN
cuesj-1226	153	17	grant	grant	PROPN
cuesj-1226	153	18	,	,	PUNCT
cuesj-1226	153	19	s.	s.	PROPN
cuesj-1226	153	20	madronich	madronich	PROPN
cuesj-1226	153	21	,	,	PUNCT
cuesj-1226	153	22	c.	c.	PROPN
cuesj-1226	153	23	f.	f.	PROPN
cuesj-1226	153	24	garland	garland	PROPN
cuesj-1226	153	25	and	and	CCONJ
cuesj-1226	153	26	e.	e.	PROPN
cuesj-1226	153	27	giovannucci	giovannucci	PROPN
cuesj-1226	153	28	.	.	PUNCT
cuesj-1226	154	1	epidemic	epidemic	NOUN
cuesj-1226	154	2	influenza	influenza	NOUN
cuesj-1226	154	3	and	and	CCONJ
cuesj-1226	154	4	vitamin	vitamin	NOUN
cuesj-1226	154	5	d.	d.	PROPN
cuesj-1226	154	6	epidemiology	epidemiology	NOUN
cuesj-1226	154	7	and	and	CCONJ
cuesj-1226	154	8	infection	infection	NOUN
cuesj-1226	154	9	,	,	PUNCT
cuesj-1226	154	10	vol	vol	NOUN
cuesj-1226	154	11	.	.	PROPN
cuesj-1226	154	12	134	134	NUM
cuesj-1226	154	13	,	,	PUNCT
cuesj-1226	154	14	no	no	INTJ
cuesj-1226	154	15	.	.	NOUN
cuesj-1226	154	16	6	6	NUM
cuesj-1226	154	17	,	,	PUNCT
cuesj-1226	154	18	pp	pp	ADJ
cuesj-1226	154	19	.	.	PUNCT
cuesj-1226	155	1	1129	1129	NUM
cuesj-1226	155	2	-	-	SYM
cuesj-1226	155	3	1140	1140	NUM
cuesj-1226	155	4	,	,	PUNCT
cuesj-1226	155	5	2006	2006	NUM
cuesj-1226	155	6	.	.	PUNCT
cuesj-1226	156	1	15	15	NUM
cuesj-1226	156	2	.	.	PUNCT
cuesj-1226	156	3	a.	a.	NOUN
cuesj-1226	156	4	a.	a.	PROPN
cuesj-1226	156	5	ginde	ginde	PROPN
cuesj-1226	156	6	,	,	PUNCT
cuesj-1226	156	7	j.	j.	PROPN
cuesj-1226	156	8	m.	m.	PROPN
cuesj-1226	156	9	mansbach	mansbach	PROPN
cuesj-1226	156	10	and	and	CCONJ
cuesj-1226	156	11	c.	c.	PROPN
cuesj-1226	156	12	a.	a.	PROPN
cuesj-1226	156	13	camargo	camargo	PROPN
cuesj-1226	156	14	jr	jr	PROPN
cuesj-1226	156	15	.	.	PROPN
cuesj-1226	156	16	association	association	PROPN
cuesj-1226	156	17	between	between	ADP
cuesj-1226	156	18	serum	serum	NOUN
cuesj-1226	156	19	25	25	NUM
cuesj-1226	156	20	-	-	PUNCT
cuesj-1226	156	21	hydroxyvitamin	hydroxyvitamin	NOUN
cuesj-1226	156	22	d	d	NOUN
cuesj-1226	156	23	level	level	NOUN
cuesj-1226	156	24	and	and	CCONJ
cuesj-1226	156	25	upper	upper	ADJ
cuesj-1226	156	26	respiratory	respiratory	ADJ
cuesj-1226	156	27	tract	tract	NOUN
cuesj-1226	156	28	infection	infection	NOUN
cuesj-1226	156	29	in	in	ADP
cuesj-1226	156	30	the	the	DET
cuesj-1226	156	31	third	third	ADJ
cuesj-1226	156	32	national	national	PROPN
cuesj-1226	156	33	health	health	NOUN
cuesj-1226	156	34	and	and	CCONJ
cuesj-1226	156	35	nutrition	nutrition	NOUN
cuesj-1226	156	36	examination	examination	NOUN
cuesj-1226	156	37	survey	survey	NOUN
cuesj-1226	156	38	.	.	PUNCT
cuesj-1226	157	1	archives	archive	NOUN
cuesj-1226	157	2	of	of	ADP
cuesj-1226	157	3	internal	internal	ADJ
cuesj-1226	157	4	medicine	medicine	NOUN
cuesj-1226	157	5	,	,	PUNCT
cuesj-1226	157	6	vol	vol	NOUN
cuesj-1226	157	7	.	.	PROPN
cuesj-1226	157	8	169	169	NUM
cuesj-1226	157	9	,	,	PUNCT
cuesj-1226	157	10	no	no	INTJ
cuesj-1226	157	11	.	.	NOUN
cuesj-1226	157	12	4	4	NUM
cuesj-1226	157	13	,	,	PUNCT
cuesj-1226	157	14	pp.384	pp.384	PROPN
cuesj-1226	157	15	-	-	SYM
cuesj-1226	157	16	390	390	NUM
cuesj-1226	157	17	,	,	PUNCT
cuesj-1226	157	18	2009	2009	NUM
cuesj-1226	157	19	.	.	PUNCT
cuesj-1226	158	1	16	16	NUM
cuesj-1226	158	2	.	.	PUNCT
cuesj-1226	159	1	c.	c.	PROPN
cuesj-1226	159	2	l.	l.	PROPN
cuesj-1226	159	3	greiller	greiller	PROPN
cuesj-1226	159	4	and	and	CCONJ
cuesj-1226	159	5	a.	a.	PROPN
cuesj-1226	159	6	r.	r.	PROPN
cuesj-1226	159	7	martineau	martineau	PROPN
cuesj-1226	159	8	.	.	PUNCT
cuesj-1226	160	1	modulation	modulation	NOUN
cuesj-1226	160	2	of	of	ADP
cuesj-1226	160	3	the	the	DET
cuesj-1226	160	4	immune	immune	ADJ
cuesj-1226	160	5	response	response	NOUN
cuesj-1226	160	6	to	to	ADP
cuesj-1226	160	7	respiratory	respiratory	ADJ
cuesj-1226	160	8	viruses	virus	NOUN
cuesj-1226	160	9	by	by	ADP
cuesj-1226	160	10	vitamin	vitamin	NOUN
cuesj-1226	160	11	d.	d.	PROPN
cuesj-1226	160	12	nutrients	nutrients	PROPN
cuesj-1226	160	13	,	,	PUNCT
cuesj-1226	160	14	vol	vol	NOUN
cuesj-1226	160	15	.	.	PROPN
cuesj-1226	160	16	7	7	NUM
cuesj-1226	160	17	,	,	PUNCT
cuesj-1226	160	18	no	no	INTJ
cuesj-1226	160	19	.	.	NOUN
cuesj-1226	160	20	6	6	NUM
cuesj-1226	160	21	,	,	PUNCT
cuesj-1226	160	22	pp	pp	ADJ
cuesj-1226	160	23	.	.	PUNCT
cuesj-1226	160	24	4240	4240	NUM
cuesj-1226	160	25	-	-	SYM
cuesj-1226	160	26	4270	4270	NUM
cuesj-1226	160	27	,	,	PUNCT
cuesj-1226	160	28	2015	2015	NUM
cuesj-1226	160	29	.	.	PUNCT
cuesj-1226	161	1	17	17	NUM
cuesj-1226	161	2	.	.	PUNCT
cuesj-1226	161	3	r.	r.	PROPN
cuesj-1226	161	4	bouillon	bouillon	PROPN
cuesj-1226	161	5	,	,	PUNCT
cuesj-1226	161	6	c.	c.	PROPN
cuesj-1226	161	7	marcocci	marcocci	PROPN
cuesj-1226	161	8	,	,	PUNCT
cuesj-1226	161	9	g.	g.	PROPN
cuesj-1226	161	10	carmeliet	carmeliet	PROPN
cuesj-1226	161	11	,	,	PUNCT
cuesj-1226	161	12	d.	d.	PROPN
cuesj-1226	161	13	bikle	bikle	PROPN
cuesj-1226	161	14	,	,	PUNCT
cuesj-1226	161	15	j.	j.	PROPN
cuesj-1226	161	16	h.	h.	PROPN
cuesj-1226	161	17	white	white	PROPN
cuesj-1226	161	18	,	,	PUNCT
cuesj-1226	161	19	b.	b.	PROPN
cuesj-1226	161	20	dawson	dawson	PROPN
cuesj-1226	161	21	-	-	PUNCT
cuesj-1226	161	22	hughes	hughes	PROPN
cuesj-1226	161	23	,	,	PUNCT
cuesj-1226	161	24	p.	p.	NOUN
cuesj-1226	161	25	lips	lip	NOUN
cuesj-1226	161	26	,	,	PUNCT
cuesj-1226	161	27	c.	c.	PROPN
cuesj-1226	161	28	f.	f.	PROPN
cuesj-1226	161	29	munns	munns	PROPN
cuesj-1226	161	30	,	,	PUNCT
cuesj-1226	161	31	m.	m.	NOUN
cuesj-1226	161	32	lazaretti	lazaretti	NOUN
cuesj-1226	161	33	-	-	PUNCT
cuesj-1226	161	34	castro	castro	PROPN
cuesj-1226	161	35	,	,	PUNCT
cuesj-1226	161	36	a.	a.	NOUN
cuesj-1226	161	37	giustina	giustina	PROPN
cuesj-1226	161	38	and	and	CCONJ
cuesj-1226	161	39	j.	j.	PROPN
cuesj-1226	161	40	bilezikian	bilezikian	PROPN
cuesj-1226	161	41	.	.	PUNCT
cuesj-1226	162	1	skeletal	skeletal	ADJ
cuesj-1226	162	2	and	and	CCONJ
cuesj-1226	162	3	extraskeletal	extraskeletal	ADJ
cuesj-1226	162	4	actions	action	NOUN
cuesj-1226	162	5	of	of	ADP
cuesj-1226	162	6	vitamin	vitamin	NOUN
cuesj-1226	162	7	d	d	NOUN
cuesj-1226	162	8	:	:	PUNCT
cuesj-1226	162	9	current	current	ADJ
cuesj-1226	162	10	evidence	evidence	NOUN
cuesj-1226	162	11	and	and	CCONJ
cuesj-1226	162	12	outstanding	outstanding	ADJ
cuesj-1226	162	13	questions	question	NOUN
cuesj-1226	162	14	.	.	PUNCT
cuesj-1226	163	1	endocrine	endocrine	ADJ
cuesj-1226	163	2	reviews	review	NOUN
cuesj-1226	163	3	,	,	PUNCT
cuesj-1226	163	4	vol	vol	NOUN
cuesj-1226	163	5	.	.	PROPN
cuesj-1226	163	6	40	40	NUM
cuesj-1226	163	7	,	,	PUNCT
cuesj-1226	163	8	no	no	INTJ
cuesj-1226	163	9	.	.	NOUN
cuesj-1226	163	10	4	4	NUM
cuesj-1226	163	11	,	,	PUNCT
cuesj-1226	163	12	pp	pp	ADJ
cuesj-1226	163	13	.	.	PUNCT
cuesj-1226	164	1	1109	1109	NUM
cuesj-1226	164	2	-	-	SYM
cuesj-1226	164	3	1151	1151	NUM
cuesj-1226	164	4	,	,	PUNCT
cuesj-1226	164	5	2019	2019	NUM
cuesj-1226	164	6	.	.	PUNCT
cuesj-1226	165	1	18	18	NUM
cuesj-1226	165	2	.	.	PUNCT
cuesj-1226	165	3	m.	m.	NOUN
cuesj-1226	165	4	h.	h.	PROPN
cuesj-1226	165	5	ubeid	ubeid	PROPN
cuesj-1226	165	6	.	.	PUNCT
cuesj-1226	166	1	interlukin-6	interlukin-6	NUM
cuesj-1226	166	2	levels	level	NOUN
cuesj-1226	166	3	in	in	ADP
cuesj-1226	166	4	relation	relation	NOUN
cuesj-1226	166	5	to	to	ADP
cuesj-1226	166	6	covid-19	covid-19	PROPN
cuesj-1226	166	7	vaccine	vaccine	NOUN
cuesj-1226	166	8	.	.	PUNCT
cuesj-1226	167	1	ubeid	ubeid	PROPN
cuesj-1226	167	2	,	,	PUNCT
cuesj-1226	167	3	et	et	PROPN
cuesj-1226	167	4	al	al	PROPN
cuesj-1226	167	5	.	.	PUNCT
cuesj-1226	167	6	:	:	PUNCT
cuesj-1226	168	1	vitamin	vitamin	NOUN
cuesj-1226	168	2	d	d	PROPN
cuesj-1226	168	3	levels	level	NOUN
cuesj-1226	168	4	in	in	ADP
cuesj-1226	168	5	coronavirus	coronavirus	NOUN
cuesj-1226	168	6	-	-	PUNCT
cuesj-1226	168	7	infected	infect	VERB
cuesj-1226	168	8	individuals	individual	NOUN
cuesj-1226	168	9	35	35	NUM
cuesj-1226	168	10	http://journals.cihanuniversity.edu.iq/index.php/cuesj	http://journals.cihanuniversity.edu.iq/index.php/cuesj	ADJ
cuesj-1226	168	11	cuesj	cuesj	NOUN
cuesj-1226	168	12	2024	2024	NUM
cuesj-1226	168	13	,	,	PUNCT
cuesj-1226	168	14	8	8	NUM
cuesj-1226	168	15	(	(	PUNCT
cuesj-1226	168	16	2	2	NUM
cuesj-1226	168	17	):	):	PUNCT
cuesj-1226	168	18	31	31	NUM
cuesj-1226	168	19	-	-	SYM
cuesj-1226	168	20	35	35	NUM
cuesj-1226	168	21	in	in	ADP
cuesj-1226	168	22	:	:	PUNCT
cuesj-1226	168	23	4th	4th	ADJ
cuesj-1226	168	24	international	international	ADJ
cuesj-1226	168	25	conference	conference	NOUN
cuesj-1226	168	26	on	on	ADP
cuesj-1226	168	27	biological	biological	ADJ
cuesj-1226	168	28	and	and	CCONJ
cuesj-1226	168	29	health	health	NOUN
cuesj-1226	168	30	sciences	science	NOUN
cuesj-1226	168	31	(	(	PUNCT
cuesj-1226	168	32	cic	cic	NOUN
cuesj-1226	168	33	-	-	PUNCT
cuesj-1226	168	34	biohs’2022	biohs’2022	NOUN
cuesj-1226	168	35	)	)	PUNCT
cuesj-1226	168	36	.	.	PUNCT
cuesj-1226	169	1	cihan	cihan	VERB
cuesj-1226	169	2	university	university	NOUN
cuesj-1226	169	3	-	-	PUNCT
cuesj-1226	169	4	erbil	erbil	PROPN
cuesj-1226	169	5	,	,	PUNCT
cuesj-1226	169	6	iraq	iraq	PROPN
cuesj-1226	169	7	,	,	PUNCT
cuesj-1226	169	8	2022	2022	NUM
cuesj-1226	169	9	.	.	PUNCT
cuesj-1226	170	1	19	19	NUM
cuesj-1226	170	2	.	.	PUNCT
cuesj-1226	170	3	m.	m.	NOUN
cuesj-1226	170	4	h.	h.	PROPN
cuesj-1226	170	5	ubeid	ubeid	PROPN
cuesj-1226	170	6	,	,	PUNCT
cuesj-1226	170	7	t.	t.	PROPN
cuesj-1226	170	8	s.	s.	PROPN
cuesj-1226	170	9	salih	salih	PROPN
cuesj-1226	170	10	and	and	CCONJ
cuesj-1226	170	11	a.	a.	PROPN
cuesj-1226	170	12	s.	s.	PROPN
cuesj-1226	170	13	m.	m.	PROPN
cuesj-1226	170	14	juma	juma	PROPN
cuesj-1226	170	15	.	.	PUNCT
cuesj-1226	171	1	hiv	hiv	PROPN
cuesj-1226	171	2	,	,	PUNCT
cuesj-1226	171	3	hbs	hbs	PROPN
cuesj-1226	171	4	and	and	CCONJ
cuesj-1226	171	5	hcv	hcv	NOUN
cuesj-1226	171	6	in	in	ADP
cuesj-1226	171	7	dump	dump	NOUN
cuesj-1226	171	8	site	site	NOUN
cuesj-1226	171	9	workers	worker	NOUN
cuesj-1226	171	10	of	of	ADP
cuesj-1226	171	11	erbil	erbil	PROPN
cuesj-1226	171	12	governorate	governorate	PROPN
cuesj-1226	171	13	.	.	PUNCT
cuesj-1226	172	1	cihan	cihan	VERB
cuesj-1226	172	2	university	university	NOUN
cuesj-1226	172	3	-	-	PUNCT
cuesj-1226	172	4	erbil	erbil	PROPN
cuesj-1226	172	5	scientific	scientific	ADJ
cuesj-1226	172	6	journal	journal	NOUN
cuesj-1226	172	7	,	,	PUNCT
cuesj-1226	172	8	vol	vol	NOUN
cuesj-1226	172	9	.	.	PROPN
cuesj-1226	172	10	5	5	NUM
cuesj-1226	172	11	,	,	PUNCT
cuesj-1226	172	12	no	no	INTJ
cuesj-1226	172	13	.	.	NOUN
cuesj-1226	172	14	2	2	NUM
cuesj-1226	172	15	,	,	PUNCT
cuesj-1226	172	16	pp	pp	ADJ
cuesj-1226	172	17	.	.	PUNCT
cuesj-1226	173	1	20	20	NUM
cuesj-1226	173	2	-	-	SYM
cuesj-1226	173	3	23	23	NUM
cuesj-1226	173	4	,	,	PUNCT
cuesj-1226	173	5	2021	2021	NUM
cuesj-1226	173	6	.	.	PUNCT
cuesj-1226	174	1	20	20	NUM
cuesj-1226	174	2	.	.	PUNCT
cuesj-1226	175	1	t.	t.	PROPN
cuesj-1226	175	2	hai	hai	PROPN
cuesj-1226	175	3	,	,	PUNCT
cuesj-1226	175	4	f.	f.	PROPN
cuesj-1226	175	5	a.	a.	PROPN
cuesj-1226	175	6	alenizi	alenizi	PROPN
cuesj-1226	175	7	,	,	PUNCT
cuesj-1226	175	8	m.	m.	NOUN
cuesj-1226	175	9	h.	h.	PROPN
cuesj-1226	175	10	ubeid	ubeid	PROPN
cuesj-1226	175	11	,	,	PUNCT
cuesj-1226	175	12	v.	v.	ADP
cuesj-1226	175	13	goyal	goyal	PROPN
cuesj-1226	175	14	,	,	PUNCT
cuesj-1226	175	15	f.	f.	PROPN
cuesj-1226	175	16	m.	m.	PROPN
cuesj-1226	175	17	alhomayani	alhomayani	PROPN
cuesj-1226	175	18	and	and	CCONJ
cuesj-1226	175	19	a.	a.	PROPN
cuesj-1226	175	20	s.	s.	PROPN
cuesj-1226	175	21	m.	m.	PROPN
cuesj-1226	175	22	metwally	metwally	ADV
cuesj-1226	175	23	.	.	PUNCT
cuesj-1226	176	1	using	use	VERB
cuesj-1226	176	2	machine	machine	NOUN
cuesj-1226	176	3	learning	learning	NOUN
cuesj-1226	176	4	for	for	ADP
cuesj-1226	176	5	comparative	comparative	ADJ
cuesj-1226	176	6	optimizing	optimize	VERB
cuesj-1226	176	7	a	a	DET
cuesj-1226	176	8	novel	novel	ADJ
cuesj-1226	176	9	integration	integration	NOUN
cuesj-1226	176	10	of	of	ADP
cuesj-1226	176	11	molten	molten	ADJ
cuesj-1226	176	12	carbonate	carbonate	NOUN
cuesj-1226	176	13	and	and	CCONJ
cuesj-1226	176	14	solid	solid	ADJ
cuesj-1226	176	15	oxide	oxide	NOUN
cuesj-1226	176	16	fuel	fuel	NOUN
cuesj-1226	176	17	cells	cell	NOUN
cuesj-1226	176	18	with	with	ADP
cuesj-1226	176	19	co2	co2	NOUN
cuesj-1226	176	20	recovering	recovering	NOUN
cuesj-1226	176	21	and	and	CCONJ
cuesj-1226	176	22	gasification	gasification	NOUN
cuesj-1226	176	23	.	.	PUNCT
cuesj-1226	177	1	international	international	ADJ
cuesj-1226	177	2	journal	journal	PROPN
cuesj-1226	177	3	of	of	ADP
cuesj-1226	177	4	hydrogen	hydrogen	NOUN
cuesj-1226	177	5	energy	energy	NOUN
cuesj-1226	177	6	,	,	PUNCT
cuesj-1226	177	7	vol	vol	NOUN
cuesj-1226	177	8	.	.	PROPN
cuesj-1226	177	9	48	48	NUM
cuesj-1226	177	10	,	,	PUNCT
cuesj-1226	177	11	no	no	INTJ
cuesj-1226	177	12	.	.	NOUN
cuesj-1226	177	13	97	97	NUM
cuesj-1226	177	14	,	,	PUNCT
cuesj-1226	177	15	pp	pp	ADJ
cuesj-1226	177	16	.	.	PUNCT
cuesj-1226	178	1	38454	38454	NUM
cuesj-1226	178	2	-	-	SYM
cuesj-1226	178	3	3847	3847	NUM
cuesj-1226	178	4	,	,	PUNCT
cuesj-1226	178	5	2023	2023	NUM
cuesj-1226	178	6	.	.	PUNCT